var title_f16_39_17008="Stenosis after bypass";
var content_f16_39_17008=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F74282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F74282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Stomal stenosis after gastric bypass",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 400px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Moderate stomal stenosis after gastric bypass.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Christopher S Huang, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_39_17008=[""].join("\n");
var outline_f16_39_17008=null;
var title_f16_39_17009="Dorsal cord syndrome";
var content_f16_39_17009=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F63862&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F63862&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Location of lesion in dorsal cord syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 353px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_39_17009=[""].join("\n");
var outline_f16_39_17009=null;
var title_f16_39_17010="Congenital histiocytosis foot";
var content_f16_39_17010=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F56146&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F56146&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Congenital self-healing reticulohistiocytosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An ulcerated nodule is present on the foot of this young infant with congenital self-healing reticulohistiocytosis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_39_17010=[""].join("\n");
var outline_f16_39_17010=null;
var title_f16_39_17011="Capillaria philippinensis eggs";
var content_f16_39_17011=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F58177&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F58177&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 568px\">",
"   <div class=\"ttl\">",
"    Capillaria philippinensis eggs",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 548px; height: 275px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A, B)",
"    <em>",
"     Capillaria philippinensis",
"    </em>",
"    eggs. These unembryonated eggs measure 35 to 45 &micro;m in length by 20 to 25 &micro;m in width. They have two inconspicuous polar prominences and a striated shell.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention. Parasites and Health: Capillariasis. Available at:",
"     <a href=\"file://www.dpd.cdc.gov/dpdx/html/capillariasis.htm\" target=\"_blank\">",
"      file://www.dpd.cdc.gov/dpdx/html/capillariasis.htm",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_39_17011=[""].join("\n");
var outline_f16_39_17011=null;
var title_f16_39_17012="Approach to pancreatic necrosis";
var content_f16_39_17012=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F77684&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F77684&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 622px\">",
"   <div class=\"ttl\">",
"    Various therapeutic approaches in pancreatic necrosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 602px; height: 782px; background-image: url(data:image/gif;base64,R0lGODlhWgIOA8QAAP///wAAAIiIiERERLu7uyIiIpmZmd3d3WZmZjMzMxEREczMzO7u7lVVVXd3d6qqqoCAgMDAwLCwsPDw8EBAQODg4CAgIKCgoBAQEJCQkFBQUNDQ0GBgYDAwMHBwcAAAACH5BAAAAAAALAAAAABaAg4DAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PUAGSk5SVlpeYmZqbnJ2ekpChoqNJAYmmpKmqqzioh66ssbKzJrCFtrS5uqO4g727wMGIv4HEwsfIfcZ/y8nOz3K2A5MCQgSo10sD1SnN0N/gaNIIANcLQdla3uHs7V7jIgoGBZIF5wEJkgYAB/kBDQK2BTjQQFICBgcmHaQXoEC2fpIakBjgjxzEABb9Nbh2zYAAgwsYTAugAMA2kZJK/5JY566lSyrwDAwcUcABgADVBBQA0GDACJ0EAAg4CCABN34BHqTL1vPEAJ/XCFpUsKCpiGvVFgQ4h2DANQYjtn09wfKl2bNKpE0ywADBJHIBgs4DUGCfiIAi3L5dMDKAgaWm6jqtlvAAQ32Cr6KaW26nA5LVtgF4rOCoiLJoM2sGAk+ETLAJ4MrdaVWoT6FE8yYAwMDvWKanS0gu3IDciNLptJ4rrfWAZBG9V24eTvxIZ37+CogGMPciwNgF9RFQ0NAvg3wOTTmfSHjgRe8a0wkFeU0SObFvS2Auzr59i/V34LufT//yqfr487OQX4e//v9n+TeHgAAW2A6BcSBo4P+Czyj4hoMMRhgMhG1QKOGFs1i4hoYYdpjKJyCGKOKIJILi4YkozsBhiiy2yJmLMMZ4xYoy1mjjezfmqGMRNO7oo409/iiki0EOaeSJRR6ppIRJLnlgiVBGKeWUVFZp5ZVYZqnlllx2WWVxTd6CVpikkBmKmYKgeR97ajrSJjNjtvcmI3MqEyebYLJTJyF7LtLnMHremSdxf+ZRKCCHvjIoOIn60aiYhAYaoJyLfvMoH5f6Uik0merRaTGbNihopJpdUEkGzphKCQTuSFCJB6WeilYFlWzgDK2URODOBJVIoBmuk9iKlgWTYABNB8W6RAElwxEribGZcTCJBtB4MK3/SxBMQsFw0kpCbWauSnIBNOEGgGpLEUzC6mbljpsZr5JUAA28AQjbEgaS2PvuJPJqhqwF4CwL8EsaBADtcP8Oly0H4CxsVgYBfKtwAAxvlq6v36TrrksbmFvcxYROEA4GIptlQb8hE7duw2itrLKTMMcs88w012zzzWZ4qfPOILrA889AX+Jz0EQXzckLRietNLM0fBrGOk6DAbWkOIbDX9RfTE2L1owiTbUMWL/jcy5cW+q11TWE3UXZsbAt6thoN0023BnSbbbdnKY9d9V1832333nLzcNHEd0Qlxhur5J4MiypvaHeg+9kmGVgB/U03qwsjkzjX8dAoU4i1EYA/0P7bDNAAc7JlBcCeg3EkD03+bPPReRMR9I+XYlQ1wIa9aB5mZg7w3ncKvYA+gLyyAPAAyVRdABPsakOAOs3WU6TTTgJRdpUyFdjgAJtnVbXUC8CnnnwjJ/dteA7EI5RQpT4xk1izKFC/eFtpXf4XIf5NdNNB8gdXQxAEHzYZQe/4wX6Nqe+v4HNeDsZgfLCwg3cgAcuD6gfaJYzl9qQoDJCAR/opnNA0PEggaWwHhlQCIzhDUOFJ4Rc+yJ4ldeZhBvbmYYCQjM9SVxEOdVjjuT8MRDbKc8w+JCH+w6oAxbeoH/P6wYMcYAX4yywB9Szwm9K0cAdlKchU7yh7wggnv9WhDEHV9vbfohAvxUcLmdX5EEW09RFHURlMqsxwRZ5UEbDnbEVMpSFE23QRoqYBzmTCMpIBsAAlJBkPJJYgBH3oRPqHAQvo5ME5XwXxx3MkS71uIfseqiPG57uIjb5niZ5khJIJkCUpZSM+85BBBfycSYNkEgm/SITfZgOdf6wSSXxAZboHIQj/tvlThbJgGvkgyqNKeXr7vFHwwWybZ3EARSfUo6BWCUuOmmkUcYCAK1YD4TfY0A4GVAAAeAFhLXMZg4+eb2b5EQlqjFJAp6Xy3IqgAADsMldUAecrUzPJ9kTQPMEYE4k2NKLkxjA85THPDHqk58SQR4B1tnOoYD/RgBYuQwZUbHOcR5uAOSgKD7pgr1q2iCNW5MnIZk4G9fZJS5ZFAA5KCMAxiAligOpIkoDUhgeyfQGc8zfIQ8XFYXWw6KJGcBf8jGABcyRMaMLYlS24VMjPNSOA/neAeA3CfmJ4DdR9chpUNo6jIgnLunIKQLiigCyRrJ1y/kBTJXhUs8dlQaF7A5BMgrOAjSynSPQzRsBAEKFqtMnB1CiT+A5hEEi1TYaLMpyHIC6pExmmRUkrPVqo5Mo6gZ6QeTsDRtqxb+64I4OOMgEzyrQ3/TTnHiJrEdS080RwDUAYOEoSO2X0gN+RrNB1Os1b9BHxejVcouFQXQBaT4fbFOw/wugRz4UKQlGfpEcs5wkJP9hmnJQJ3tBsKwN2mqA5MClHtxtCGhFgEqThNK+jyTcK28CXzHO0qiubcEdTeIVG/bSAL+pr/skwkrpuCIu12kIfr1L3Gg25Id59cFeraGh6VYuhtU1QxWZoN709hWNJ45ngI8w4got1wbZ0Il22flUYzYzLn5RCfls7EySWLWsJ+3ujZ95jmkmt4krzkKL05LkMfIoxZWtIxWW/Dj25SDGqGOAPNLh0aIMtxpa3ocSiWJSRea1sOIcrplJUJMjo7HJigoxA+H8oRfXIMbi+4v9KDFXVwTkATtpa59Xl1yc2kandFUqRtxM3TXGVM7H+P+q8OxMAzzrTs/B5a14EoLYLjt3ehgUqXDpelweevildMYClQHsaCSseo9uhPKMpAyHU5OY0jOw9AAjTJq1lBEB4Audryusl4TEl8KrwzCjrQlpEcfGoamOwas3+WnfypoFq04vrR90bSFsGJvNLkO2oxxuH0wbad1WwbiVG+21pbt8xXt0q4vQy0UP85j4aMg95jFX6iiv3hmJiIyJ2dp5D8F9UCGdPg8ZkI+o7jtBsbFODOKPDO6ydBUhK2bJXW4hGDnfflm4vQXiGyGDUt/j1coon/Dt83W8B58ZtUH7SV7Gei/YngFuaUob5oK70QgNfec+KjoAwi4AKL395kb/yexO1CWkGrlTKYG7eYB1a3jbSWhzQptndKSX1DI1Ya09tRcJXCvw5Tlob1mFOmiyH66oAFS7D+lXxTZy/Of0jiBRK2HWm6jVuYnBKZ+reLi9x6+mVX+2itHuA0UvZ6vc8EsV5er4ru6Phk1ouXHerY52t6DNDwgqZLeMClNbrrHgA703Y1N3Jt5dBUk6bVNmK8bQJ965twUnbwkfFKFz56fk8znemVDqzc7X9lUUbvHFfvmyWzmFKmguF0psA8LRo+qT0KVCnvdG8VofPALPs/C7cQS9JCDhT+1LTk6TjezmO+Jr4X15lSnGwiBv0aw2eBKUPQmH4DehscFMyjZL/83HcmbnbZyXBdTXPs8mfVLjeZAgaU4QXbCmBponBBCHTPWGb9ozY2RFFNGRUPcFbYxnPA3oOOoBgY8ggZmnQhWYBhcYBEoXUiOQEEphCjw3WzaoUM+zDchzDg7AYOOHAijYeSUoSFgnDDEIBIE3UsDRF3pWXgPEF2uRRVxFCZiXf7CnRsPnQF0YOPF2BLnnhNOzGq0Rha2HAGYoeYbFTgwFTUuwgGuif5Omgm5ygD3gftu1FNRBD2iYZ7bjhxHWEDmRHiRIh6ogh4qThBOCh17ATq7HZEeoCIqYiIzYQo64BRHlfIhYZ5Pocp+4iM8Hil9IiltIPJ0YaZl4h6EYZ/+pqISXuAtLeHavKAqV6ImtiIsPJG+lKIq1iIl22AizaIvBaCe5CDzF6CerKIzJuAe3iIzHSItgszTUeCVDU43YKCXXmI3cyCVI043gqCV0UITiMCrDQY790TktgY52wI4Doo7u4I7jGCp1aBby+I6ksj72SCn56IXryI/nCI8HApCbcY+IY44FSY/pMyl40o9g+BIGmSAKOWf72JABiYouEZG1NpGqyJAc2Q6qMgnnggwhKQkuAw7lIgmwkhkl6TFnASz5ciuVoCvtQC+SgDGzUiuZ4SwGcyzJ0hLLMgnN8pNo0S0RUy3X0hLZIgnbshlGKTFn0S7kIpIukS4mORz/Urkv8TIvwfIS+FIvw0EvKIMWCfMNAmMWBXMwm1GWmuEw3+CWLgExUNmWFDMcIJMxAbAxLdExI2kxAYCTmhEAJfMNJHMWJ8Mmg9mW7HCSStkejIkzkBmZkjmZlNlE4XiZnbCNmLmZlqCZnPmZPeOZoDmam7CMdNKMnoKagKKarriLffOLEciahsCCHRmGSBiNmoKbZxKLujCMu6mboAKcK8ibXOhXvHiKr9mLCymcrGibLKBylHhU0DmHyokCHyFQvgibdxEA2GmJo1gUj1QC0zkD1xkNwfNMJjCeMlCeEmk+WhYAijce3RkDBZFBiFJH7xmf7DkD9RmczllOayGe//hQA/v5IJijFaVEAuopbdxpnubjPlH0Ew1KA/15n5gDoSVQoPTpWRb6n4+RD3nkfpYUejtxDQ2AoKv0GANAHSdKCQwQghLVYNSRQe6TFUS0AFohhJxYih86oOVEDyMqYSaKotmjoixKpC8aUfyUEp5Vo+V0ozk6BW4DohPaS9ThAI8BXjjhPgWQQfkQHe6kEIyVffygQ9TRSNHRpcxxXiXxEdSmiXVEpQJlpdyZpeMRpvXgpf+gSe6zGudFXiWnAGeapA2RQaqUX+j1gKNID+5XZFsBndvlFtajFSXxGNVAHUc3obexpeRVn+V5fflwQFEqBW7DqIwKSjg6oJG6WP+UOhnZg6kaWhBhKhGe2qCgGnIFpaMGCDhaYQ8S1qvyqWUlUQAr9RE+sYePVKE0EReyOqZJ+gCc1hoKEKFuepB406vACqzXKax0UazwCZ4jVRLKqjvM+qo6lxTRShLUmqhZc031JgkOIK0AuhofAWyrUUCTwACWCp6ZKlATB6/NWp8hKAkPsIFgUQVs867cKa/QWa87xA8Dq6/Zkw/9OlCTEITZI7CVULAKcbAwgTdtlRShJxHlWRBuYRMP0BerQbHyWqGPMQnMY1Bn+qeSoGi6ejkgu7EjK5+sdLLLo7L82rIc+rIEi6nOSrPA1To3q6jOOQ1Z8UiCOmTxsErNeqb/+0qx9Qqgbcqd5TkND5C1JhCqoxoFbOO0WstY4ONMU5ux5iqx1YC1i9aq19m1SQG2JSC2NUe2eGO0xqq25flF50AdBACpWyG0lPSt9em1zloQkfie2PemRgg4fAufftuggDumg6uqhZusIWesrJSynnWmjGsCjlutOGublHqwoRp6+ZZHjxFB95cAVjuxhesPhJoP8apD+UCjlHB/hzS2O4qcWqu6fsG6ICoCrwscljS7b1u7NWtMC6u7Tdq7f0oOwLur8/YReeS4L4u7IvCl29m6QftIsRthO5QUvJNEwEWoPjYJjcWuYmM32isC3GsQEwq+rqS5IUG+lmS+u5u+/7K7viFIFe5biJCrgKZJBDQWoUxbnU2wwGPwjD1wDVnoBrTJBBSMj//5wO4bifGrnQrcwSskmyzAuvhAS+3JnDRgwvvloBvsnSDMjCp8miTMJwkcnTOMKTWcmzmMwy+si8ILbjGcnA4Mi98Jw0VMjD1MnUkMjD8MjU0cm0u8mlPcmsZJxOR3nFmsj0N8m08sjUFsilvsj2P8kFfsxVE8nFU8m8SpxW1sAy9oAg7IA3HMbF2sbvGJAuVhPXscA3PMRWv8ewqYgC+HNVaXNoTsmorMAvnAwLDngpALGERQx6jWcX36PFR2yN9LOUYhhSSQbX98iGm8YI4cAy9oa9Dnbf+x2DoJAF2yRskroMkqMkWhXMlfTALT0ckzUMeSPASwfMS14AImlADz+cl5fAL/VALJbJ3HXMteJU+cdQ6+kYCnnMgo9nphjAJZ5BYoDAO/nAKy/GEl4MzArJ0I0ADNYVBfoV/U1GA44Ugr9To9Bk3W180DB4IGUUz57M4H7IjrADpuWF5Ee3Q+MQ8qxM56QUMJjRcD/RYCVBfZAHC31nEKYJ8jIF6n011Ayn2jJEuh1DrYh3I/QXI8Vh0KEB02gUoJcQ5f8XHWnM1E6AJz1AAtpYH1PF5LVIMdO8/ngHAlEB1be8I3wRDm103Y0c429jq0g2RWZpVCOQJa9gBatmb/tXFauVNYPThcHnvR2HBSCPCDk6GjObhbH9VlRlFaFsVJfuPUJhK++IcXHGoa7cXAVo1QMFR4CGXRkweIsHBckjhvSykJNHkZjoxO4MNNMhEUiLV1qwVNQRhEYP3YP+F/Zq1mdFHQpnBb/4RSPLFxWvfSZSy8gR0ATUlod2HXIRXZLWo9cWyDHGESX43Xn0xQAMoVCAV1TvdbuyERuvdR6eBBkdXNN3wTLvCutTOtYRVBWWVoZ1UNPIXLXb0674p5achngmaF/VzOwtECoKOGp609GKFOM1oCWLUT0yXbE4cAj5UXfM0cRFTKWhjaKEB7cDcQkpEOksFU9t1TWBhE/9NtzHnBZ/hdDdmQVtNRGI63bGrdcTNd04uBhV0Fa1ToYNKtd892Vcpt3r13Gr81UNUjaOnQPx68yNLlAgGlGGBRAAXgE7Jn18KVWP/TTWBBV2BtAq3naajhsS9+dZYcQTzUYmOW2Ao6c3atHhv+Qbvl4SRU4Cgb46IM0ybAWUExzagnEgSOCvkdFKrlg3B4GRlU4xl6Gjg+4EknWnSx4plletgs3yewzTPR4f6EwmJ34iTg3WdI40Q+26aV57JdPelgemMOXJ294CR+AitNE97zRuxcPebbTt9FArxGV+O1ca3nzvsQgmzxTIjF47BpQpMTEO9JTHghE0y06Oe94f+hfhD3V1faRXqQdH1xKFN4dQAYfeXNzV9g5F/pUWzuQ+nQMWy3/hDBlHNT7l4KDmIMrhC0BOeTnnIHdtF96BrEZhCKNxJBvV99/lsGwX3wpw+89h3wXeg7rMFp3JzljsiQEshSQM6qrN1KfMdMzOZOZsPj/gTsrm3u/pvwTsXnjsXyXpviDsT/DsYD34j13qEBr0ff6sNpPA3HjAT3Dsh3jETZze/9joAqQPHlmO/Lg3MMD+UlwDxb7UciBQMR/+QFjwIO8PA/8M3tevBkUU0rjwQun/BRHM6OIk84vx/vdvJDSBYUWvE7UPNr88YYnwIAQfNCb/Mgr9P6sOi/BNX/1m5sQmQaH4GvIohyfrHi+j3ypJpNZOURIOF3yvGvCVBxJ2cPIB1k8AkWIMdEwn5Ih8pQvfPzwSxg/mYA9Rahc7/UECc91HNx8FxvCBYQysHXQIrSsyZPv7TUZo/2k3ToLX1f0TVJez8CA+33REQAgK+l+jb4a/FLD61niQ+vF28f3M3iBpU7zgPdB0v1c+F109rYQMjbDEY99CSlOq/6tn0TDFZaT3dQbNZSotaGnZxQmMcU3EPnqBHrFH1zVi4b2AncVKF0nc9YQ/dPgn7rFyX8A/TaaC49CBuLrU/9R5fbUDdZ0M/ZHlRP0WXY0b8SFm3+1k9cqk1OFtX6ow/+/5gNAoA4kkBQoul4qqUwAEYhEvMgoE6gCEdAxGYvEQIhuhkCysDsR1P4Dq0ptWo1XVnVoYzWBAKGJuCLgVganeOiSJAGdkeEU2EZMBASgcHi0AgkGFwNUmkVWkWJBBzclOTtLdQtyQiOJREh+Ngd6PAANH7iACDAABTgsTTOEbK2khgeWoFKKhmIOb0kmhwQQC2aoY2N6C6CjgjUITDQ3p0qElyOIiQtzXTigIKSipyuhgJ4t8ASjqsMLQQsADTAGJeg+wgOCJUiMywLLCior4B9JjRwJbBVuRQFUZxLtw6GmltkBiRhACBBmgfP7OETFofGiQZGUHg8NmMgwSxXPP8JUMDAHQmPIUc0CIiOwJwDBygCUFCJBLwBDo6IQgZOpzdVB0kixWJSlqiXbUrhgoFSpakCMCJOfENi6kpRKHQ6XSfzR82bCPTx41ns57cwM3qhAgruqFJXdI/VU5JAHcs5SowI0EtPBAM9THAE/itMxAM1SR+juKvoipjEexc7DDPgppICRs4scjJAyQCJTjbOBcBZCaPOCxLfgby0iuShO+R5PeJ69aJITETvwFmjs98ARqgZAHWgTgKiqXCEk/24dl0qyg0vyjyk120RSYCs9rz4SXd3DBToZcD7gO86QEYrwAkbQfHjtZQzdy43usGB1KWnsMxOLYgBoGy1/Wf/oIILkjMbg5H586CESVGX4IQMOnYhbf5pOMUSpUxxgAIWdViSFRaWmCJkCKqYoYov9ucgjBq6OONkAqFoo44nyrijj0ix+KOQNA6S45BHFskhkksmySOTT8ayIZRTklQhlVfapeSSjdRoEE1GTtcjlk8GeSF/XY5ZZZNmwoJmmjhqSUWBrAyRTW4qcBkhCnnyl2KZb5IppoFktaknoHFG+SChJbh5aINwasiSdTg02k+fJf7p6JGZPnimoZqyYqWGnoKqJqRbtGPYR3JI8sILBbxAzR2NwLYAaLHluc0nbMm16IyclrojsCkMoKpqhv1kAHoB5GNYQITqUYA6TvwB/4hEwTqZrXXGrpbsss0q8eyX0U4LRLUJXIttoqFS1g4MNW3lVbFS1CnKDTOhgEAC3/wQhS69fmnjsOq+OHAJA4y1QEwA6EOAT8fsa6lCC/8gALoT3UlwZGtal/DCDT/cRsTPzKEOxQRYLFECGWv8CqIEtoPDv/+CUi9QqKXUGb/vCeDAqgBf2qHBLROp7RSgNFMJRI/w4Qcggvgq1A+3Gke0CqJWgTQlR+ChR9N/BDKGN1ITQPXPVq/wsjkxq7ZIvCPU3A5b96rhg0UO2EApEDXsc7DeQRctJdoFC7onDo35MZY/TpHtDU4VXzx4jEa30AjiHzvG+BeOv5Gy5JObiP/qN//axmzcMdyH2BILjMZE3oslACLcf4NJYeEloIbjp6Hu7uPQcC8hM7KfuAYb1F/qJQW1k3ye9u0ktM7ssUr81Lq0xou9RALKm8t889Wxi+V5vf/4u3cjfW+q4JOmH/j6R7Pc/qBqM+nAyIFSrgLOrq2khAIA6EAJacmeHvahLJFpwloLcNYaArKr1ZzNT8+bnfwmhDX2VVBR9MvggRwUATsYYiNoAWAD5pCuAJCIUV96jzJ0kpOd2M1ir/gSexYREhENUIL542CLOMZDGBmpdj8UxwTPNwJZMQGAO0BMMtKVPUxo5gEzYN0knBY20fTMCMwYkA7fN8QuevGLQtv/oBhPta4WiLBv73CbCFwoMSj6AFaj2BcDYtOGL8RAAQowVwQJt8MySuiCgHRf+JLiDcCRAJGOMh/qgjef+pwnPTP0BhtGQRXu1MEWzFODVUSwnl8VcZDSEaQoA0lGQigSBakEFCNL6aFQutJ2sIyl+kInpwKgB10JRJckCrAKCLqFOctwDQNB1UpabuyPyFyRD5cJoCBSpgD3kKMnUXjIjhgBh8g4wHniEob7GXOWzrxRGMcZJnGaE53OE90nzhI9b65ii2LoBgusyEVWqnOZx0wnLIXIT0adEi+q0Ym+AFBHVEhkFWGZJ0JJIJRwKlMg7pjT5/Y5pEpBiZT/rGUh/+W0hIBg8g6FYcIvsXMAho4UVt7TlEWzlhuKSq6VdUSfgWAKoWewtJktmCmDbIo2aFrBp6VsKQaf0r5WWmyPCxJqP3C6SJ2aoznkIwlTWwZUdjqTkbICTAGEuY7gOfRdkhBEANOhLCXg4FwMmMMc7rkpWMKqksNh1lx7YKyzMmuB4RoGGrpFglv5wDCCmKtb3wpXN3ykrnUFJl7BFQAHtu0vfrXaVTdKxIiiICLb7OY222JUFz7gfyiEG688t7I5xM+w64OAHSKQyACslSqeaKNXbriPkH0zBWL4mFKbagImvhAAoaXSBVm7BAq8NrYSmW1OapvN25YWnEYVC8N6a//VgG5UqyZlaCUnuhkQnrSJTLOVHejjzwsxkmoG0MW/tjhee4aVG0obkBpOU4AEsmZKGk2BetnLRlPYoWuQgK9ATTFfymL3n4wswE8Qx1CMUPOzbnXjOhDgOY5gyXznIZEMmcvcsMBkVQ8VmQgwF6HRamQGFCYuVEuwYRJ72Lkp0JxDI2ZiBJvRsqB7ZVA7k51SnGKkCoiwZsDRy0hay3omm8QqfVfEA1ZzAdyh67fWo2TsjUAfxpnsCEDjAzi8pZcsfvL/ojxlAZzZysVbaXW3PDwcZ0nHly2nnME35zrnmMd4znOL5UxUZP55z/vdM2bvTGg7X+3QLiu0ogGaT0L/V/bQgY7lpOs86EYnms9YWo70hFTpKVQVowJp8ihDKSk8X1p3L7KZfhMsKyLjKbWQcYDsyvfooMrOU6uoKirP+yg6+w3TqbbLVFvBa1Zn1NUjSYmsNdSAZvsR2EkJtT94PQhSd5DRp7Z0n1WtImTjL85V2IgMbzCPW+HGBIJtZNV40z1rJRI9OpGVFDwdSmToxTAW4Y4LzQ0rXFqrpEugIRrk+OJqShIQtTDyEnqobdUxYQH924ESBQhMV/23rORd+Gogq65he2HhxVKMu4m3h3u07n+14rcgkJFLBmynVVstMhKoIkPV2vKDdiDBRlYxr7/ui0vAPSJsGxAxyKks/zeeUFZXkMTIbfoAB9tYukp+DmE0dwQqARNDF3JXTYtITyiewDYzHz5CB5QQtitIoW1f40tGpbDL+2LHT7s9AtD+bwDvsqHWMXJatTPMMVSHuTTxMQTmEh3mbHOGM3De0SmQO+hBWdbr7BsDkzZ+auXla72LAW2HS7vAUSEGI4JSigGY18AkO4EYxhe2LL8zxYkg+zlDfzM7WGOJbjHOMCcBU3wrI2dJbDzRQI5fz7dtOZWY2kfcoEQebIT0YkB9Lv5rgO2y7QVSXFKk0bjsfststHjbWRBM0WAbKu7CJeDKtgV2b60Xmf2mH2hcTLzrkSW1BAU9aIqbGwZf2x05Tf/KCK1Rvb3QQtXaViTB3cwA3d3d510JyAUXBUWBiV1dlqWD4CGGSgyBiNiCVHgFgwnXj33DeawM97laNSiNvXRG5YHZ//0Ge9SBe3zVwsmBvKWb4xkazODUduBgW8AGSJ2Ab+hBwGiZEdTRnYTU8ZQfNegB6J1RrMGgcUDSsugS9rmYFU5cV03PY+mDE0EUo83V60QBEQLHydXHFErZDwZhkZ1ZYtTBSbENAFGF0yXYhMBDsHzagvQCGI6Z7f2IA0BgBAbgtyWgK7SfjnRfihTHICYbo71IAvDKmOyhZUlgilgbFTSGH9qapnEbJKZTJWZXIWKaAD4epN0apaXiJ4L/orDdYeXsgSHBgl9YG+090yoKRCa+iSh6m/xcIhBFSCJSYoLZVGhxYrBNAX+coE3NiS2WWivSySHSnN5gCy8SmzNiWGq0mqk5YlLkCfR0I5MsIiFYmzDyh1LVIgCKWxTKhk/Niaj9ITtiSrFVwTXFozyWTzCGIwp6ogukimQx2VhNofEQFsMpwV91xhDIURTEXMO5H6PhGyDom22AX/QYx8zVC7rZnHTd4w7iyV0FA8btkkRUS96RhmkETMclEi2YQvhxmut0xsXdQDoUExjhIziq28LNXMeppFrp1WNNXN5RyrrRimsg5MKJpFrNXGNZEDG6y1zIYRsJQmjhi1wE/9dwjV2hFNlCkmBWKuK93VfUjQII5tFKbE+R8Rxs2QwnCQLxDaO2JUziIUOExNB93dE9nOCiOOD6/UQ8uaQ9VthAuR0ZcOQYceNvuUVaMsBe7qVpCcDNzUW6CF0YCOXZeZzcuQVhJl3i4VZT9mN8NQJDwsDxoUZogpfbkIpCumT1SQE2lh0gasd3dV7pTdf1LUFUfmMU0dRbAqLW2CZriAEV1UIlSUMbvEE83dPs0cFfsoA3yFMpEJhN6hn7WN5vLgLxEZ/ZwNc1kF9NIAHuORTloaXZWCcveE0OKcg4IgTbiKZUYqA/hMyKoYRW1glgdKXqfCVEwt/hbWDT5Zb5jf8gblIKiZjgPgrLYSKOCDpYKezfHXSWW0wT7SxECsxnO/0fL6idCQVmgYkEZR5jehbiN3aBgvIdTICI+nWoCPQENY7fvagRCdgNAA3GN6ULiRogiIHoZwqUaUalQQrB6iDHGDbSE86QG+oFCTqhOtrSdILafr7LD4LCEcIhCTaCl9Hhhz5ib4LVlPboEpqcSZ7cE6kk0f3GXCgcN0VLSq1HZTDPs2FKiFJjF3ApTzJQtTgokwUDlxDHN8wH9LQgWtbgncagknnmOkoaLhqIMIbbTVLQjoyYbJwHls4PolriK5qTNSbFJj7Vw9lIYlhXGAJiKSIapQISpg6RqY7TL7r/oo6OIjRmFakqGCmWonoOhGuWCqryEK4SBD1Wo6wiBalwEK2OmpLyJqO2aqheW46giS4SIqxeTcAUabBaqhXYKqgyKSq6Kobwqh76KkkAawYJa5cBGSoUkDrM1QnIZGAY4MhVTVKmx082ALx+Wfn5Ww1GDoY46xcxErtmk7Fg3CUgg1ep1RyQS07iyqs0ZKcZVMr9g2LsZJ1KEnqFKLcMT2PBKwFFnDCoVfqEKxGMK1tZqFe23VweTMKQrGNCJmTOaxdY3cWcoAZlK6CZmsc812CmxmbphGOWDHWFnQ2cJX+qEuB9Qlx6R9GdqMsa6JJeK554jEzsEW5BZvaYjLg4/ybHJpiu0BMmKCeA+V4Cao0YaCfYrJfYruzrjMLmwSyyXuphmoAMBJgY7Nq4ms3Y4BHLmh7pjAB3+ibm7YTZENLSEosoJA3XvJfYPlFial4wfE/HJiZcUJIRVCgCGk6AVsa9pijiyoPZomjaGqs3Jm0WbCvnAu7kXs7PwC3rjav6cU7/nQ7iFaDlXOf5+cHROtFeLogEwm7iBN7iiNjmsMDjoIzlLm6CcVpzeBMbJGkXkuDBbCmI2Kkm1QL2WIbZBmphZVuoui0ghK6iAok+RlvnRo/w3ObpoqUzPG9xnKXlnc6ZyUGebqmP2QTELtyn5qi2gZVfXdkmIQ8gcE/1Wv8tqz4I9xbr6JZAY1SChRGCAPtH6OIrp0pHtUqhQDyAND6jAysa4zKIAjcrIDbAJLIbV3kV3FCsYvDVCzYWMJUcBSmcHZmSBUMGBAfuNrowthoqDSeKzjkk1+iPWt5XN0EPzQpmCdMrr7SdA2bIZD5qA6tto6kqE0/rqzIaiJUnQ+Fk226REHfBeG1R5nmv5RVq54pqE1/wE6cAImkws9obozWGKFiYjVIxBZXu1WRuSyBAWNyYCr/gFxOwhJAdGk9XGsesoJFxMx7FGc9hhsGS8A0AysDvG+sGWimvAcJgAtjAbpiUGXZxHrfwEq+nK/QxBTepDnqkqO7Yr/1qITv/oh87WSCrIisDaq9FoyuosujuMSmboilDXkiKVcMxpQiTHEgqxlqu27leVL6eKjfOAwQlkIXNZGuEKas0HNa2nF6oA2zsMq4Ac7uC8veC8axaqmaRpc958BHsnR/UrFyyTc/mRF8Sa4K18w/t61mObD28nd8pHXScgDSjgzqQAr4c3lTmXTmjsyhnmi3X8ihnFvZt7XjhZBRs0RSnM5htLSB389o68HNOVyU5XzW1Zj6PaxzUQBxU3ybwKEQTdCkbtKPVsAq4MVkGBh03tA39TEuTXxdUKEUf9Dy+iAYjtEpj0EJFTGUUHpFVqFDAxT4vBFLT3YrxKE0XszEjIx++//PtEmMjX8WRmpy0xHT8jq9V1/QMUEMdPDUnr4ihwOMg8BpPFzT4isJ6SCmItE5ppKXCqUZ+TDMg8LNeXDMZZodXj3WoBqEku1SnaOWinuKbJHF+krW27vTnrlNFO3Eo4Y06MML2OjYVwLBhrvSVeCoDb3Lnuhy8xbVEjLYVrwpb3cEPXOwPFIbHaZw0mzYxD0GtoJtncVRPp7QEjoj+MQ+/HoyxFCTRQZHGARMxT5LCvegqbzYrgvZQP2bhrYw9m8BlotZF3A8Kvezaiat8TXcbsbNmVCXQ2bY7p3ROV4dxKQFyrYBgY6beQeUPB54+AHRaQhGKBSYOeeVxs9BfH/82qr3fERRB8wW4cY5HNo4BfAUHQjQRbDvB1sYKTQkf9d72Wpe3T3fuilGmzvBoFaf2Jgh3cQJf79UCahbK4/I3LttwTndgzjr3BbpIODiG1FyfNLL4UDCh/730C1RljLboZY9qMs3IaGzz5FprTuMNeECE+PG1JOcuhnNE/P4MWEQ5fh43FOE0igsyRH7UI8t1ab+4FlSM/hZG5CCZLtn1YoQ16qqh9Ug4ec+IMbaCMKr1m8LSrWQCm4/Of5mc9Aipn8ZHC6XHeiRvlRfnlXcrFMPmkB9JYusxbkuIKs/5iTu6LWNwKP43Z/uPZ8sSIGpcaOuS9pCk/8CgViOcoF7/RjP8jJ1SigwgQC/xBdaV69kuHDEDkxIvdpYvt59Bda6Gkn1f4Nc9qGXGF1Jvw2O5gF1yyWWK4A2ALOqJtwJ8d9vZOmSPMQDzk66CK1jy3vS50yQQJxJB+FWMRA0UeKF/IzAoBrOzABtE+NZeMVXvuj6Rscy6spwc4izLcEXn7GgSFB05qF1WF3oWmVIzhJ64OByoHU6ou9YqOY5jk8TGOw9yr69wq7Vber2HsnfFcE4VWpnD3JZ7KcP2aYFZRrm4WAHJUYMbhngsfHHieZpH8rSbtwrE7R9LvKzxSYLYCVM0+qHLO8bzYCcT+aZyMr4zCaPL/KTjGjkesodA6yDw/3SkY3nEVxAj8SSoE+wOVPOH8CnXo5us4IFAapxhK70/qktn07kYtsq/hsZfJKwAYGTMMN1/Ak2brNvXT0JRZuwKGwDYj30FKy2ud67tfl2zn0VUhII/y05BgQLemUDciSPVtzKjMRfJ1nz8ZQw4fwPjDUjOM8oGiredCLs6Iw3kX2/g+zejEZ9w3sHjirTcLxsMRHieb0KIkz2FV/hjG+u/kG9lyOYRYSGtDMD24STF41RNzL6dgDvrBkUT3aLFWzQHg0iDHu/hm0zMEDyP2wBbOPkE8uOts8K3Vn0hVn4p3N9nhaDs2kyBBpvxCwPeaP+uAAUB4hTLenD3T7jkH/9VKHUcCBBKUAQGEQAAgqxBkAzAILiwPLxFARjvWSIxRjCG6ohMKpfMpvOYeqqi0qozQEAlsdau9wuWUsVW0UsgkAG0ixEivSaidYEDnKZyKIxIPFaL9EJCMKPD42OCJyDYwmVweEaUwBfGNPZ1Wam5ydl5ZZXpKTpKWhW6dFqqAghFqPqqmqokC9uEh+laC0v7qev7G8Y7BUxc/CQMgDyQ8NJywBzg0CO3AN2QnAVDsoAN0PAyaSy+1YX8+xBAWZ47vmk+2x5PjPwubw9GbzVwvRCw0MBPAYEB0lQISBAoGzeA2A4aSVDj3rxyEiu2qxfIosZO+TZ6DAZKX0QTBQz/qBhwgtmABQe+JTD5J4oAHlgQCArQ4uMrcxh1+jymqefPih2HGoVnSiQAdC35cVHRICeAmdgAJWhEwOHRUjw3weH0desoocnEmi1q1ihaJznOAHj2QlrbAgsW/agqKMGBbt/upg1KUVNYwWosDt4F+K/akIqHrrUVsbHOroQ7HZaMKTHmj483E2Us5ZZnjZSfMPCHRMGDmSXC9Z2EAoUBu3SRwLF5d1mzHoym0qjTdgCDai+u2fVnRoFJ3Th9rwkSeazm0RY7U5dn/brjwFIgHijZZmqBA0Nmh4OIokYbbg6uHRmMAOE+AP24qfDBYCahmQwYQDx4RD+5KFCDAXvM/1cfHATWQhZZ2nEF2oP2ZCchZ9w90R4CDxQggHFqlIRbM4AgooNtMghABA+3mGAANHV8xYJBCLQEgwGPHHFAHVMcsOJsA+S4F2KVOFihJxQW+cuRSH4WoRNt8NDAgl+VpNUqUay3RBo5PgCAAyrWwFQB0jD1FX8McPgeXU8BIOWBYL4ow4JCgrTkRU3WOVFSePpUmhQLMuUcACV5I8gJVBwnlXNzqShIDbTBeURw+RU6lSALJLdco86ZEUB0ojS4pzhKhkrKqKSKeqFHoumyap50nprknbDuJOus8fSpqqewtAoMqLbqYuqvQ9YqrDG4FjuOr8hCqOeypRLrrC/HRv/b63TUchLstUA1q2210JK65gy6xmJtt69ua265lqTrLbdqsdOJH+zwSu6w7NpLxr3n9qLvnPluFe5Y847L7L79utsEkeZme7AX0y4RokkEQAdXANe8Npw1DLSlgG07FFEpDAuEGKR4I4QjKXEWb/xCx35As5yjOtj3LL4NI7zuzd9CoXPB/1oRH5uRNVCYVv8hZKU6Bo1XXn0ryBCwmRyaefQRKFDih6MuC4Ble/Ua3DMqO4fNcNj8/uwEijoAecSgKoSIE40vdRmAnAZ9aCMPz3Vj4kks5CTAjC6Z5EDdNci7BnACkEjC1/iYjW7kkCOF9uRg5/zEll3yYDfR74X/kwRVKvRT8pQGOO15AFz2fYByUkcmOn2Kd+OluFj6m5nlYuOse9m6ZzR2ISTwwKkAFV9c6HGG7vYe3iEnwA1upQvinqTKo7CbHzoQokhvPuf+O/CV/+57+GUF79NlYilr/vnj945++zzH/5H6AKsLP++Wlx/+w/InjL/90e9g/CNfqv4nOYchsIDpYqAAB9g+9pnPgd2iIOT8h0DKPe5/FrxWB8l2wAxiboPy+2C0TKgzDIpwfpd74PtcmMAVajCGMhQfCSMIQX2h8GYqlKEE+5fDe+2wYT3sgv2MQa8ufKdTYoCXAm02wSCya4gEDOESVDY3JRzxFayIVA0CZgUH/8igi6hwohX1NzkqCkuNOjxjEhJQkMBlqTDAIKO4NtEAgs3CjEFUWAWl2EBAwpCGSohBEtAEpJmcLGPFCVlt+tKpHBHiRhVrAWuKEAS9neSLhICk8RxBvCDYqFApqORbXMRHNBIyjYL8oyp9eCEI3IQCSBjZC1YiqBoksgD9mRrS6KMA9uRxPOKSZA+g5IxgzoQ8yrGjvJZZTFCyySQP2FrivJHMf6gBjG5c5QVbqS02CrGbEEMIIiE1A8HViHEFiFE0J8mDIPzAdM7kpDtpYMxH5OgmPKqBFuRJEpPwrYUvZOUrQXhQERYRAFlEAA4sCanWCVQ8txNPL7+4HGT2Tf9QhlLaM3l5JozOgHMTvaMWooIEhggogAX9ZkJTCE6zLbRw4NgL9phhB+qFzAQ7RYB/dCAzGPCgYugsyU81eUcs/JQEQU1AKEuEBy0Q9QALaA03+7jAmFJLnFMk5y+SSAqw2gmKQHwpD7Xas4WySo+jEGuyWOrSlsoUrTCl61nJakCzEtGue+VrFfGaP7kiVLAK9WpF3AoGMl7VceDDoV7/StgMqnVXbPXiExCLBMWm8ntPLKFf1/jZNoa2rZVN7CUWy1nD1jWyd2UtBw3LnJxg7HixMYFdoEe3FyyABiyrWxI8mYxHsIBSL7vLxIwrzy3AzEBGAFDNCBpXb871sY7/TegAxvii83SoMOmRXfSgtjpxXU2LxPSDe44QtKyJZ5pL6diCFKs1jsr3uTeMInVF61rPBg8PQIIbAtx2zWOuggczwcnGalA4u60gJ4ibSoqSCs99CoJtmk2cHQawIcZ2trrSHWyHC7tfXWaXEp6z0uhQU2IVKEc0pEvTRbuhudoh7kbKSY3MtkCI2g0BIhpWbWs/vFogZzXEb9ERJA1A20OBYwFDAMeBsdecI/xUAWh6yqIgLODjNg4RzNjC9vKwhx6PdlZchVWZF+bjX2G2vhu2b377dWZX3pdU6FDap+A63TfjV8ivHXMgATtIAPZZz2Wdc16hm2c+Q1bRHGa0/5vZfGhHj9PQgSW0EXFQ2lP9MNJne3Sna0gOP99xq3j28Kc5LWhQ7y6hWk5BGhYh4UmgaQirQUmhwuxcW2260qfmdapVHeqEKkAaWtAPErZElWRjWgWDAjCZS51WUYNL2uH0KoVdrYbdFmoIBJjbHSKShgyDFtAGtfSfzR3oXztBSth+G0JOY5L/4hoHBdlxppG063SvutHqBvYwgoeIEgTKDCUwSY7ALQNEEC7M40a0qfuN6hH6+996jd0m1oxvaAe51/qe4cQXaheBdKLOyMp3uSXdVUp33OP+Nnl0OX5ymNdwsoOGtK8lXmiU3xznLdf4j2WeaKCvkOb6dXi0Vf8uZ52vPNgTp7jNl85CfvMc2ESXOrX3FOdQZd2DaS7602MO8Z2znOpdtzrSq312rqf94WEv+WbvTO6Xtx3sU1f1QnMg4s3Sa4vByIbAYhX3oM9d7nUH9d1LcABjgoHvlbBjUN5uJJ/3Fd1JFzqIrevQH3FBUn34Iswk/IbfkMiSBVgkoYpQWx9oeTzQILY2gulIbmSSG6iFu9E3PnjBF37msEVAerBAteioV9lLYwd+Xmc0AXQXL1AJSDa4h4CunVdQ0qh95APP9n17OvdDj+Us+9CCvhDAnXK0rDTLpIYWTfgrAxguI1gRE2YLFCWAYAE7GRAirAD+9j/n/tEpT3j/uxcpzvACWQFSaGJ+8DQVSDMlYxJRrgM6AYYXRqBS8bdgFYUfDKV/0iJ5i2Z5uCeA3bdfOWET3HNL6jBjPNAGOFEmdJBTjXR6JgB/BHBUFeN6bwNRzVAx7TRQDNKBcHZ1eLJ1pBaET8B4o+Fyuqd9OfeBQ7Z2onCEnpGE2Td2UOd0TVd121d2e9aEk6d0dBeCl/d1AViFYFiGvCdIOUBHXthYWriEEfeGZEdkSlBNdrZHUwB5meVHCfN21teGbcaE/geCcWh3W9g8ppCHS+B4UviDXCiI/ReGkgVbnvcDEjYbM3N6CkAym3eCKMAMsNc2QPUbscYAnlg3TMYxI3VL/yWgAHuBBSrTAL3VMZwYAMKRDDDzh4aYcgCodrxIhWdofo5CYDIgfdCEh3gYfLGRTnpYfMemOsrYfuN1EgnHBVWWFb8kjQ0BUjzGRBY3Z3vYi1+Idr74f4SVgs7BTu50jNhAfr4XBeoYYF+hbT9Qfy2QYIfjT1EgL3JDOIbDjoCjfzcCiLp4buIYjl3odR92jnBQUcaYDKsDfAeofO+YKOMFI+8mgxQZILMDCA22XicmSa/TDQJpiOBIhOToLEN4QpM4ksNoEL2RitJDi8JRj0hwVF9BcBmJg1DWAlGlj5x0Pb0xk0YgTQNZhEuikkh5lMuShYFIkGj2hCm5lCX3lP9miJJMOZUVkpRYmZUNN4ZKCIy/aENYWJVkeJVUGZVceZYeiJBmt5Ze2ZaOGIlO+JZy2ZUPspVFkpfF0pRwmJZoWZe6dpeCOZjPhn3lGJeTFpi7uJgFmYtix3RuGJZiaJBimZiMeZmO+Yg1V5nuMDBeEIVggHElSZeZCZWNeZqEBY+x8JmX1oNfwCujiVWcuZlsOZe06X+ryRWtaQWhCZv3ZpR/yZeFSR17CZeWB48YA4uy+By5kQZIpQ081T3bEHs7BTXZ8Inc0GpbIFy8lYp4EB8lgy2NqJidKZXCCYQRIkuCQEvoJRXJl2vZWGPVNAN6sQXxRQPSp59cAAcxAX3/bHKDgVA9E4k1gbOG43mYgziZChqZH2dY6uhf/Eg3BCJhL9BPd4gC/cROG6o3/el3C3ZtOLZJE3o4CtCK9PWYVug+bjmWDho86lglHrOREtV5dyhjXAOKwEQzqHOdNcluIjpqssMjDvBf4omg/MeGtZmeqFl5yHkTBHBkQbkbqxekUPBl09kciGIDhmSBMRJwp+UKNMCTd/RfNHOkX2mZV+iUhGh4ZWkW3ngr5ImZSmqXC1qapikWIZeIHJigkMimZtmiPUecmianmnmbtvmnsDSo09anSXqoS2qefpqoSiCbYVCpaTGFiEmn5YmngBqoS3ALl/qbdZKpDPqpKmqS/5rqf6EKnJogqutTqKnZqQe5qX4ZliRiALHFG7txSRF4Srz6Ma6hKbeFii3TnJHUeiZTBA51EgWBHbHapI9apw0qqNYVEddlYUdwfExTY0eAUq1TF9w6G+XFNajhUPI5NM73OkDCNhMCreMYqYAZr4g6qaPGX3WgfhZqOkgAUD4if/e0OHozMSTarvOFEuzXkwJApBJRqpJKrZB5qm26XwVxr9/hgBcmfymVKKbzOjw6o53jFFkhAzQ6MTn6rI1Krw+Lqk0XsSqbBApXsY+CsfOlAlNlOlOGJsQ6psVjgzt1XobEsO9Kq9LKqbUKsS27GYfBbUyCpCmLtGm6omS5qP9QuIYO8Ev30LCOWq+mGnVSi57TOq/HSbRzOrZH27Uu2rSQOqsnGbZg+7SUGZxW+bZcq6bVyqTwmqJye7a2Ord3arQqurUO27daa6e4WbaAOws3obiLy7iN67iPC7mRK7mTS7mRCwqVi7mZq7mby7mUe7mdC7qhK7qju7nlQLqni7qpS7pYx7J727qu+7p/i4atm6p8G7sue7uwK7G5O7ivW7uGW4i827u0K7xrq6q3+7t+W7x1K4fLm7zAW7zPq7a8K70sSr2xW71Qm7vZa7Zwu73La7zKG7zOC76yq6jEC77ca7vf67vlq77dy7IXoLgZ4G/yexMQkLsSoLgeUL7/KmC/gkC/4FsBirsB/jbANxEBuTsBiisB/QsABywIBVy+FiAIGNB0HVDBwksBN+HAKkDBL2DB/csBgqABTecBJCy86xkA7enAI/wCJdy/+vsCF9B0MhwAAZy7ESAI+NvBNkzD/bvAL1ABTRfEASDBvIsBL3DEQCwIQ+zAGGwBrbvBUVy8GhAAIdzBAADFWSxLHNC6Xby8GRAAMMzFAeDFHazDDcyyOvzDwrsBN5zFKpDGcRwAE/C6GGDHy2sBTkzHedzBPPzF5QvIcTzIcWzIh4zIiazIi8zIjezIj3zIqivJk6y6n0vJl4zJmmvJmczJnRy6puvJoSzKmCu0bBu+/2rZtkVrvmB5t6z7tYTZyqZ8yoQby6Q6tZhhnL/Sl/BbuE6ru57KvONby+eZtm4bzHp7zLM7zKict2ARDYa5lt8QXowazapDtofbBNJ8ze5yHBazF+gwfVWwCM4KBtqMqU3SzQ3wzRbzBeYcBu4Mq+4CSc9MN61KKNP8BSNgh8WZKvNcEIVjz/Ccz+mQcVA0zu3FS5Vw0JUg0EexFgddTQn9ztbM0BR9Fk2izYtwoF3Q0F2gzwUtz9as0ZrQ0Vbw0XppLQsN0P1wDQZirJD0I7s6AlYrnf4A0+RRNzmgTHnRD5rCI3WjzwzQFwXAJTTFzt9gpmI2QyrdKSw9DS8tCP8xjRsj8ADMkCn/ENU4rQA6XRc8fRO6pNNBPdRFrVNIDSwYTdHMkBVMZNTXQATsbANUbdWFgNW3dADokADMMAmQ5ADHQdRLwYowQB/BQR5twUQmWh39nNbAx9Y69dbuMdWqM9c5UNe1eNcwoNdCLQh9LQh/vSF1I9jz+CO9ddgdw7T1tdDjzNKncaK/1dSNM87ooHl09A0CwNqVgjzT3A8dU9tskg7SnCNELdjeiho+yM30rNorUzdGSihzkNuynSO03Sm3vQi5XUu+1dv6DNwkgNcpVdy4o27mLM2LIADdrQQlsNbPbdm16N3lzd5459vqMNIlsAD9YE574AMIUDj/iYLYpy054q065G3eh8TY6j3b7S3bhVADJ/2SMkDf9i0o+I0T+50aph20Bk3PK83OIWIc8uQA4Fwp0lACNsElBRYXtw3i2kwjgtBk3KDPb/0CpG3P0HYJTF2u18Dh4rHZAH3PgoITIu3hKH7U1rziMT4CLp4OMJ4Ohj3jh3kJ5swMXW3bTJ5bL/AAPK7NIw7kmw3iPP7RD2DY0ONb9t3TPB0EJuvfnQbl/kDeMl7lqoPl1qzlJe7hXX7YBA3mXt0xZK640HPmSX3h+wLRVDYccA0ALe5b4+yJIe5IstMx4yzkyGMS2b3k1qzdPJUE6AAl300rxz0mhO7UKoDojx4N/wedAyVeIrsd4pFOKJN+5yzDJZdeUiqg6YQC6Cga3iLN3uR9BJo+0uP9zKfe6Koe2+zs5ToyAgQA4SZaioJdesxN4f0d6GiT0bvORLTOVOwN7HKh641D7NFg5wuO7K8o2My+6M+uBNFu4Vib0jcRi7LTAGW+IK/xzDTFDNLQZBFB7w7A6isIPSejz8SRAGItCASSF1xi1saNNulsBCwt7zWw74WgAMzAJfkOFeAQDf1+Mv4e8HpN8C1zHAmA8Jyu1JE5z+DWKSH/AFNG8RLf8hZ/evce7iHD2dqAEC6t14NNPTfNJuvurmitKZUyB+Cw8p/Y8jr98iOg7xj/4cbejf9xcVuCjfOhbdgAkdU9n9go6xEogFTs/sq+wPWkccu9GWXnPPbiXPYXrfUVgQ5LJvZf/wptLzJvv8ybYNS2+Be7LA93v8/bsfaqHLi0PLyS2cvWu8qyjM14e/jHG/gJGbfAHLVrWviEj7vni6aMX/lQ+77RmvisnMrQ/PlmdvZKOfogffl0G/nrm/rNW/fD+ffbnPmYP/iSP/m0H/qECve43/pi2/naW/uguYZ2oROLmFCbnyx7anu3jyyHofcNw/zQVt3M1qqDcRrIPwp8R/yEhQzRn0ujkP2e2QS+GTzKoCOFwNy9udFfIP728Pz7Vf45cP7inP7A/6ZrmKkoUmP/CIj+1x0PICAMAFmaABGcK1uq7fnCpaAoBlAIM9/7PyBAgImAQBkPORsEHIBDIHAwUqvWK7ZoUs64LaYTKsWSy+bsaIv1sgQ6BUMHEEQLi3n9To+mSYUoAoFCwA3AgEjBlkFB4F8AzkAC4JNkAAKAQZSl2GblJYEjm49ozI9bTdzOnh1e1MLhQMFBpZPBYIBACubtTknk5CywJ6UmwUJlQwln4GAhGamaz8AAnAPTFFPAAENKisHqHc3Ir2XODoPCA4ImjoPmggjUXQoDuElwQHL2dsqfQkMUJ24GJWDAqWC3R/b2aCv1A5ovagysjdnHTYjCPCaKkLskB506dgDc/7mKF2BegHoalSEzxOeiP4BN5hQgaFATQozfNDLsQwIiDCQRNEXZWAAdAh0LFNxx0GBp06dC5vjUBUDBDlsMIk3ZkuwqjgcKDCVbcLLBpQNMS2SqlwbtE6ZYUQBtUVcoUSRukCpd69TsEBJcATQoq4DAACckdCVmMY3uAbhqF0hm2iCNEAEJ2qSZq/XZQxMQiEYwMQDBAFuZDuxlkCAXLgBQR34lwXFECtaJ3JhAsDnAA3GGLqGd7dTEZRpHXcMeUmBEJpoMUikDnmKHcalDtLg4IpooBdOoVUtp/fq6bL+1qRrCXX53ohK+gwS3PY44guzI+5hvngO6Cq3JQQIUD/+glx1g7EVjRV287SFAJpoUEGEdi9hngi5QdCXFIStMxUkUB3QYxCJEGWBAJeWlEcojY1jFYGg+OBgFhERNGJ9gvUwomAEESDLAArr4qE04OT4hBYslsrNjEAREFkACOAin4U9dXXHXD6dl0kBuCFwyRyAvUBgAjux1qCE6PuJQQx00WeIWCgpoOGaZTALgpW1hGqmLFqe9wo5VdFqoYHcx9qBlPl1+KYCemNi40Tg7oHlYlHPcAt+bRQgy56Ml2IknmFZ1yGcafmbzSKA2DsrdT2uYEt8fAsxGwqyynURYVS/MhcqIWwTmjJEPSAGXp04Iy9pmhH1Jwq51sYCljLD/4lJrgkYSVtZUJKD1orKmSTrsst2WUJitgdG0UbK7wgHaKFleclhuAsJG61orcPTtFEnBUeBIZd6gRQHPpVfkfspNp4OoO5AalwHzMYDqC9TemtyCPdR12lUExLscwhHXe8K9R+Zb003BOeDvNysKXGvBtnE8ryEKBziCWg1v9nCPHhdp1h0UFwpjtCRkooomlzB0yTpQ5rpYM5D04utijiRyqqQpslaHFEt1oskBEUriartBO0r0JAy90gs+TmRjB2MrGakhPlLEfcACf0hCAENS0muJIITofaWhPGC8WEUvvXg0pDGLfGQvax91S0FaZBIY4ixFoY/hL4waoCbJ//T9R840FH1nFAn4FIR30iybm0vaXCT6JMKdOQYUjdfxeOlwOkr56Jbn0zo/msvcyu+fQwx7OUmb7hDQZzhfRa/Ps2ux9NVbf/2zgWO/PfeJW++ss92Lj8b14TM//vXRo9+F9uu7/z6078tPBqvPgz8//lfU77z5Fef///faB8ABmiF+BDwg+u6HwAWKr38/YyAEU0e9CFIwbBOsIAbLoMAMcrB5VehftiC4P2vxgFsfFCBnpNehEDrmaV/QRgpCeIBYrc+A2zNh9XCYwQ1yT4fP82EFHdgqKrBwBUCU3sIIdYLo6fCIF0yCKU5XhhWaq4UzEAsDAPCaE1gDfihcgf/6RjEEJ5aBjNBzYfV4uAQ0ipEuPRTiGrcHRxBWcYBaGKHiemDGoHwRZFIkAxXjSITO1LEBbOyeDWEQRouNEY4+2CMC1ajIQyahkW/soP+MUJe4aUwnOHmdG+yWRanpQRO4ccTfjkODBOSmaKGEUhZ9MYwMpaiTkviYBKEYLZsQJncleBjB0pG0RyhuKjIpSC9pdA9agKhNQuOaRRLytzMkkgUU6lHTlviSYWbilvNAJYkYsZE8pMCbKAgFMWZiC2XKZCx7SMAdoBQFpxGPYBrMJQyu2TdgCWab7JDnWkAxz3CGCxzlJMQ3NZHOWvAime4sXTwrQU+z2Q9sPaCYEND/Ux0DBUgW6PhbARxgluAUoRBiMcFJUUOYed3Ro/x8TG500YBkZXQqg9NkH41yMAFoJotbLMFrZmiApfRmM1TsqRZ5Kos8assweMNMHTvUH42mMae+6IVn1uWy6WxxKt0YDlgAcNLfmSA7X8XYXGTq1Ma4rCs8u9MIYlODmFVLepL8AlazolXpMKdJdBkCWsMyFrKWwKw2fdfwyLUUxCiGJm69lUrlOpZD1LWigPMBk2pKq1OFDmAGYMAwEbCqATTTSg97QGJsEaSZXSgHf5vdAXSR2U6SAFQ4tSAP+uQlooTLKQh4gA6SwSYyFZMAw7QEqKLHpNRooYgdAhWjIElE/6u+bQxBsBJ0L+HVF3iptEWkk1W66yIVLLdHP1qAbQcFCr/m5hCDqip1FUel68pnUdq15J0Q4N06gpe7+h2va3k0JCClNz7r3a6IIFQmy3pwBorV7J1udjzPtkWL+ZnYCPiJnBssZSx8SpZnvSUytZYrvOGKb4No9i9krmApiWgAVvh1suIidavUGRe2nvqTqKriZdK97ROXoBh1xZKvcgCOG/MbVhfUsVYmvgrRrlWucSHADY/tWVyHMGPKFpGa+FTkkFWxV3nRJ8l44mcRnexfKONBynVFi5VphWG/bllWXS6gRXlQN3nSNk5kmvCKDIAPcSZNYAIl7kbWlYBPqP9Aa1UOtIg1pIs9/6HPtv2yXUzROW2JxARzOVbrAlbcZD7CNYQYEIFooSDn2s51P8Z09nwQIWz6TZuuI12LavsJqfkVZEV7stdUkLZQ3yEbD4VSPOsAWLLdin+wXsGs9zlNi+A6Oko+dCK6fDRgl07Yql5bsaNwbHgGQdmKo6izLwtAYuXPLFbKM/swiclqyjuNdeTeXett13vLEd7vy0YC3u2+GMYGz7jVNwXpjXBq8ht7+V54ARtePn9DPJLxrbj8FI7xDj584xyco8cZqPGQZ/ziJLe4yU9OQJBvD49MVvnIlwDDKEj8eYtcYMyp4HKVG/zgZtg5z6d3wpYvzVf/Sax4zlmAxaTq8QWvJqFdat7A+N7cj5UM+tB9jlcZ/RFqWAdy1q8H9BAC/eMpF07Gmm6Gqh8w6WxH+9cZHORJcj3udqV4GxyRgEoER9oxi8VAYEnLYrQSEB9Jh7yTjo//5kUWw8BHA6Qm23Ok49DTlElsHsEIUjbpoGvhfE/OOVC8e0jWgALnoZUqSs/HcwiYFwAUhmAhy4/kHR7vOFtOP9DUvzIn5jSmJmA/ldmDkyTNxjjLe2Dl2sGVzVoZjLxkCtUkWui9HI9vZeAB1W5NxmdW4RN8wnpS5WBjB4T1gxNqCthwhXSk7DHpWEh/PkHCn81t/ehZ7xvnQ8QeE4mo/z+SkRzuXRWzCJb9ORb+HVaT7J/wyd7/GWAAhlzy5db2mcSGJFhrnYZsSYlmaUGaVErixVeSNJdzmIidfJ8KfKCg5QV2fUkggdboQJiXwCAgjFZpyV8mbZ13WYlnPZkQJFcD+l9pucGb3N6zLdG3EMV8KciE+KBxuWAQLsIQ/gECFBnS4SDaTUVJidlW9EIR1AyJAcaHrVL8haDWsQC7rZrrhYv3pYSZkcySgczL+FWFLVrn+VcdXhiWxaHQxduhDNnfzEVrNeGaZcYcElMs8GEJaNjCDaBgAKKnPU0PFiLeHCIkPCALMCLCTeAMkCB7+N2IMITnNJrdaJajAcDDUP9SEMXX3Hji3ECeqRWAVTCf6CEaCZiaAhzZEAzafZkYL+KaofEaFg5RD0Qbr/UNLkyirjWJqZEJ2SRAImAbOvjSxjmio6DKMfKCMiqZEDSjHLxTNErNNMKSEaobBAmCFV7fGdrdCaRhz+nS/7wd1lkj98hj0HHiAiVAY5nh3LGjL5SOwN3TOq6PPfIcPW5PQcLcMPrj3Q0kQwaQQz7k/BykRI4PPlbkxEUkRr6jH24kAFGkRzrcQoZkg/HRD9QM9miGBJ4dScKXRrZkv5kjTKZbP7YAAhhL/DlATiaDiFQIXQBkP2SRSjHVFb7kTEKkUR5lQ5akUi7kJrkhMGnRWmz/0d5lER2sFjZwCZkgTRoAVznWZFPGZFKGJUeCHVnKpEkWY7IkFTo4gAAAk1kUWQM4AOu4gTf8YBpEJfKx5FkyZab15dShJWAeYQ62wbIIQAM8QGIm5lhYm67lhmuEiYgwQh/IYjXy5WASZmFmJk2GHWeimCksy1K4ZVs6QVyOC11+Um6YRUP4gdSZ3Vh+pmY+kGzK3XS9z9Plzx6Apqyt5VVMJeLlADJdJesQTr60pl4WJVhWwQwVXBnR3NeBpBWoDxN0HQDlpllmZwuIIgXOwNGZAQ5h5y3e2V8u5z24obbkJHr2JJngQHFCxpF05YI1YnwdQ+lMEwl0kb1YJwz8/1R0zqZLfMtrilgJLJ38vJ14YmaDJMIMqeIjOdL7mIV2xpoP3GQ9Oui8xZc+5gkaHlLZrcBh2J01xoLckOfWwd2/YWiCxiZtEkF8bAs4wYIO4EY2HRprpV51OCBN2IR9Jgp5/VpHiRLxnI5FOMKJpSU89gBKip1vKmeSzsDy9AY7UMiTIFvRHF592AZEFVrcjShqkBbwkeMxZdHrVcc8vVM8LcLq6IQ9yBMx0R436RPqoRMi5dlQEIVRpIdqiNVkBdz76RU6DM8WrkD/WYi8qCThlIAgrBYCchiSscpUhU/S1Sbq4NZoaEJpFFbSAElRnRsyvYbkJIL1vVVkDaiTJv/ppUZBePhCmNAB3nwqT8EqAyYOqcbVetAFdqhHEIiZ+JVhhOVR/aUVhLIoMeZW0ZRWKILpBQKYBRLq8O1GqegXQERJoLBCEk3IaPWGfUnXpNZmt9bWZgzX1OzAcT3aLVLK36hXtpkqxHlpMhkXb5UrECaOuvaaoorJoyAYC4qrfLEggNWpYOadp72WF2YYFzbLnz7LJbLHktKELkhhonrWW/mMkcEMb1KqebZoC4AgasjYuM4Bi4EsGZ7AxGaZiAIoxojBqxZZjVUsrc5ZEVkFy0zFjAGLxxoCJC5ilAGsX9pLmWBbHmlKNgXbJzYU7EAj8QgXoKgAUQzAteJAoRH/aeZMaOlhbMYW6wwYn586Th5h3lANwiWkor1AlL3OI8p+yTq4nkh4LS6imoKgadkmGfFol7kBLdcaY5sQLc96JgZ9KBW4o0BeLcZ+K3juFUlKJ86xK86NpB3xJxUAXED2IZJabXk+qfhs6EwibiQpLsr1LOVi7eR+7vyFrujyLemWLtUKLqUSLmeyLupqbOW+7m16rhWsKAEl5GaOrtidzm6e40VSqOzOrupaj99KQ2tWwW5WZ2DS7g+g4NXJDyThLuxWrfKRldsqn088DOc6D9Bhp+siUMjw4/BWT/HygIFWgfbyaTo+S2CYaEcKLxY4bxds74FiaOyerr3YAA5c/293Ftaw6o/jei9mMpD0fiSA7i73Ou4MSKgSBQX95q7ltgDkHUQcKBtAlRKZoBfXtKmaGh/BaF4jDFToyYGkzQwdVCkylanpAm8nvgF1LARPmJIJGCkoIoIiMALtdUQ6XQKFMN7WlIONOmWWDEPvkWnuWBuekKg2+AM2vEQQSFQtOg3gpQY7wK0OL17zuVY/EIJM7KOXUR0RHwKHOHE7tQIrjDC+iMAJj2mP1gYn7ASy/V2ZgIMjcJY9tNMwxR4CfEViYDELp27LnCdHEc766cdUGPJXRKBXFCCfJkgRkLAUgN92yOpSFXClPtGdKpTBKEBSyIp6IIgWFl1WbYWfLv9yr5KFrVBGWnxMW2hB9gmrEEsDtsCDS30DrCLxJTzG5JhDf+yqpZwy9EVKKjcfTIFLXKBXoH2VwDhmZ0awY8yyXfIVqC7VwNCGI48AJOvGJPtUrKZQrRpCKdNLVFhFEWRHnO3Yjq2mMU/GHwOonfzJPMmvl9AJHeYr5VChFX5IXmRrNieRvEIh84Ludu4GjQiKqsQHq2SIdXEIG+mzEo6I5pkIimzwipjIvwb0JQtOLyhEoJUrLitOwmQXe0kBCyar4tQrbCXJUBLinvwvBL+0tXD0MoJJeh30hWSzFpTrk4DghaA0GvVXT9vIpWWLTQmAA3iEibQz9vWBw0BMFpn/2MwGx8zWEZr9it6ULFidcBK1LJmtMPXmlrR48s58DFbfK7NwYRhly0vtwLGkYUiJVXkkSxoibMB+dRwdi2e1bG7MQi4PT8yQGc1iIgGaiWnOGWylIW8IQuiAtEtPr13THV6nwaFSs8TsIcac8B2FrHK8rGWjkZpdSK2cc5nRoQ2soTO/JOQZz2dJgiyuGeIkzdVMwlSMo2ZnC9BG7U9KQmyxFqfNU9var1I/9kA/E7MZzegoT9HVsIcEht0GXzqVB9bQDdjOjd5i9MU4d4h5rUsogB1ujpFQm4SMEa+Z9KxZMb68ot3cQMLIbTO/ryJhdx9Qm7HNLa4tTwzpNnd4/23eeI95jy0gkLNkj858w3a2CMxzR+7vYlz5uuRpY5Ili2WDE6hFPrD4RvhgB29Gw2/ILfhSWngGPbhIviSIfxCFZyjVAffqMq5sfi9gsjjqau7rJrjouvhZ0viMHzCGO7aHD+4AP+fz9O7/2LjD9VkJ8fYO4Th7r0/DTmSJ626P1/iTx69Lp+8AuR2Kg5H5te9rQpgDf2cb7ZH7GqX5OJHtnoCFos/+hDkgu3eMR/kVlDkDV7mbt9ERELl3GvlDcK6a73iGq937QMH6Et1y2+aaW23SBV5OeAPcmg3tBfFK54yi58FWiNsM/3c2yWgCnfgTjx7ymIWaHkIeh+lYcP+eZmGp0eH5QbECKXGTt5VNwMDSMLWxhuPvCQSxGpN07oCfKFEwqZENK7DFWv6ZJZTOkeSOqbsAFEvbMmxBsoPTrM+5Uh66j8VGrdZVsA7Pox+IetCDEekKoA5Gpou4+fVYWYUQWQXSAlLzDKcfbVXfgnVgrvTMerz1dnEfU1jZR/kVonq1cGeioFrmRoHfAeQ7gQBHDZSfftDAssRGUhxA/xX8A7h7DJD7KKc5r9bfsxPrYB56tFZr1LzXDrpRtuOrhNSeICbqfDG0+1g5HZaJ9WULuv/gstBgOWiWCsYAbSX0C+xFaI10DphIiH3ItOInnwMFlSQRPAOaHwwVZwH/IT0r/MuRYNJ/FrrivBAuNGtIkb4qYcaPr/U4kfTueUYK7heqd8RgmLUHYpQlttmLc4tZV5IR2YjzO0yP2qiae2CsUH0YYlfk4R3aRgL4ajqj+gssmt8jmUwVFKQpMm8UukD7e5vltIR1VkdPvrywDLBHPVQ19ZoE/qBbCJHt+8vVLNErKBAoCSv5+Z1rNBE1eSxX7+XI7aK/A9ASbXMG/mLPLcGFy/dd+pV/seAGkvXVE8yTa4jYlLj9IoSJLc5/J8EF3C8mTXS0IqQlzX47fp+3ANFqgWo/rWp7Y3GfZyyFcjoPAuigonO+3Oxl0ym6QN0KI/b3+woIi5RUmerD/wDY/37c1lB8gYAwAGRpnmiqrmzrvrAZwHNs3zChMDdR40DbzzUMGkuMgqGFcOB0vKN0VRTCGk7TIREIIACCQiGQSHYLPp+hS2b4TgL2aCAAjAOFBYDcXW7ZBFNBVSqEKSKCiYqLJYYojoyCCVk2b5FTkCeZlzJdIy0HCks2k5yYRkMRbF0mA6MlDV+hC2EHDKKWPnUlBwEPliQLvmBzuyQFTgF1YQANnwGBpiybJNTS19gp1tbZ3d5EMdzf4+TVqFdfJnd9iHYGuTULA2zvQwYFJIh0DAhsX9AA7rmrFo3ctnIIux1MyLDhnnAOI5YTpwnGA2UkEAiIZaKdEh88LP8hSACAQYB6JoTpcQaAzhoeCf4FEtigAQBhBcctBDJvgA+A1+hIpEJjKJGcQo1aKWq0HYqeJZwGgdpC6ABKUijKiCFAgScCf7oc8GiAARc0NXTgOQks45liYQvIDIhvwRguOb/tvPFgB4AExlbAmxpYW16dTLEBBXqDccvCSltw0wrEMQupb/pGyVcMiOY9h1vVuRUaB2VzkUlwTD0t8Y12CkqbaEuYdSPX0iybRgrZ9iOITT/BEc75iFQWSR2ky3pO6TwyB3wXwr0iLIJeq/BYBxC2wR20dkYr+HXnlWo2dU7K/a4Hmg8uCvSwByMHAIHyR/ayuM8GAIJPSjTTRRn/C3ARQCxs9BLIcwO4wUd8dpzRnoFLCBUHHnpIdxt1KtAxQAHbhQXNGhnJlMZJF+ZBnyezBYDdSVF1dmEAIxRQRy8HWPfiGoE0MCAPPnaxS1+CnPaQhkhuCM4LHM3SDkBNxscSCYMxw4woABAZFYiP7WGTOskQkEZLy9nhgDAPEAMAlloOwmEKCtTxxn/HGCBAGX8JcKcM0UATBgNmCTDmAGUis8cyCjy2AIQOfInkZDAMkEB0US4w5Yg1IGAiRovq0ShOapbwxnH6CAAqIjZy52KlTxJwJ0x6cplUL0U2l+Sjb6KwDorPBLLrPa8MRloCBrwoVgmakiAUQPz4A5pI/wg02wUCAhFjrIu2SvYCjvbNQKc7/fhzgI/EgkZQsmAgAK20XpjrwwEurYJPkpC+kNSvAYJGon+bkrAGG0rMi9kMpBZTLao3uvhrq+FOi+6sRm7l5q24vmDNasWZi3EzwoHUbUYF+IUlCn8mkd5MAcDUL78v/YWAShyvaV62rb0QJ31g4KODnXjCgc8woJVsI7Qtx2SuA/jQ0SnFqFkc6S4b13STey5usfLSwQSwEnGjEqem0lrHTCh945bZ6qtbAppqlomeMnFCx73mdUP6VWegi61yd3eOBjZgFh6W9LILf3iY8LcCqQIU18qaLu7fW/Z9l1+uJ/w7Bnd3YRkkiv/0PO4iQAw6WKLjAC+4jLP0AufCrHvbtdaCAShgNNVRORtuAlwT7HWpnhcwwk9c8J1g3puXBd/aytX6NtMxGlU381Js7PaSMdAGfUT1JqIbOXEnQprylcEQxl1A/ihg7Hvco65XWBrglTKIOMBGhtVQqHcXDrxYJkPPX3/Dc5NaRP8EEzH/RSJ7RZKNN7oniKtoj2YrqMUteAarWjTiSzdzHwMcWBygaWIZ+JDaolw1N/5RzoAJGSAKNYTAFVLMSNYgS8O8gC6CqCo6ezgAAbgwAFqMIAxe2Iy5BJIvVzAQISp0oUFOqMTUtLCJLISgCsiCtnxwyYZrQtRmYiGVkdn/kCY2wcmehpJEKCqEiWYko+rSKB0Yig9ASyheS7qQKKCoBUvPyYMIbmG+RswEH2FxwqLahT00stEUZTykQ56oSKW4sZFLdBokESPJSUaGkZZcpBQzyYlEchJ82vqkGg0pymw8spSIJCUqw1fJVaZwja6cyCZjyZxW0vKBtrylNzCpy2ucEm65858nm7g9RQyTgL1cSi6fUEBU/hIhA5OMAk24zEMc6Bi9CYL1BBG3YuKSei4wybxapKpppsASRzynVrbZg4jxEgXiRMEbFMTMjOVgnc1kpyor0pBoTsOcSDRkV7C0Nt90E6Cz5OcL7hSbE+jzBQ/dDz6nENFQVvMQ/wloKDmNUFEVdNSh+XRnQk3wr3YBkQwGShPhKmSgL5T0C2HwShnm2VITNGwsA6IfNcF5GRvtIFUp0sOM5CECEBnICe4T0huSipESfMgTY1BAjgAiEPl1QRjTkoH9VgrKmr3ARugi3OcwVaKW1LQ73xFBL/QAEq6WIK10WNWPXlSG7/ggqkFywnbG1wbJsfKiuhJAWNeBHQLsK1mSyipaz6DWsLUVP29lbFzHNVc21PUMd41dXu9nUjH09QzLa8wNXlILwflnBGxK1AB+hy1/pUxogppBpfg0NT18i26uUcUqOlKAWyDARkv7FGMkRakwxoaDH0NuK0bAo/DQUyAe7P8momTGtq4SpQQQWEUEWuQGkcmpBmTlV0tYO66O1UAfX+BIajcahkCgDTC88AU8fMVc2coiPhLEhUhdk102UIC7UMjix/SVqS+stlvlFdV555DeL6xXwVZ0L57gS4Je/CItAPFdQOzLHfyCaIIfnU5oV2CAveWtsauAV8IOUOLhfYJQb/gVbat1n0IClrcrEkBJ8VAtZe2iiO/g4QLesEMa6VQolqDDc/EBxGgdFMHZweHkboysVRQLW5YIL2JXnK8BI0IHOLqWlNH5iRm+7DlswbCPP7YwOIZYG7BcwQyvHJ0sG7bAXcJRl8lsH6lWLcoQDpWZ5UGPwXQpxlYmy5v/fzNiFRjqImPplZq8mGeFOQHSiAgFSqTXiDTBbEq4pbIVj6EMrE2tIEkRIWNi0ZaNIbkGy6rQOGU2RtoijbrGROMt0gQGktwsDgR5l9UqnWAqpSxUYvgEpRXMg3ZU0T8kMUk9QgLr7zbDbG4+dqNF3IJd58PXpwt21YwmFByB2mMe0TCuQdrsTzx7JCVJM7XX/IaNKVrbfzWN+M6AN0l/WXLlxhu/cdoFm9A0QTYVy4USoNNXijpnrj1dVofKOvzNEUNvyOORrd2lhff2fQTySplKFznQTs+iLHBffBfwLy7YcB6yM/CKu/M3G32iuSUvHBLO4pTiqWUMxgNctT8m/6JI16nm24azC1ReYa21HLywizmxac7zm9vRrySoec8L7RWg1zzJ1i46WZCeb9Em07rcPvuUeXoEmKk97SiXgtvfzuiy093sbL97nOFuhDGU8O7vtIHf9V53fRPe8Hk/fNyvq/gD7r3xJ8c75BNf+Ml7dfGWXzvlM4/4znNe6ZuvDTm65vDQc+/vZgx8dcaQTTIilJJ2j0RSvJmCpNjA9kbA/eMr38DWa3MTpA/ow7OC0HQSc/ctcICkF4j6R7xeLyPtvehv7/unxR70itB9N4Ivy+F3w/hKVL0KGrAL2tPt+buMfoX7dth/qK9hBigpjxDwJQcGqWcb7oN6rlNT+P/L/6k0ElXREVR7QCHyJ3mXxwJ75Vl4sjkSx3AbREc5JwCBlDMyJTrdQVei01iB4DGmZEgeYlSKdTd3VlZUowYEOCPNd3yGdEfxJwcJcn8OAh86dSJ2IiHnowxL9jVFFSIk6ETqFzOuZYKOkhEkMXti4iLCMBYTFhiz9yWzZYRdMl4b5iumwig2gRHMoH0PdzH3RQsfJgoWBDa25RP4djOqYVyu0lsmU29zY2Gklyw1pBggGECVciklKF5UUwfB1QCnsoLhh3wmkEE7gIS9BiuDUia6cBNYOIYUSFVMNgd2+IV4CIRJdwJd1n7mAgbvkzTlZzrJY2aigUUL04lT+Gr/PrZjP/NHU4iAjNcCbVYnD6Nj81Jj8hMn3FInymInL6YuM9BlhNYHpAdmrfWBD3cvVpYvWrYyqngwgOhC4peLLmKIZgYtG6WKs7iDvBMh9KCM6HdGl2gC5zZuc2FhAHBrHERVCtBQz9YKWQAUGGOO6JgFqKgoEOJHdNESWCGIStIC9gZHsPVpwrGEaNgMYeQnI6Bpbogs0ZZmoSIpRUiHxwg1ZaJqScg3V3OPtSWEkCR+AtYVG1R+afJs1hhopgZb6dMSkTiFUXOQ32iM14cC3TFHUgcUeYQP/4Jz6paD5pGTQFF0N5l/BlCPFuIskCiUrsh3KiB2cHQ4QJVTP9Eu/2qhg0e1Itd0cAfycw7ZDhfxkkFoDRUnFq4zBlE3O0lYO1l1O8+4Qh7pglMYLpQljHgWaFYZLQbylGSwkmGphHdhfsIXk593JKZXDuC3UGuZa953FJDnkeXAhYEYjpx3TMw3BaHAa+mXmNK0mPyYEI4JjUE4eZKpeKEZmLz3iqQJmJh3mqNJeKt5mk0zmK6plPskmrPZSbxRFTTiSLUZm4IJm7ypUJ4Xm62ZCMtymyvwGbqJmb/JmL/Zj0mpmrt5QMY5RYcJfcrJm8zZnL35nKTpSS/FWTYRJIkSVBGIPlalNctiP0WJIfHFDjmVPnLRfb6pnduZgPRpn5tpeZL5Ev+gZkGM6CkN4IF7YJnLMl1Kg4UdMQIwQyfX9JepeZ+lKZsQCpzcGZjeuTddVkOqeI6xA0JBVJwIFi8Ak6D5GDmbKJ8POqHOiZ8qKjGoKRGdqU4wcACs900pCiZZsirC4Z+mVgJLWAKiAKLoeIUNVxwCeaKRNJ/2Un1oqUQxGqHY16JQCpvPMTPd4JjW81HKJ0ACNXAz+Rzj6Q9RGS0gF5J7gFkdhzoZs3Dt4ZVoF6UrgGb1BxlPmnWOsU2LtjonQ5xM6qJK2pzPhBx9egl1ulEuQH5cep1650ljU5lx2qfCcE+2yafK9KfL+ZmvRoNWSVQfsh3fyVR1IIM5GBgiEAf/JAKqb2AXpJpTJSVltWSprAmCXwAz+wCmXTISrho6d7Aco8KAZiB0amBZM8ieBLh/dHBTbFqAfcBZXwB/rTh8zWSh2aJb/TGKiQgqyjKJHUY/L4Fc7xUr0YF77ZVclOADdpETC9oZiAmri8pf2tUKdLQLdCCgx7o7bAgYtNGrtqBfxhYYcBg2NdGHXrJmAJGuhwJxUQhtz+qb0fp5gfqoA6YpPTaFv9JiYlFkPWRms0iiH4OxQxY7+0hjnpio7Ap4smoW9FgHt1gHA7COripe6ZKvulMnhhaMDpkzG2qTeyqyQ4QPpQhahbqipimlflqhJ1CPmoKtLFkol1aMXIR//yjZPAOmGr6oA4FxpEFrSA2bTIx6XxViDEt4Fb/lqrAls8g2bRHbkCjhMj2qswO6kSxxlPE4DENaqTeqog9be3JZVhS3C2I3cBrHk05Jqp+QcRKSqgpgNu+ZtV2IDYYYA4y7ZlIQua/Jok+RDmkwr84iFL91ZJ4gOuQ0dmeRC12XZgMygEYZDZyrcO95lEB5BiObn/VJtJVrt8IZnZA7qE+hu07Fux3iu7UroUyTpztVstAJmZnnSd2hifvnf/QADfSnLE4gqq6lf+rDVc7bBwD4VFK1IirCBydxgLYrvBRDvKVnvN35mZr5cKDGvBEJb0j4Lkv4raM4sNTVJgqbFP8H1lzAhaBaGLtGK7S0m52Aqr6N50mZiGdA0RVA+4mPEYqrUCaGKGYMXDj6y3EiClpHSbmzC6e028EePMCYmpv/A7zCZEjjiJHmIo9J844zsY4SJkRO5cIk4EUsrI/0Vm1ty4rKlZ/NRBWgKbv0mbco8Bm6UUwcfD3K2zc0aZbKArtCCRQ7KUcl4JPRQDhJA8U5SZQS1y5HmZMBHLy11xvI+U9YJKmINE1+GcZiTLREPBxmPMacNJx0R8eFucYymnpCrJ1v3J4nAQ0FUnA3tcF1MB+HRMdvx6jpQSE7QoDiOciwQyPDqpHcaHNxoIHvETsLUJ6qdQfcGx2A3DecbC7/oaOsMDK+5Iu3QXg2JIGPO4h7hnLIuFvHIJgeIKQmfeifm+gn9xpbC6KI54UGWiBfoOOLm7G/GXYytSagvAwo8PW/bAzCUtrHUgsNlFUuikPI7LI/UITIaqfIPasm2DhyfUIA6CJYJWlsGWOza5ssK3toQ2fN5LIE7wy96SBY4YzKIezGq7x8EAc0MPIhj1E03MyCvqlpu4sDSUwF5mS+Wmt9R4kIJ3lFbxs0bDg0c2ls7SaF0pbOYYvBezpqWaMgKHmU+jylLUrNGeMnnQOXHvcYjiPLw9cEclzCjEA7yERbNmq5R7uzK1mXF5cocAk6n5vOJVF1VFK67eyLWcXF/0FTaKl7cQ2Sz7K7tclrwLT5cL0gw5JLfTfd0EWAx437wRTK0ymN1Yd3oWiJng+4ybbKVS7hF7WWf511gZn8vWe5HWKVcKxLBkX60GRdtGatysirnwKVDkpLhqcloOslFAHSZST1WhcdWyuRhWdZKTdDGwUbNrfFxlZt2LOcvoUdxA+HzyWairWIDysrZhYyAA8wawFhYr2ITquIaM9bZ2HNiib6om08zXtcwKO9vrBZYlmDaqYCsAPpIpQmFLdAYW/VtEankDVglvVWJr8W1p6G3IX92SxgNJEBZrCHvtIa3AdsSFudD/Ozngw3pjkXuw7gFx0xcDNicJYFynm9N/9PdwIu/Z68Lc1vtHStPCN++xxuKjdSe5mK6poqDdq+SdOyx6T+lJzoC34FYJkkcBE8UAD4lw1OYRIv60u/fankndUHvWxTgOEuEOHOU8sf8lL641ZNJ8PMUMa8dYHnM1PQwDlXBdctpT8k4NwwKd4Oi9axmuC0fIwBVMWvpWxLgL811p7u9T4aZUVqoydNuIhK29jkJRUaYZ1GLtr9TdpCzrW17C+yrSopJiqwPTVGd46z1g6EUo010GOsvWJcbsKfyd3CHZzGUZ3X8BMFzuf7HEF+Dj3ptD3gbCY5yoQ1bKWqEgU+kaMLEFytXByaRpLxwBjLbeeVnidePuZXXdj/M9JUEFaYOGDqJgDk4AibzlboEEUIYq0I26gJoZHoKaKEIofFmMhrAo7efh3fBXcee+vrWqPrAXcAg/QFHv7pdzuhC84MLYDqNiDtNRzo/R1D7ubqLuDQkXDotR7aMEDcBo4N1B55g+3sqzxOmDyzqYIjNkiAvdvi4iIuNQXsDBcuaw7ioqY/fNWAfUQl60DXLvU+J4UWwdojEsgLVVmqxbi9Aui9QlUfjo2DiA7uMODdXKHtldC9zH7uEPpL1MoKa/0D/6om7e4iWI6gTpXkrsUA7ZCwBhvrOz201GlF+0pBng6kTtAW3VquGPaJugwLajiuy1WF4dGHf/ishlLx/18+3k0/5KI+TuxMeievQ3MuL/Vrsf1Gap3jL6mNpKve7KEiQxEcX7gd2wnisYYGGnP4VqNgRHPDxc0oMMWwzWDf24L9wQQs4v0N7Qrb0TM7NpdsCT3au8cA3WPEaXA7AjL/pigdFQEOkBsOpOH2aE5rzFPLyx9ukXHDxaaGtTp2bE78+HhP2E8fmekuKko9jAOC8j8wIxK8C7eO7CJXdPbepkkq9slOFjwZ2WvhvdMoIV/3A0SNPgpvcZ0P0kCtljB9l3NB+v5t+qDO4IIO5mIvBX7fkRaP+tsf6mG+5x4fBBcy5dp/+t4//WJe/U5//eBP8yLc/dQfze2fyucf/v9DHOLYSeTtipmxDgJEAJCleZoiuqIBoRLKwdK1DYw3rvO9rZpctUMhIPABBAMks5bTPZvSKbVqZUWRWZooEFiSDgrCquFNLABFb8BwhZLfvC2WKewBkXmfC6iU39CtCLZ4zQAGvWTdsTiA6fwlPSJC9RBSYmZqnlzadKKIPSR5xZk8yAAkIJgsBBxukjDClnzG2pXq7OHVtiiSMLjO2lbO4WbqyqI0HPFERgq3WEJPU1fxDiK1viYDHBgBDDCTDKwGJXi5Eay5hQ8UHJwHNACYBSQwiJwrLCCwvc7y4gWPDQEDORCsEnAmjTo23eKtGgCxG5t7e06xCsBgTYE0fZ7/JBAHK6AlMgLWJIgnSqKXVQMDOABgQIEXAQvizft4riMOMvXulTBoaICXAfhctAnDBsHJIkB/MhgprRrVqsSaXFPzjVacdfQapHx16h+OIwIUAFDgBqPEGQ0eCQAaUgQZcj2rkdTxNlbBgwhapUGwRMERFQ1c7huwRMQrbw/2AFtg4J2AeSUKxPxYgim0vCQgsAkQgZPJd96OCAY3D3CD1WMGxCQRN5GINK17xo0a0kS4JAUYMJi7tYSzdwzU5k4lEtO1rFafS5XifKMbvihmJ0lwefldxqFd9VZTHUC/pUAQ3qXm2UaB6i4MkkA4mYQ6bzNUrEHX2/4Couh0hZSA/wEILMNAeQGsoll83GWynicmgSHEH+G10d44BhBwzgALHGCGgD35UUBPByLIG2rlCICALpLIBkZ7JJajSXPQ0Uijc0HwwJkY4nBz1gwIaJeEAlGRBoADIqplIgl7yQYUfX7hIIp6c/BwWyuKHADPXwHYNphZIxympH1AAgAMhlmctYoC+xikW4K+kLCbMA46AaF1Ex7xgCtWMhKmbCIqqApuTp7Q20nAFSDAithF0l5yc05Vo6R4TcHLZF5YplBLKPiHRpmEDeJFAWQ0FICI4b00Tz1tnLdKeWRtQicLCzglBFEKCKqpp0Kd85A/+7kSg6msZnGlkSK+VMCbQAADa/+DVEJhSCQSLuHfNy/F5F9Hmib10RkzCLHqeOAw459RKy5AE1MuuiFudFdNGi9AldbIjbxaQHsvIs/MC68V4emr74wBEwzIjbTUa0zB/tJw8MIoxODsswxTAfDD9UZ6scZ80LvxxrJ6HDDIIZOMcL4lo4yjdCkXPDLLNp78cskDy4yywzvULK/LJ4gxbrwWQ7czXgqbQMRwgRCNccw5f9wx05IKvVlscqx4Ar8s9GbvlBQ/pzUJjmiRdINiq8z10y07fXbQS7PgDZFUd3L1CkB3zXbXZC8Ttnpkm2y22gKn/XdVUcsUJA6TqehVqQK8lFABTm0kqgkOsNFKS6mJRw//G0eEewYDN2HabyA8tPPORCedoRIAwqrlDUMaceQRLqwbIFQwX1eOuYX2oMOAf2iVmk5+5LGruT1H6cOPP55kLDjaKztvFeEp0mJZkhiBuiRiC5x0wHFntiAli8ST4Og75A6qmwDYQeo3bwm4tX33p5EP6ky+r+Jn+ZnhYv+QQAdAfLpzwzfOIoK3XQ8toFLBAJMjnLq8yX1lix7BbnYzClJhejESgjdCY5/LhMYAjQKf1YqAAAZEYoDoQZ8LYNQhe/iMOXbjFDPy04ZpQeiDODhAxFxhoKWkhyKHAM9yUHfCAXbHFZQjTAf9EQwGsgtGrQqiE5qHQZ0FTjp8u2Lf/5inAwMY7g5JKkH26BGj8bXngCxATpBOsjrk/GYjnCPAo0zgxnd58Qbh0d/4qJUWswxJDQVYQptSEUEyAtJ3DEqLCEUUAwKS4Ugl0MYYSQAqhfjmjSIk1BQDKMEucjFeFvTBOWAlhERhhVTO8VrDtoi0aHySIkS6Q6kcSRMjvMQVIwyOqUpwHM+lC0FGS4BaeKkAVHYOHdyKISUIh6p46DJCdqIdCQxChmQdkj40SZLFfnm8YSaJDaPqQolqKRNRjQCc7WIDCdHzqjyOLpT3GiUPYiCnRGTQlYPQJz6toTDCkWdq8rTDDAcKsQvGEmcGhVraIvCdExBoPr4iRREYJ/+E+TTleMZTwIHgg8rjPKBxJugoUkQoqjTE7kDeWEN5ggSVfARgHyqdYBV50LOF4iuhA62awayI08FlkQUgPY5PpEkub5ABo8aB4zZUmUk3hkkMaeDK6r6RrjQ4wDL7S883EGAaFzhQUbbKJigb9lMZFfSs7dOpWpsZ1BXYrkQWuks4kCoTEY1whdZRAVE/ZMNxCQEIcf3NgQ7pxxGFRkVQ4gZA2+pTbDgWqGmN7MSwQrrYHJBPdeEcO/DKru7RQhTnKUAg+RgE0ebgqkHRiCGjdCdp1rGT4itrHSAxCavQbZ6Tpaxbd8vbnkLPBq7bDq14t9lR2MOz5WOHF9BSHvj/UIQZufzHc5/ALQRgkzyGOGwyiRUfVxmCpma1bY1yuws81vQ55sUgzX67VoLKoYw/nd5tq7LeXCA0nvp1r+j2y99YvZUJ/YBfW6f3OI2aiwEYmaRGNNWRmTQJuR2hS1JKsKov2WOqf4IcOIoSuV5WFp41YEmJjHePVFHYpBk2UuXC4bvmhrK9/0VrcGcMX//SoHvfO1RwBBCZyRygMqrN6vcYOeQGiKCI5wsHYMhHnKU2EjjCQe949bgYXcqlMo9IMgCanBpPjkOsb+OijG3cW8ua+cYiznEUUbSKAA1oGYOVxANENNgVrTAcElWHHdssG8VSubZ6PMKYEjvXqlZT/0Srw6sJFcli+VKwzGmWAz2bQJT6zpOfV6DvcnmMyjSlZR+qLcFKjzBqRJcQUTbhEj0mMUJPixnAsQRWkAnFJFQ3+daMBJg2yPzYSVuh0kg4RVTuSwme7nNrOGbBCDv8hagYS5LILTECAjltQJ/AmJ9eSJ+X62yj8FLRMpw1oYMhLhRbdyHevEc4yHnGSP8a2BkMsA0iYeygaTrYvpW3QtfMb2vE+99qzukNsNVE26mYJ7yr8JNEgCGvcGsJqLSPCpSgkBd+E5r5BjhbJ91Ygftb0CDnOJpvYKUx2NvU+zBSTswi7qoyI4HG+sPEgzWCk5gky0xi5ZlDPvJhLPvnBP8PutADnl72VGcAIgRDb+Z80ZcDoYnoUDTNy83Dm4MBRnPlOSI+7vF9Fx2yHQ87bX2rWXvH5NR3keiTyDieXFcrITYfXx01q2yf1wjZVZDbG7xOdqAT/e9HH/oQ4hGTSAhFxSV6egqeYM7yDLKqvLv6+IzXhuKeY+PzHjsT7t12VFPVCnzfNNgFD3i8m17sA5fX6Bfm900AQe9UaD3JUZ96Thj99mXnvDBoX0HfWnxPnrO8RZN6Ks4qK3gm4AhMV+4C0MnDBLZzHIcjHuLB677Kgc/+7rcPcgPnXH2grSvjs2a9taClBLEf66Bq0CYdq2XmmCY978Muae7jvsZ/57T/dpeS5+LfFQtd03e8wvp9V0+80IcEBTQFGbtIlO/Rm3jhX/7VX9EJ2/4BHxjUEawdDjgcX3pUUuNFRSeVwh1tlZ404HLB3fVp3wTCUgUK3QWSHf9ZngHwkqlgWAJ8IC1xhAmEGwkukx2hUwpmTkvNn77B4M/dnwv2G+HNYOnZgOfBWxKO3BK6oAzaHxSO2CLJ0+s9oRZioP59ofcJnBdmIRiO4eqdIRn+mxlaYO5lHxa+IRUqyXyh4Rqyoe7JYQzeIdZwoRTIHiwE4um1IBN2HwUaogT2IX+54dz8IXstohLCoR5G4Pf5lkhl1FNsDnKhwYvF1KLVBLb4Bk1YRDrh/8RIsRMo4tIpQgX0NYAnpl/bUY4XaBgiYl8iWuEE7qEkxlJU7QP8NdIMMBmrCYYaWZI4nBwdxVGiGMYRkod2lNGthRX7GGPjudYtql4iEmIh4mIllqFv/VVelYOeKRqfLZFFvcJcKZ29Adqh2dEtvcPtZE58JFYCusE5WqMRjZkivqA2bqPI+eMuVqHZndGrLeOqdQmD7YiFrQZYLUHPNCMoeJIkRSNcEMqTKaT6RUEI8qMtamMu4p9AWmIsTdcu6cO2ZZi7vVEoGt60zYMKpApviIotsWToiMsyqaRGrts+HmJPch9I/qQ3tmEkUgIE/h4dfiNRjmTJCV4jYoJRiv+MUiYlUg6lGOIhNvIhVfIbUMahUG6lVEaWUw4kWH6lVc5hHm4aLuQWbKSMWC4lWqaeSE6l7V1B1qglgxCVzZClvHElJZplVsKlP9UhCjjAuzWNVvLlJN6eXFYlG54EKRabh7kiLLJQPLADhvEEACwYybjlXNJlV/4lLzrmQfJYSFAja4VZWQgJuRyZUuglYgJbXy6mVyZmLLHjCqWIPT7aEdhlVR2AnoWGonnDawZmUypmXNJmbGZgN8CRqmEkCWhDb0oSk62cKcRiyHRmYxZnGDIld34mt1hGguEkEGWNqBzXdX2NYWpMdpYlbH5daI6lYzojIuTlzOylct7ne3b/ZxpipdXMJyCwJXF+pl+6Z5oxZnsOaG1uJ3/2py4mp34mKH4u6FU2aEg+qIHmpx0WqJnJJnLC51tWqGdyoyF2qOkdqIJGKISGKGhuqI2dqISmKIa26IyVqHF+qIgCJIPmaDdmKIdeqI/O6ECxJ4rGqHc6IYXuqB7k19MMKYwWqY726EI1VimdABCg0i2AXjFgqWB6ZJIyYY0aKcd4aB7a03IMYp1o0ZbmUz+uKIFO6FmqIZy2aUSV4/BUlF3NB4mVQz1wFDuNwEcpQEhNxGb4qcM5GEqdlEoNC4KcwZJ4TvMpT3j5ZBN+5HGa6I+66Mk4VGj4YKDm5QLlAPkZHzhc/1mQnc9e3RyjmRFz1mJgWdXKZdXy8U8soMZX0VGW0QU4kNU/smmlRimNYiqwxlJcYdcThSoA5qnV6VUSfUqGuMFf4ZNgBecPbcodcBcBSNFi/dOv/heYQmmQdqFvBegBXdKxdqA7oI99gFYsoFZ8kFZUmFZo4Vp1npObXOO1xtZizRavdimJWqqN7ieSZmPbsFr5CACvmKuufOAH/U7/QRf9TJQ8Omy6tUR2vcq11uAUvdOkLml8vilgxinItqkOQJqUcisj/muYpmymUuGASUy4gqt7eavAxqyv1ewVNamKjuyYhqxoPqmwfqzP/qyciuml3uwPdKz0nKzMrizNBv/tb+XsYCLty0QtkB5tWAZrty4tflHt1vLWzBJt02qtbYaD8GnUheHpDiKO8pVK0krW04LozhptwIbtwDLbqGSH+C0Zsu7g+WmmAhWG21JF1bLs1TrWi+qsl/onPfrfOPKtAFKEBxlr1xpugYmtyBYtwH6nBhIKByYFuvYmI5lAuVIu3OKo4jrojWrnij6DuNwgSuog5KqinZ2B4FJK5aoV2GLu5TItUkph9BAu0Jru6mauytrtFPyu8wTv2OLuWSGujA7v4XotZemu0Bbvt/br7h7vl/Kuxx5p3faq03Zk6javhtKt9oYv+GbvFXZv3LYv9U7vFEYvkcqt5n4v+q7/r/eOKPfGr/SqLoLWr9UOLf7mr4X+L/2irvtuL/v2r+UesJPuLyDwCzJoGtc1wZkmML+S7/xC8Pti7bC+HBJM8CJUMJxc8BZg8AKPrwGXL049rwCvKNsxwQgXSUlgQgqnbw4zcAub7AMnrgoHxcvpCkOswcEC0QjvhOyI1BJrXMUdmCbWRJ8pBHzMRE2oAK08IhBrMAtz8A/zMNOsx6Y6RBAzWGB4CQq83yTUxlf0hC8ugBvvnC8Ao4+gz5M5VYBWFa1o3vKibAPnbtb2MRuy3Z7F4yuAkT/QcCa5wF8xsnvIsZ/VcYu0XYZ8wQKIgAII1PVmMIt2MfT2rP5uMtut/2AZYYZmRpM1tpYL8NEqN+Qjd9pBdluWHgZdlGws2S4Cb7Kb3q/1hnJorA+3CYsRONgpa+S3ICADThfmaYZJiopIRIIKaIslj0C6qOdn3nIH5/Js+rAnB/DGUMfddbP4rnBQbjMMRzDVFsXtdrI5nzMX7zIoazHxZjPPDjAv+/Hf8HGM3bP5rnPhfrIC6zDPcKTG4HF/hbP6FjA5n689B/RIYRZNZKZMxlRS3RIzZUJ41KdBt7NC97PwvjNAJ7QsHaORGA5haocDuMFZTAPAFGZn7LMLezAAazJCTyoYQSdrIRsfbeY4TAQmli3GocVL8Q6bpOJOy1pHMy9SB/I/n/9uQ//Z5zFGeZSDQZxqNxTAvg5AQ76x/ODtuoZVrtoFwAznex00AY8zJ390U4c09XQZThPCHaVLDFHIpbBTCsVIth6gWF+zU1Mqj36xkAJy7wqy4YCKA5T0Q8yAA6DFSdRiCfQGCvJRcRxCvub11Bg1jSm1YGc21AY2Z5MkagpLRP9CPeAttDr2JpbkIzSsuExR4hlJNfdcWTM0X+vyTJv1FksNIiSvFGR0oMVzbW80Wtv2bJ81c1q0FOy2pWXyUdczPP+2Ni+0c4e0TM/z3G7213Y2dv91zeSzZ2+3PpezP8u2dzc3SE83dDO1PD83NtM2epe3Wr/3B183JH63zdZ+N85mN/zed1u+dA/vt/zawXcI+IATeIEb+IEjeIIr+IIz+Bww+INDeIRL+IQvuINT+IVjeIZruIRbwoZ7+IeD+Ib744iTeImb+ImjeIqr+IqzeIu7+IvDeIzL+IzTeI3b+I3jeI7r+I7zeI/7+I8DeZAL+ZATeZEb+ZHreAgAADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Navaneethan U, Vege SS, Chari ST, Baron TH. Minimally invasive techniques in pancreatic necrosis. Pancreas 2009; 38:867. Copyright &copy; 2009 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_39_17012=[""].join("\n");
var outline_f16_39_17012=null;
var title_f16_39_17013="PTSD checklist civilian";
var content_f16_39_17013=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F51518&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F51518&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 629px\">",
"   <div class=\"ttl\">",
"    PTSD checklist - civilian version (PCL-C)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 609px; height: 786px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A score &ge;50 suggests the possibility of PTSD. The diagnosis of PTSD requires further confirmation by clinician interview.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Weathers, FW, Huska, JA, Keane, TM. PLC-C for DSM-IV. Boston: National Center for PTSD - Behavioral Science Division, 1991.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_39_17013=[""].join("\n");
var outline_f16_39_17013=null;
var title_f16_39_17014="Postpartum psychosis: Epidemiology, clinical manifestations, and assessment";
var content_f16_39_17014=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Postpartum psychosis: Epidemiology, clinical manifestations, and assessment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/39/17014/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17014/contributors\">",
"     Shari I Lusskin, MD, FAPA",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17014/contributors\">",
"     Shaila Misri, MD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/39/17014/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17014/contributors\">",
"     Stephen Marder, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/39/17014/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17014/contributors\">",
"     Richard Hermann, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/39/17014/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women are more likely to experience psychosis during the period following childbirth than at any other time in their lives. Postpartum psychosis appears to be a heterogeneous group of mood and psychotic disorders. These disorders have in common the emergence of psychotic symptoms such as delusions and hallucinations in the first weeks postpartum, although some women may present several months later, usually with psychotic depression.",
"   </p>",
"   <p>",
"    The onset of psychosis during the postpartum period constitutes a medical emergency. Women with postpartum psychosis are more likely to commit suicide or infanticide than the general population. Acute management emphasizes hospitalization to ensure safety, mobilizing the family to ensure care of the newborn, antipsychotic medication, and treatment of the underlying disorder.",
"   </p>",
"   <p>",
"    The epidemiology, pathogenesis, clinical manifestations, and assessment of postpartum psychosis are reviewed here. The treatment of postpartum psychosis is discussed separately, as are individual psychiatric disorders.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/62/29670?source=see_link\">",
"       \"Treatment of postpartum psychosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/58/28583?source=see_link\">",
"       \"Overview of psychosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link\">",
"       \"Clinical manifestations and diagnosis of depression\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=see_link\">",
"       \"Bipolar disorder in adults: Epidemiology and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/47/34552?source=see_link\">",
"       \"Schizophrenia: Clinical manifestations, course, assessment, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychosis is a disturbance in an individual's perception of reality. Psychosis can be manifested through one or more of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Delusions: fixed, false beliefs",
"     </li>",
"     <li>",
"      Hallucinations: false perceptions (eg, visual, auditory, or olfactory)",
"     </li>",
"     <li>",
"      Thought disorganization",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Prevalence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postpartum psychosis is relatively rare (prevalence 0.1 to 0.2 percent), particularly in comparison to postpartum blues and postpartum depression [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17014/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/11/20666?source=see_link\">",
"     \"Postpartum blues and depression\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Multiple studies have shown the relative risk (RR) of a hospital admission for psychosis to be increased during the first month postpartum (RR 1.09 to 21.7) compared to any other time in a woman's life [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17014/abstract/1,5,6\">",
"     1,5,6",
"    </a>",
"    ]. Approximately half of these episodes were a first psychotic episode, while the others had a prior hospitalization for psychosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk factors for postpartum psychosis include [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17014/abstract/2,5,7,8\">",
"     2,5,7,8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      History of puerperal psychosis",
"     </li>",
"     <li>",
"      History of bipolar disorder",
"     </li>",
"     <li>",
"      Family history of puerperal psychosis",
"     </li>",
"     <li>",
"      First pregnancy",
"     </li>",
"     <li>",
"      Recent discontinuation of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      or other mood stabilizers [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17014/abstract/9,10\">",
"       9,10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of postpartum psychosis is not known, but research points to genetic and hormonal factors.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Family studies of women with one or more episodes have found an aggregation of affective disorders and suggest a familial susceptibility to triggering of psychosis following childbirth [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17014/abstract/8,11\">",
"       8,11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Preliminary evidence suggests that rapid hormonal changes following childbirth may also play a role in triggering [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17014/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Postpartum psychosis is currently thought of as a manifestation of a bipolar disorder, Type 1 [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17014/abstract/1,13,14\">",
"       1,13,14",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The other disorders in which psychotic symptoms occur in the postpartum period are:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Schizoaffective disorder",
"     </li>",
"     <li>",
"      Schizophrenia",
"     </li>",
"     <li>",
"      Major depressive disorder, severe with psychotic features (hereafter referred to as psychotic depression)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A registry-based analysis of 54,087 births identified 120 psychiatric hospitalizations for a psychotic disorder in the first 90 days postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17014/abstract/5\">",
"     5",
"    </a>",
"    ]. Among the 120 mothers with postpartum psychosis, approximately 75 percent were diagnosed with bipolar or schizoaffective disorder; 12 percent had schizophrenia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postpartum psychosis most commonly presents within two weeks of childbirth. Hallucinations and delusions are usually present, often with thought disorganization",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bizarre behavior. The clinical features of psychosis are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/58/28583?source=see_link\">",
"     \"Overview of psychosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In postpartum psychosis, these symptoms are typically accompanied by symptoms of a mood disorder, such as manic or depressed mood (or both), severe insomnia, rapid mood changes, anxiety, irritability, and psychomotor agitation. Persistent severe insomnia (not related to caring for the newborn) is often the first indication of an incipient mood disorder.",
"   </p>",
"   <p>",
"    In some cases, the patient may appear to be delirious with disorientation to person, place, or time, without evidence of other causes of delirium [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17014/abstract/15\">",
"     15",
"    </a>",
"    ]. The patient's mental status may fluctuate between periods of confusion and intermittent clearing. In contrast, non-puerperal psychosis typically presents without disorientation to person, place, or time.",
"   </p>",
"   <p>",
"    Delusions in postpartum psychosis tend to be related to the patient's mood state (eg, in the depressed or mixed state, the woman may believe that the baby is evil or that people are poisoning her). In a study of 108 consecutive women hospitalized with postpartum psychosis, 53 percent had delusions about their baby [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17014/abstract/16\">",
"     16",
"    </a>",
"    ]. In contrast, delusions typical of schizophrenia are often more bizarre (eg, the CIA implanted a transmitter in the woman's teeth). Command auditory hallucinations may be present, instructing the mother to harm the baby or herself. If there is a prior history of psychosis, relapse during pregnancy or postpartum is likely to have a similar presentation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/58/28583?source=see_link\">",
"     \"Overview of psychosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link&amp;anchor=H14#H14\">",
"     \"Clinical manifestations and diagnosis of depression\", section on 'Major depression with psychotic features'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=see_link\">",
"     \"Bipolar disorder in adults: Epidemiology and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Bipolar disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postpartum psychosis can present as a manic, depressive, or mixed state among patients with bipolar disorder. Women with bipolar disorder are at high risk of recurrence in pregnancy and postpartum and which may present as [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17014/abstract/9,10\">",
"     9,10",
"    </a>",
"    ] postpartum psychosis discontinues mood stabilizers before or during the pregnancy. For women without a prior history, a postpartum psychotic episode may be the first manifestation of bipolar disorder.",
"   </p>",
"   <p>",
"    Standard clinical questions to identify a history of mania include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Have you had any periods of increased energy lasting at least four days? Were they accompanied by elevated or grandiose mood, decreased need for sleep, rapid speech, racing thoughts, or unusual creativity and productivity?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A less direct approach may elicit responses that suggest a previously unidentified hypomania or mania:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Did other people tell you that you were too active, needed to slow down, or were talking too fast?",
"     </li>",
"     <li>",
"      Have you ever been given medication for anxiety or to control your mood? If so, what type of medication?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to the clinical interview, talking with a patient's family members or others in frequent contact for long periods can be critical to getting an accurate history of psychosis, mania, and hypomania, as patients are more likely to recall only their depressive episodes.(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=see_link\">",
"     \"Bipolar disorder in adults: Epidemiology and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Schizoaffective disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postpartum psychosis also presents with manic, depressive, or mixed episodes in schizoaffective disorder. The distinguishing feature of this disorder, compared with bipolar disorder, is the history or subsequent development of chronic psychosis without mood symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/58/28583?source=see_link&amp;anchor=H12#H12\">",
"     \"Overview of psychosis\", section on 'Schizoaffective disorder'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Psychotic depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;This condition presents several months after delivery. The psychotic features occur in conjunction with severe depressive symptoms . The psychosis commonly takes the form of paranoid delusions of persecution. Neither hallucinations nor agitation are common. Psychotic depression is often preceded by longstanding untreated postpartum depression. Clinically, it is then referred to as \"late-onset postpartum psychosis.\" (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link&amp;anchor=H14#H14\">",
"     \"Clinical manifestations and diagnosis of depression\", section on 'Major depression with psychotic features'",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Risk of suicide and infanticide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Suicidal and homicidal ideation (directed towards the infant and sometimes towards other children in the home) are common features of postpartum psychosis. Symptoms of mood dysregulation in postpartum psychosis, including agitation, aggression, and impulsivity, could increase the risk to the infant.",
"   </p>",
"   <p>",
"    The risk of completed suicide and infanticide are increased in postpartum psychosis compared to the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17014/abstract/17-19\">",
"     17-19",
"    </a>",
"    ]. In an analysis of Danish registry data on 1,567 women admitted to a psychiatric hospital in the first year after childbirth, infant mortality was 3 percent, with most of the infant deaths preceding maternal admission [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17014/abstract/17\">",
"     17",
"    </a>",
"    ]. In the year following psychiatric hospitalization, rates of suicide were higher for these women than for the general Danish population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Course",
"    </span>",
"    &nbsp;&mdash;&nbsp;Episodes of postpartum psychosis can be severe and prolonged. &nbsp;Postpartum psychosis may interfere with maternal-infant bonding, which is also disrupted by inpatient hospitalization of the mother.",
"   </p>",
"   <p>",
"    Women experiencing first-episode postpartum psychosis appear to have a high risk of recurrence. A retrospective study using population-based registries followed 50 women who experienced a first psychosis episode postpartum for 7 to 14 years after the initial episode [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17014/abstract/2\">",
"     2",
"    </a>",
"    ]. Thirty women (60 percent) went on to have nonpuerperal psychotic episodes. Only two women had exclusively puerperal recurrences.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     ASSESSMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women presenting for medical care during pregnancy or postpartum should be screened for mental health problems, psychiatric treatment, and a family history of mental illness.",
"   </p>",
"   <p>",
"    Patients screening positive for any of these items should be further assessed for a history of mania or hypomania, psychotic depression, or a psychotic disorder.",
"   </p>",
"   <p>",
"    Patients with a family history of psychiatric disorders should be queried further about a family history of hospitalization, suicide, mania, depression, or psychotic disorder. Patients with a personal or family history of one of these conditions should be educated and monitored during the first weeks of the postpartum period. More intensive monitoring and prophylactic treatment should be considered for patients with a history of bipolar or schizoaffective disorder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/62/29670?source=see_link&amp;anchor=H11#H11\">",
"     \"Treatment of postpartum psychosis\", section on 'Prevention'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to diagnosing postpartum psychosis as a primary psychiatric disorder, a clinical evaluation should be performed to exclude other causes of psychosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Medical evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each patient requires a comprehensive evaluation including a history, physical examination, and laboratory testing to exclude other medical causes of psychosis. The history should consider past and current general medical and psychiatric conditions, current medications, and the use of alcohol and illicit substances. The physical examination should include a basic neurologic and mental status evaluation. The list of potential general medical causes is extensive [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17014/abstract/20\">",
"     20",
"    </a>",
"    ]. Major considerations and screening laboratory tests include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intoxication or withdrawal: review prescription medications, herbal preparations, dietary supplements, and over-the-counter medications; obtain serum and urine toxicology",
"     </li>",
"     <li>",
"      Metabolic",
"      <span class=\"nowrap\">",
"       encephalopathy/delirium:",
"      </span>",
"      check basic serum electrolytes, glucose, CBC with differential, BUN and creatinine, liver function tests, urinalysis, and oxygen saturation.",
"     </li>",
"     <li>",
"      Endocrine dysfunction (eg, thyroid disease): check basic serum electrolytes (including calcium), thyroid stimulating hormone, and thyroid function tests.",
"     </li>",
"     <li>",
"      CNS events, (eg, neoplasms or trauma): Perform neurologic examination; head CT or MRI if focal neurologic findings.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Findings indicating a general medical cause of psychosis do not rule out the possibility of a comorbid primary psychiatric condition contributing to the psychosis and requiring treatment.",
"   </p>",
"   <p>",
"    Although the primary treatment of a general medical condition causing psychosis is determined by the underlying disease, antipsychotic medication can reduce psychosis and agitation while the evaluation is underway. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/62/29670?source=see_link\">",
"     \"Treatment of postpartum psychosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Psychiatric examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postpartum psychosis appears to be a heterogeneous group of mental disorders including bipolar disorder, psychotic depression, and schizoaffective disorder.",
"   </p>",
"   <p>",
"    DSM-IV-TR does not classify postpartum psychosis as a distinct diagnostic entity [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17014/abstract/20\">",
"     20",
"    </a>",
"    ]. Instead, patients receive a diagnosis based on their mood or psychotic disorder, with a \"postpartum-onset\" specifier if psychotic symptoms developed within 30 days of birth. An example is: Bipolar disorder, severe with psychotic features, postpartum-onset.",
"   </p>",
"   <p>",
"    In diagnosing the mood or psychotic disorder, the psychiatric examination will in particular consider the following elements. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Clinical manifestations'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The onset and course of psychotic symptoms (eg, episodic versus chronic).",
"     </li>",
"     <li>",
"      The nature of the affective symptoms (ie, depressed, manic, or mixed state).",
"     </li>",
"     <li>",
"      The impact of these symptoms on the patient's behavior and functioning.",
"     </li>",
"     <li>",
"      The patient's history and family history of prior affective or psychotic episodes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The patient should be assessed for comorbid substance-use disorders. Self-medication with drugs (including prescription drugs) and alcohol is a common complication of mood disorders, even in pregnant and postpartum women. Women with a prior history of substance abuse are at risk of relapse when they develop antepartum and postpartum mood disturbances. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=see_link\">",
"     \"Substance use disorders: Principles for recognition and assessment in general medical care\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36521?source=see_link\">",
"     \"Dual diagnosis: Severe mental illness and substance use disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The differential diagnosis of psychosis is discussed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/58/28583?source=see_link\">",
"     \"Overview of psychosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Postpartum psychosis is a relatively rare condition that typically presents as bipolar disorder or psychotic depression. Occasionally it is a manifestation of schizoaffective disorder. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women at increased risk for postpartum psychosis include those with a prior history of bipolar disorder, a history of postpartum psychosis, a family history of bipolar disorder or postpartum psychosis, or recent discontinuation of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"       lithium",
"      </a>",
"      or other mood stabilizers. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The etiology of postpartum psychosis is not known, but research points to genetic and hormonal factors. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Postpartum psychosis most commonly presents within two weeks of childbirth with a combination of psychotic symptoms (eg, hallucinations and delusions) and symptoms of a mood disorder (eg, mania or depression). There is also a late-onset variant. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Psychosis is often accompanied by an apparently delirious mental state, with disorientation, confusion, and a waxing and waning course. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risk of completed suicide and infanticide are increased in postpartum psychosis compared to the general population. Risk of suicide continues after the postpartum period, making long-term follow up of these patients necessary. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Postpartum psychosis and separation during treatment can adversely affect bonding between mother and infant. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women presenting for medical care during pregnancy or postpartum should be screened for bipolar disorder, a history of psychosis, and a family history of severe mental illness. Patients screening positive should receive a more detailed psychiatric assessment. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women presenting with postpartum psychosis should receive a basic medical evaluation, including a history, physical examination, and laboratory testing, to exclude comorbid medical conditions that may cause or exacerbate psychosis. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Medical evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/1\">",
"      Terp IM, Mortensen PB. Post-partum psychoses. Clinical diagnoses and relative risk of admission after parturition. Br J Psychiatry 1998; 172:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/2\">",
"      Videbech P, Gouliaev G. First admission with puerperal psychosis: 7-14 years of follow-up. Acta Psychiatr Scand 1995; 91:167.",
"     </a>",
"    </li>",
"    <li>",
"     Brockington, I, Kumar, R (Eds). Motherhood and Mental Illness, Academic Press, London 1982.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/4\">",
"      Brockington I. Postpartum psychiatric disorders. Lancet 2004; 363:303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/5\">",
"      Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry 1987; 150:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/6\">",
"      Tschinkel S, Harris M, Le Noury J, Healy D. Postpartum psychosis: two cohorts compared, 1875-1924 and 1994-2005. Psychol Med 2007; 37:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/7\">",
"      Nonacs R, Cohen LS. Postpartum mood disorders: diagnosis and treatment guidelines. J Clin Psychiatry 1998; 59 Suppl 2:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/8\">",
"      Jones I, Craddock N. Familiality of the puerperal trigger in bipolar disorder: results of a family study. Am J Psychiatry 2001; 158:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/9\">",
"      Viguera AC, Nonacs R, Cohen LS, et al. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000; 157:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/10\">",
"      Viguera AC, Whitfield T, Baldessarini RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007; 164:1817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/11\">",
"      Jones I, Craddock N. Searching for the puerperal trigger: molecular genetic studies of bipolar affective puerperal psychosis. Psychopharmacol Bull 2007; 40:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/12\">",
"      Seyfried LS, Marcus SM. Postpartum mood disorders. Int Rev Psychiatry 2003; 15:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/13\">",
"      Terp IM, Engholm G, M&oslash;ller H, Mortensen PB. A follow-up study of postpartum psychoses: prognosis and risk factors for readmission. Acta Psychiatr Scand 1999; 100:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/14\">",
"      Chaudron LH, Pies RW. The relationship between postpartum psychosis and bipolar disorder: a review. J Clin Psychiatry 2003; 64:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/15\">",
"      Spinelli MG. Postpartum psychosis: detection of risk and management. Am J Psychiatry 2009; 166:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/16\">",
"      Chandra PS, Bhargavaraman RP, Raghunandan VN, Shaligram D. Delusions related to infant and their association with mother-infant interactions in postpartum psychotic disorders. Arch Womens Ment Health 2006; 9:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/17\">",
"      Appleby L, Mortensen PB, Faragher EB. Suicide and other causes of mortality after post-partum psychiatric admission. Br J Psychiatry 1998; 173:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/18\">",
"      Babu GN, Subbakrishna DK, Chandra PS. Prevalence and correlates of suicidality among Indian women with post-partum psychosis in an inpatient setting. Aust N Z J Psychiatry 2008; 42:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17014/abstract/19\">",
"      Chandra PS, Venkatasubramanian G, Thomas T. Infanticidal ideas and infanticidal behavior in Indian women with severe postpartum psychiatric disorders. J Nerv Ment Dis 2002; 190:457.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6956 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-A20BFA4EA1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_39_17014=[""].join("\n");
var outline_f16_39_17014=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Prevalence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Bipolar disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Schizoaffective disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Psychotic depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Risk of suicide and infanticide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Course",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Medical evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Psychiatric examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=related_link\">",
"      Bipolar disorder in adults: Epidemiology and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=related_link\">",
"      Clinical manifestations and diagnosis of depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36521?source=related_link\">",
"      Dual diagnosis: Severe mental illness and substance use disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/58/28583?source=related_link\">",
"      Overview of psychosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/11/20666?source=related_link\">",
"      Postpartum blues and depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/47/34552?source=related_link\">",
"      Schizophrenia: Clinical manifestations, course, assessment, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/58/5033?source=related_link\">",
"      Substance use disorders: Principles for recognition and assessment in general medical care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/62/29670?source=related_link\">",
"      Treatment of postpartum psychosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_39_17015="Effects of exercise on lipoproteins and hemostatic factors";
var content_f16_39_17015=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Effects of exercise on lipoproteins and hemostatic factors",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/39/17015/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17015/contributors\">",
"     Lynne T Braun, PhD, RN, CNP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17015/contributors\">",
"     Robert S Rosenson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/39/17015/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17015/contributors\">",
"     Mason W Freeman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/39/17015/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17015/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/39/17015/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 2, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regular physical activity is important for the primary and secondary prevention of coronary heart disease (CHD).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In terms of primary prevention, numerous epidemiologic studies have shown that physically active individuals have a lower incidence of CHD compared with sedentary people. Furthermore, cardiorespiratory fitness is associated with a lower incidence of mortality from cardiovascular disease and from all causes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=see_link\">",
"       \"Exercise and fitness in the prevention of cardiovascular disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In terms of secondary prevention, exercise rehabilitation in people with known CHD reduces cardiovascular and total mortality by 26 and 20 percent, respectively, but it does not significantly reduce nonfatal myocardial infarction [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/1\">",
"       1",
"      </a>",
"      ]. Furthermore, high levels of physical activity (2200",
"      <span class=\"nowrap\">",
"       kcal/week)",
"      </span>",
"      may be associated with regression of existing lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/2\">",
"       2",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/41/13977?source=see_link\">",
"       \"Efficacy of cardiac rehabilitation in patients with coronary heart disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although the mechanisms by which physical activity protects against CHD are not fully understood, the benefits may be mediated, in part, by the favorable influence of aerobic exercise on plasma lipoproteins and hemostatic factors. This topic will review the influence of aerobic training on lipoproteins as a function of exercise intensity and frequency in both healthy subjects and patients with CHD and describe the evidence for beneficial changes in hemostatic factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INFLUENCE OF EXERCISE ON LIPIDS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early cross-sectional studies comparing middle-aged male runners to sedentary men suggested a beneficial effect of exercise on lipoproteins [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. The runners had significantly lower serum levels of total cholesterol, low density lipoprotein (LDL)-cholesterol, very low density lipoprotein (VLDL)-cholesterol, and triglycerides, and a higher concentration of high density lipoprotein (HDL)-cholesterol.",
"   </p>",
"   <p>",
"    Subsequent studies have found variable results when looking at the effect of exercise on the lipoproteins measured in a typical lipid profile [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/5-17\">",
"     5-17",
"    </a>",
"    ]. However, these studies have varied in design, length of follow-up, and exercise intensity, making it difficult to form definitive conclusions. The magnitude of the effect of exercise on lipoproteins appears to be related to the intensity and duration of the exercise program, individual variation, and whether exercise also produces weight reduction [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one of the best performed prospective studies, 111 sedentary overweight men and women with mild to moderate dyslipidemia were randomly assigned to one of four groups&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/19\">",
"     19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      High amount, high intensity exercise for eight months, the caloric equivalent of jogging 20 miles (32 km) per week at 65 to 80 percent of peak oxygen consumption",
"     </li>",
"     <li>",
"      Low amount, high intensity exercise for eight months, the caloric equivalent of jogging 12 miles (19.2 km) per week at 65 to 80 percent of peak oxygen consumption",
"     </li>",
"     <li>",
"      Low amount, moderate intensity exercise for eight months, the equivalent of walking 12 miles (19.2 km) per week at 40 to 55 percent of peak oxygen consumption",
"     </li>",
"     <li>",
"      Control group",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Compared with controls, all exercising groups had potentially beneficial changes in plasma lipoproteins, including a decrease in very-low-density lipoprotein (VLDL) triglycerides and an increase in the size of LDL particles. An increase in HDL cholesterol and particle size and the largest effects on LDL were seen only with high amount, high intensity exercise. None of these improvements, except for those in HDL cholesterol and triglycerides, would have been detected by a standard lipid profile. The beneficial effects of exercise on lipoproteins occurred even though there were only small decreases in body weight, suggesting the effects were due to the exercise itself rather than weight loss.",
"   </p>",
"   <p>",
"    These results are supported by a more recent study in older men and women who had lipoproteins measured at baseline and following 24 weeks of exercise training. Most measurements improved with exercise, and these changes were independent of diet, baseline body fat, and change in body fat [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The amount of exercise made a larger difference on plasma lipoprotein concentrations than the intensity of exercise. The effect was graded, so that higher amounts of exercise were associated with greater benefits in lipoproteins. Nevertheless, even low amounts of exercise were able to limit or prevent much of the weight gain and worsening of the overall lipoprotein profile that was observed in the control group.",
"   </p>",
"   <p>",
"    Other studies have confirmed the graded effect that the amount of exercise has on serum lipoproteins [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/17,21-25\">",
"     17,21-25",
"    </a>",
"    ]. The concept that the amount of physical activity is more important than the level of fitness with regard to improvement in the lipoprotein profile is supported by a study that randomly assigned 149 men and 120 postmenopausal women to one of three exercise programs for two years [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/17\">",
"     17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      High intensity (73 to 85 percent peak heart rate) group-based; there were three 40 minute session per week",
"     </li>",
"     <li>",
"      High intensity home-based.",
"     </li>",
"     <li>",
"      Low intensity (60 to 73 percent peak heart rate) home-based; there were five 30 minute sessions per week",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Serum HDL-cholesterol did not change at one year but showed a small but significant increase above baseline at two years in subjects in the two home-based programs. The elevation in HDL-cholesterol was more pronounced in the low-intensity program, suggesting that increased frequency of exercise may be important and that maximum increases in fitness (as seen with high intensity exercise) is not required.",
"   </p>",
"   <p>",
"    A meta-analysis of 19 randomized trials (n = 984) found that aerobic exercise resulted in an 11 percent increase in HDL2-cholesterol, independent of weight loss [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study characterized 200 men on the basis of baseline triglyceride and HDL cholesterol concentrations. Subjects underwent a 20-week endurance exercise program [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/27\">",
"     27",
"    </a>",
"    ]. Men with high",
"    <span class=\"nowrap\">",
"     triglyceride/low",
"    </span>",
"    HDL cholesterol profiles had the greatest HDL raising effect from exercise (4.9 percent) compared with men with normal levels and men with isolated low HDL cholesterol. In addition, the only significant correlate of the increase in HDL-cholesterol with exercise training in men with high",
"    <span class=\"nowrap\">",
"     triglycerides/low",
"    </span>",
"    HDL cholesterol was a reduction in subcutaneous adipose tissue.",
"   </p>",
"   <p>",
"    A 2011 study evaluated the early effects of exercise training on HDL cholesterol levels and HDL functional characteristics in a small group of sedentary patients with metabolic syndrome (MS) versus those without MS [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/28\">",
"     28",
"    </a>",
"    ]. Following three months of moderate-intensity bicycle exercise, the MS group had lower triglycerides but no change in LDL- or HDL-cholesterol levels. However, an increase in the HDL&rsquo;s subfraction oxidative capacity and paraoxonase-1 activity increased following exercise training. Further, the MS group had compositional changes in the smallest HDL subfractions associated with increased free cholesterol and cholesterol ester transfers to HDL. The study demonstrates a dissociation between the level of HDL-cholesterol and qualitative changes after short-term exercise training in MS patients, thus highlighting the need to explore the functionality of HDL in addition to the level of HDL.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Gender and physical activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/15,16\">",
"     15,16",
"    </a>",
"    ], but not all [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/17\">",
"     17",
"    </a>",
"    ] studies have found that exercise training produces different results on the lipoprotein profile in men and women. As an example, one study randomly assigned 132 men and 132 women to diet only (step 1 American Heart Association diet), diet plus exercise, and a control condition [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/15\">",
"     15",
"    </a>",
"    ]. Exercise consisted of brisk walking and jogging three days a week for 25 to 45 minutes at 60 to 80 percent of HRmax. After one year, the following findings were observed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Men and women in both intervention groups lost weight (primarily fat). However, weight loss by diet alone did not change serum HDL-cholesterol compared with controls.",
"     </li>",
"     <li>",
"      In men, serum HDL-cholesterol, HDL2-cholesterol, and apo A-l concentrations increased significantly more with diet plus exercise group than in the other two groups (+13 versus +2 and -4 percent with diet alone or control) (",
"      <a class=\"graphic graphic_figure graphicRef50708 \" href=\"UTD.htm?18/16/18702\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      In women, diet alone was associated with reductions in serum HDL-cholesterol (-10 percent), HDL2-cholesterol, and apo A-l. When exercise was added, the decrease in HDL-cholesterol was abolished, and was not statistically different from controls (",
"      <a class=\"graphic graphic_figure graphicRef50708 \" href=\"UTD.htm?18/16/18702\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Serum triglyceride concentrations decreased in the combined intervention groups, whereas the",
"      <span class=\"nowrap\">",
"       LDL-cholesterol/HDL-cholesterol",
"      </span>",
"      ratio, total cholesterol, LDL-cholesterol and apo B levels were reduced in both intervention groups.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Another study of 180 postmenopausal women and 197 men who were randomized to exercise (brisk walking for one hour three days a week), a step 2 diet, diet plus exercise or control found that after one year there was no change in HDL-cholesterol in either gender in any study group [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/16\">",
"     16",
"    </a>",
"    ]. There was no change in total or LDL-cholesterol in the diet only group; however, compared to control there was a significant reduction in total and LDL-cholesterol levels in the diet plus exercise group. These data underscore the importance of diet and physical activity in the treatment of elevated LDL-cholesterol.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Exercise for secondary prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exercise training programs produce favorable changes in the lipoprotein profile in patients who already have coronary heart disease (CHD). Most studies have shown a significant increase in serum HDL-cholesterol and a decrease in serum triglycerides compared with baseline values [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/29-33\">",
"     29-33",
"    </a>",
"    ], while others have also shown a reduction in serum total cholesterol and LDL-cholesterol [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/30,32\">",
"     30,32",
"    </a>",
"    ]. These favorable changes in part correlated with weight loss. The usual exercise intervention is three days per week, 30 to 45 minutes in duration, at 70 to 80 percent HRmax or VO2max, for 12 to 29 weeks. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/43/31417?source=see_link\">",
"     \"Components of cardiac rehabilitation and exercise prescription\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One study evaluated the long-term benefits of exercise rehabilitation on lipoproteins in 553 men and 166 women with CHD [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/33\">",
"     33",
"    </a>",
"    ]. After one year, both men and women had a significant increase in serum HDL-cholesterol; however, serum HDL-cholesterol continued to increase over five years only in women. Serum total cholesterol and LDL-cholesterol decreased significantly more in women, while no gender difference was observed for serum triglycerides. Other studies have also suggested gender differences in changes in HDL-cholesterol in response to exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A meta-analysis of 10 randomized trials (n = 1260) found that aerobic exercise in patients with cardiovascular disease increased HDL-cholesterol by 9 percent and triglycerides by 11 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/35\">",
"     35",
"    </a>",
"    ]. No statistically significant changes occurred in total cholesterol or LDL-cholesterol, and no relationship was observed between changes in lipoproteins and body weight.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Potential mechanisms of benefit",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanisms by which aerobic exercise has a favorable impact on the lipoprotein profile are not fully understood; however, some information has come from the measurement of enzymes involved in lipoprotein metabolic pathways. Exercise increases lipoprotein lipase (LPL) activity and reduces hepatic lipase activity [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/4,8,10,12\">",
"     4,8,10,12",
"    </a>",
"    ]. The elevation in LPL activity suggests that enhanced lipolysis of triglyceride-rich lipoproteins may be an initial step in higher serum levels of HDL-cholesterol. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/2/39978?source=see_link&amp;anchor=H15#H15\">",
"     \"HDL metabolism and approach to the patient with abnormal HDL-cholesterol levels\", section on 'Lipoprotein lipase deficiency'",
"    </a>",
"    .) Furthermore, hepatic lipase catalyzes the conversion of the larger HDL2 particles to the smaller HDL3 particles; reduced hepatic lipase with exercise may lead to slower catabolism of HDL2 which may be more cardioprotective (",
"    <a class=\"graphic graphic_figure graphicRef61616 \" href=\"UTD.htm?28/21/29015\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Exercise is also associated with a reduction in the serum cholesteryl ester transfer protein (CETP) concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/36\">",
"     36",
"    </a>",
"    ] and an elevation in the serum lecithin cholesterol acyltransferase (LCAT) concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      CETP catalyzes the net flux of cholesterol from HDL-cholesterol to VLDL-cholesterol and LDL-cholesterol. Basal CETP concentrations have been shown to correlate negatively with HDL-cholesterol after exercise training [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      LCAT catalyzes the esterification of cholesterol located on the particle surface; cholesterol is subsequently displaced to the core, which is the initial event in the conversion of HDL3 to the cholesterol-rich HDL2 particles.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Exercise training also may have a modest effect on serum LDL-cholesterol. Recent studies have evaluated the influence of exercise on the chemical composition of LDL. Smaller and more dense LDL particles tend to be more atherogenic than the larger, more buoyant LDL subfraction [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37274?source=see_link\">",
"     \"Inherited disorders of LDL-cholesterol metabolism\"",
"    </a>",
"    .) Although calculated serum LDL-cholesterol levels are usually unchanged after exercise, LDL peak particle diameter increases [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/39\">",
"     39",
"    </a>",
"    ], and changes in the chemical composition of LDL (increased LDL free cholesterol, cholesterol ester, and phospholipid content) are associated with decreased adiposity, abdominal girth, and plasma insulin and glucose concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Genetic variability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exercise training produces characteristic changes in lipids in most, but not all, people. Some of the variability in response appears to be due to genetic factors. As an example, apolipoprotein E (Apo E) variants may modify the response to exercise. Apo E facilitates triglyceride clearance by mediating the binding of VLDL and intermediate-density lipoproteins (IDL) to hepatic receptors. A study of response to exercise training in 120 individuals selected to equally represent the three most common Apo E variants",
"    <span class=\"nowrap\">",
"     (E2/3,",
"    </span>",
"    <span class=\"nowrap\">",
"     E3/3,",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     E3/4)",
"    </span>",
"    found trends toward different lipoprotein responses to exercise among the various subgroups [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/40\">",
"     40",
"    </a>",
"    ]. A subsequent study examined the effects of Apo E genotype on the response of lipoprotein subclass concentrations to 6 months of exercise. Results showed that Apo E variants influenced the LDL subpopulation response to exercise, and subjects homozygous for Apo E3 experienced the most beneficial lipoprotein effects from exercise training [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Exercise also produced different HDL subfraction patterns based on genetic variation at the Apo A-I gene promoter [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/42\">",
"     42",
"    </a>",
"    ]. Apo A-I is the major apolipoprotein associated with HDL-cholesterol.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     INFLUENCE OF EXERCISE ON HEMOSTATIC FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Platelets, high levels of plasma fibrinogen, plasminogen activator inhibitor type 1 (PAI-1) activity, tissue-type plasminogen activator (t-PA) antigen, and increased plasma viscosity play important roles in the pathogenesis and progression of cardiovascular disease. The effects of exercise on these hemostatic risk factors has been evaluated in several studies. The following effects have been noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Moderate intensity exercise for eight weeks in men reduced resting and post-exercise platelet adhesion and aggregation compared to controls; return to pretraining values occurred after 12 weeks of deconditioning [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a cross-sectional study of physically active and sedentary postmenopausal women, VO2max was 83 percent higher, and PAI-1 activity and t-PA antigen were significantly lower in the physically active women; plasma fibrinogen levels were the same in both groups [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A large-scale observational study of 3522 subjects found an inverse association between self-reported leisure-time physical activity and plasma viscosity in both men and women [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/45\">",
"       45",
"      </a>",
"      ]. However, in another report, a ten-week program of moderate intensity aerobic exercise did not alter whole blood viscosity in patients with CHD [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A small study found that men with intermittent claudication who underwent a six-month exercise program experienced significant improvements in fibrinolytic activity, while no change was seen in matched controls [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17015/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, although a training program of short duration may not be adequate to reduce blood viscosity, it appears that aerobic exercise improves hemostatic factors associated with thrombosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H472188367\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanisms by which physical activity protects against coronary heart disease (CHD) are not fully understood. The benefits may be mediated, in part, by the favorable influence of aerobic exercise on plasma lipoproteins and hemostatic factors:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Exercise training programs produce favorable changes in the lipoprotein profile in patients who already have CHD. Most studies have shown a significant increase in serum HDL-cholesterol and a decrease in serum triglycerides. Exercise training also may have a modest lowering effect on serum LDL-cholesterol. The mechanism of benefit may derive from positive changes in the proteins, and in particular the enzymes that regulate lipid metabolism. Exercise training may influence the functionality of lipoproteins as well as the levels of lipoproteins. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Influence of exercise on lipids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Exercise may alter hemostatic risk factor by reducing the risk of acute thrombus formation, improving blood viscosity, and positively influencing rate of progression of atherosclerotic lesions. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Influence of exercise on hemostatic factors'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/1\">",
"      Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004; 116:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/2\">",
"      Hambrecht R, Niebauer J, Marburger C, et al. Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of coronary atherosclerotic lesions. J Am Coll Cardiol 1993; 22:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/3\">",
"      Wood PD, Haskell W, Klein H, et al. The distribution of plasma lipoproteins in middle-aged male runners. Metabolism 1976; 25:1249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/4\">",
"      Williams PT, Krauss RM, Wood PD, et al. Lipoprotein subfractions of runners and sedentary men. Metabolism 1986; 35:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/5\">",
"      Giada F, Vigna GB, Vitale E, et al. Effect of age on the response of blood lipids, body composition, and aerobic power to physical conditioning and deconditioning. Metabolism 1995; 44:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/6\">",
"      Schwartz RS. Effects of exercise training on high density lipoproteins and apolipoprotein A-I in old and young men. Metabolism 1988; 37:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/7\">",
"      Kiens B, J&ouml;rgensen I, Lewis S, et al. Increased plasma HDL-cholesterol and apo A-1 in sedentary middle-aged men after physical conditioning. Eur J Clin Invest 1980; 10:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/8\">",
"      Weintraub MS, Rosen Y, Otto R, et al. Physical exercise conditioning in the absence of weight loss reduces fasting and postprandial triglyceride-rich lipoprotein levels. Circulation 1989; 79:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/9\">",
"      Rubinstein A, Burstein R, Lubin F, et al. Lipoprotein profile changes during intense training of Israeli military recruits. Med Sci Sports Exerc 1995; 27:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/10\">",
"      Thompson PD, Cullinane EM, Sady SP, et al. Modest changes in high-density lipoprotein concentration and metabolism with prolonged exercise training. Circulation 1988; 78:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/11\">",
"      Despr&eacute;s JP, Lamarche B. Low-intensity endurance exercise training, plasma lipoproteins and the risk of coronary heart disease. J Intern Med 1994; 236:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/12\">",
"      Peltonen P, Marniemi J, Hietanen E, et al. Changes in serum lipids, lipoproteins, and heparin releasable lipolytic enzymes during moderate physical training in man: a longitudinal study. Metabolism 1981; 30:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/13\">",
"      Motoyama M, Sunami Y, Kinoshita F, et al. The effects of long-term low intensity aerobic training and detraining on serum lipid and lipoprotein concentrations in elderly men and women. Eur J Appl Physiol Occup Physiol 1995; 70:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/14\">",
"      Williams PT, Stefanick ML, Vranizan KM, Wood PD. The effects of weight loss by exercise or by dieting on plasma high-density lipoprotein (HDL) levels in men with low, intermediate, and normal-to-high HDL at baseline. Metabolism 1994; 43:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/15\">",
"      Wood PD, Stefanick ML, Williams PT, Haskell WL. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med 1991; 325:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/16\">",
"      Stefanick ML, Mackey S, Sheehan M, et al. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N Engl J Med 1998; 339:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/17\">",
"      King AC, Haskell WL, Young DR, et al. Long-term effects of varying intensities and formats of physical activity on participation rates, fitness, and lipoproteins in men and women aged 50 to 65 years. Circulation 1995; 91:2596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/18\">",
"      Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003; 107:3109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/19\">",
"      Kraus WE, Houmard JA, Duscha BD, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 2002; 347:1483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/20\">",
"      Halverstadt A, Phares DA, Wilund KR, et al. Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women. Metabolism 2007; 56:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/21\">",
"      Wood PD, Haskell WL, Blair SN, et al. Increased exercise level and plasma lipoprotein concentrations: a one-year, randomized, controlled study in sedentary, middle-aged men. Metabolism 1983; 32:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/22\">",
"      Kokkinos PF, Holland JC, Narayan P, et al. Miles run per week and high-density lipoprotein cholesterol levels in healthy, middle-aged men. A dose-response relationship. Arch Intern Med 1995; 155:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/23\">",
"      Sunami Y, Motoyama M, Kinoshita F, et al. Effects of low-intensity aerobic training on the high-density lipoprotein cholesterol concentration in healthy elderly subjects. Metabolism 1999; 48:984.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/24\">",
"      Williams PT. Relationship of distance run per week to coronary heart disease risk factors in 8283 male runners. The National Runners' Health Study. Arch Intern Med 1997; 157:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/25\">",
"      Williams PT. High-density lipoprotein cholesterol and other risk factors for coronary heart disease in female runners. N Engl J Med 1996; 334:1298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/26\">",
"      Kelley GA, Kelley KS. Aerobic exercise and HDL2-C: a meta-analysis of randomized controlled trials. Atherosclerosis 2006; 184:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/27\">",
"      Couillard C, Despr&eacute;s JP, Lamarche B, et al. Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Arterioscler Thromb Vasc Biol 2001; 21:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/28\">",
"      Casella-Filho A, Chagas AC, Maranh&atilde;o RC, et al. Effect of exercise training on plasma levels and functional properties of high-density lipoprotein cholesterol in the metabolic syndrome. Am J Cardiol 2011; 107:1168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/29\">",
"      Mendoza SG, Carrasco H, Zerpa A, et al. Effect of physical training on lipids, lipoproteins, apolipoproteins, lipases, and endogenous sex hormones in men with premature myocardial infarction. Metabolism 1991; 40:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/30\">",
"      Tran, ZV, Brammell, HL. Effects of exercise training on serum lipid and lipoprotein levels in post-MI patients: A meta-analysis. J Cardpulm Rehabil 1989; 9:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/31\">",
"      Cowan GO. Influence of exercise on high-density lipoproteins. Am J Cardiol 1983; 52:13B.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/32\">",
"      Heath GW, Ehsani AA, Hagberg JM, et al. Exercise training improves lipoprotein lipid profiles in patients with coronary artery disease. Am Heart J 1983; 105:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/33\">",
"      Warner JG Jr, Brubaker PH, Zhu Y, et al. Long-term (5-year) changes in HDL cholesterol in cardiac rehabilitation patients. Do sex differences exist? Circulation 1995; 92:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/34\">",
"      Savage PD, Brochu M, Ades PA. Gender alters the high-density lipoprotein cholesterol response to cardiac rehabilitation. J Cardiopulm Rehabil 2004; 24:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/35\">",
"      Kelley GA, Kelley KS, Franklin B. Aerobic exercise and lipids and lipoproteins in patients with cardiovascular disease: a meta-analysis of randomized controlled trials. J Cardiopulm Rehabil 2006; 26:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/36\">",
"      Seip RL, Moulin P, Cocke T, et al. Exercise training decreases plasma cholesteryl ester transfer protein. Arterioscler Thromb 1993; 13:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/37\">",
"      Marniemi J, Dahlstr&ouml;m S, Kvist M, et al. Dependence of serum lipid and lecithin: cholesterol acyltransferase levels on physical training in young men. Eur J Appl Physiol Occup Physiol 1982; 49:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/38\">",
"      Houmard JA, Bruno NJ, Bruner RK, et al. Effects of exercise training on the chemical composition of plasma LDL. Arterioscler Thromb 1994; 14:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/39\">",
"      Williams PT, Krauss RM, Vranizan KM, Wood PD. Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men. Circulation 1990; 81:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/40\">",
"      Thompson PD, Tsongalis GJ, Seip RL, et al. Apolipoprotein E genotype and changes in serum lipids and maximal oxygen uptake with exercise training. Metabolism 2004; 53:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/41\">",
"      Seip RL, Otvos J, Bilbie C, et al. The effect of apolipoprotein E genotype on serum lipoprotein particle response to exercise. Atherosclerosis 2006; 188:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/42\">",
"      Rua&ntilde;o G, Seip RL, Windemuth A, et al. Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training. Atherosclerosis 2006; 185:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/43\">",
"      Wang JS, Jen CJ, Chen HI. Effects of exercise training and deconditioning on platelet function in men. Arterioscler Thromb Vasc Biol 1995; 15:1668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/44\">",
"      Stevenson ET, Davy KP, Seals DR. Hemostatic, metabolic, and androgenic risk factors for coronary heart disease in physically active and less active postmenopausal women. Arterioscler Thromb Vasc Biol 1995; 15:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/45\">",
"      Koenig W, Sund M, D&ouml;ring A, Ernst E. Leisure-time physical activity but not work-related physical activity is associated with decreased plasma viscosity. Results from a large population sample. Circulation 1997; 95:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/46\">",
"      Levine GN, O'Malley C, Balady GJ. Exercise training and blood viscosity in patients with ischemic heart disease. Am J Cardiol 1995; 76:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17015/abstract/47\">",
"      Killewich LA, Macko RF, Montgomery PS, et al. Exercise training enhances endogenous fibrinolysis in peripheral arterial disease. J Vasc Surg 2004; 40:741.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4548 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-287B6DBA01-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_39_17015=[""].join("\n");
var outline_f16_39_17015=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H472188367\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INFLUENCE OF EXERCISE ON LIPIDS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Gender and physical activity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Exercise for secondary prevention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Potential mechanisms of benefit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Genetic variability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      INFLUENCE OF EXERCISE ON HEMOSTATIC FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H472188367\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/4548\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/4548|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/16/18702\" title=\"figure 1\">",
"      Effects of diet and exercise on lipids are sex dependent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/21/29015\" title=\"figure 2\">",
"      Effect of exercise on lipid metabolism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/43/31417?source=related_link\">",
"      Components of cardiac rehabilitation and exercise prescription",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/41/13977?source=related_link\">",
"      Efficacy of cardiac rehabilitation in patients with coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=related_link\">",
"      Exercise and fitness in the prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/2/39978?source=related_link\">",
"      HDL metabolism and approach to the patient with abnormal HDL-cholesterol levels",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37274?source=related_link\">",
"      Inherited disorders of LDL-cholesterol metabolism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_39_17016="Clinical manifestations and diagnosis of familial adenomatous polyposis";
var content_f16_39_17016=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of familial adenomatous polyposis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/39/17016/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17016/contributors\">",
"     Dennis J Ahnen, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17016/contributors\">",
"     Lisen Axell, MS, CGC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/39/17016/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17016/contributors\">",
"     Paul Rutgeerts, MD, PhD, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/39/17016/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17016/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/39/17016/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H11752496\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Familial adenomatous polyposis (FAP) is characterized by the presence of multiple colorectal adenomatous polyps (typically more than 100). Multiple colorectal polyps may also be seen in individuals with MUTYH",
"    <em>",
"    </em>",
"    associated polyposis and hamartomatous polyposis syndromes (Peutz-Jeghers, juvenile polyposis syndrome, and Cowden syndrome).",
"   </p>",
"   <p>",
"    This topic will review the genetics, clinical manifestations, and diagnosis of FAP. Surveillance strategies for FAP and the clinical features and diagnosis of MUTYH associated polyposis, and the hamartomatous polyposis syndromes are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/14/16618?source=see_link\">",
"     \"Familial adenomatous polyposis and MUTYH associated polyposis: Screening and management of patients and families\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/6/37990?source=see_link\">",
"     \"Overview of Peutz-Jeghers syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/9/3224?source=see_link\">",
"     \"Peutz-Jeghers syndrome and juvenile polyposis: Screening and management of patients and families\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29530?source=see_link\">",
"     \"PTEN hamartoma tumor syndrome, including Cowden syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11752503\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Familial adenomatous polyposis (FAP) occurs in approximately",
"    <span class=\"nowrap\">",
"     1/10,000",
"    </span>",
"    to",
"    <span class=\"nowrap\">",
"     1/30,000",
"    </span>",
"    live births, and accounts for less than 1 percent of all colorectal cancers in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/1\">",
"     1",
"    </a>",
"    ]. It affects both sexes equally and has a worldwide distribution.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H547090028\">",
"    <span class=\"h1\">",
"     GENETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Familial adenomatous polyposis (FAP) and its variants are caused by germline mutations in the tumor suppressor gene, adenomatous polyposis coli (",
"    <em>",
"     APC",
"    </em>",
"    ), located on chromosome 5q21-q22 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    FAP follows an autosomal dominant pattern of inheritance with near complete penetrance of the colonic manifestations but variable penetrance of the extracolonic manifestations of the disease. Up to 25 percent of FAP cases are due to new or",
"    <em>",
"     de novo APC",
"    </em>",
"    mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/3\">",
"     3",
"    </a>",
"    ]. Such patients do not have a family history of FAP. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/44/43717?source=see_link\">",
"     \"Glossary of genetic terms\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/56/35718?source=see_link\">",
"     \"Overview of Mendelian inheritance\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/46/43750?source=see_link&amp;anchor=H4564816#H4564816\">",
"     \"Non-Mendelian inheritance patterns of monogenic diseases\", section on 'Penetrance'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H11752517\">",
"     'Clinical manifestations'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    More than 1000 different mutations of the",
"    <em>",
"     APC",
"    </em>",
"    gene associated with FAP have been described, most of which lead to frame shifts and premature stop codons [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. However, large deletions may account for up to 15 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/6-8\">",
"     6-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Inactivating mutations of both",
"    <em>",
"     APC",
"    </em>",
"    alleles is thought to be necessary for the development of adenomas in FAP [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/9\">",
"     9",
"    </a>",
"    ]. In the majority of patients, the expression of the",
"    <em>",
"     APC",
"    </em>",
"    mutation involves an inherited mutation of one",
"    <em>",
"     APC",
"    </em>",
"    allele, with a somatic mutation or \"second hit\" deletion of the other allele [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/10\">",
"     10",
"    </a>",
"    ]. Mutations of both alleles result in the absence of any functional APC protein and thereby aberrant accumulation of beta-catenin leading to transcriptional activation of several genes controlling cell growth and division which cause or predispose to adenoma formation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/33/30234?source=see_link&amp;anchor=H13#H13\">",
"     \"Molecular genetics of colorectal cancer\", section on 'APC gene'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Mutation of the",
"    <em>",
"     APC",
"    </em>",
"    gene also plays a role in the development of sporadic colorectal cancer. Somatic",
"    <em>",
"     APC",
"    </em>",
"    mutations are found in as many as 80 percent of sporadic colorectal adenomas and cancers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/33/30234?source=see_link\">",
"     \"Molecular genetics of colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The location of the mutation within the",
"    <em>",
"     APC",
"    </em>",
"    gene has been associated with the severity of colonic polyposis, the degree of cancer risk, the age of cancer onset, survival, and the presence and frequency of extracolonic manifestations [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. As a general rule, mutations between codons 169 to 1393 are associated with the classic FAP (see",
"    <a class=\"local\" href=\"#H534324030\">",
"     'Classic FAP'",
"    </a>",
"    below). Whereas, attenuated FAP (AFAP) is associated with mutations that are typically in the 5' (5' to codon 158) and 3' (3' to codon 1596) ends of the",
"    <em>",
"     APC",
"    </em>",
"    gene (see",
"    <a class=\"local\" href=\"#H103627351\">",
"     'Attenuated FAP'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Several other genotype-phenotype correlations have also been reported, although there is considerable variability within families and among individuals with identical mutations [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/13\">",
"     13",
"    </a>",
"    ]. Mutations between codons 463 to 1444 have been associated with retinal lesions (congenital hypertrophy of the retinal pigment epithelium [CHRPE]) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/14-17\">",
"     14-17",
"    </a>",
"    ], mutations between codons 1445 and 1578 have been associated with desmoid tumors [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/16-18\">",
"     16-18",
"    </a>",
"    ], mutations between codons 279 to 1309 have been associated with duodenal polyposis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/19\">",
"     19",
"    </a>",
"    ], and mutations between codons 686 and 1217 have been associated with medulloblastoma [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/44/43717?source=see_link\">",
"     \"Glossary of genetic terms\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H11752517\">",
"     'Clinical manifestations'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11752517\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Familial adenomatous polyposis (FAP) is characterized by the presence of numerous colorectal adenomas (usually hundreds). A number of extracolonic manifestations have also been associated with FAP.",
"   </p>",
"   <p>",
"    Patients with FAP may present with gastrointestinal bleeding, abdominal pain, and diarrhea but the majority of patients are asymptomatic until they present with symptoms of colorectal cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H534324675\">",
"    <span class=\"h2\">",
"     Colonic manifestations",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H534324030\">",
"    <span class=\"h3\">",
"     Classic FAP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classic FAP is characterized as the presence of 100 or more adenomatous colorectal polyps (",
"    <a class=\"graphic graphic_picture graphicRef59413 \" href=\"UTD.htm?8/19/8504\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef73267 \" href=\"UTD.htm?30/12/30917\">",
"     picture 2",
"    </a>",
"    ). When fully developed, patients with classic FAP can have hundreds to thousands of colorectal adenomas.",
"   </p>",
"   <p>",
"    Polyposis typically develops in the second or third decade of life. The mean age of polyp emergence is 16 years; but the onset of polyps has been noted in patients between the ages of 8 and 34 years [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Colorectal cancer occurs in nearly 100 percent of individuals if untreated, with an average age of 45 years at cancer diagnosis. Adenomas in patients with FAP are identical to sporadic adenomas and do not by themselves have a higher malignant potential. The increased risk of colorectal cancer in FAP is due to the vast number of adenomas that occur at an early age (",
"    <a class=\"graphic graphic_figure graphicRef58291 \" href=\"UTD.htm?28/26/29101\">",
"     figure 1",
"    </a>",
"    ); over time, one or more of these adenomas invariably progresses to colorectal cancer.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H103627351\">",
"    <span class=\"h3\">",
"     Attenuated FAP",
"    </span>",
"    &nbsp;&mdash;&nbsp;A milder or attenuated form of FAP has been recognized [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/22-26\">",
"     22-26",
"    </a>",
"    ]. Although there is no consensus regarding the definition of attenuated FAP (AFAP), it is characterized by more than 10 to 20 adenomas but typically fewer than 100. Adenomas are typically localized to the right colon and are diagnosed at a mean age of 44 years [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/24,27\">",
"     24,27",
"    </a>",
"    ]. Patients with AFAP have a high risk of colorectal cancer, possibly as high as 80 percent, but with an older average age of onset of 56 years as compared with classic FAP [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/2,26-28\">",
"     2,26-28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H534324165\">",
"    <span class=\"h2\">",
"     Extracolonic manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polyps occur in the upper gastrointestinal tract in 30 to 100 percent of patients with FAP [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fundic gland polyps are found in most patients with FAP. These are small (&lt;1 cm), sessile polyps located in the fundus or body of the stomach, and some patients may have hundreds of fundic gland polyps [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/31\">",
"     31",
"    </a>",
"    ]. They are composed of normal gastric corpus-type epithelium, arranged in a disorderly",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    microcystic configuration. Dysplasia occurs in nearly half of fundic gland polyps, although they rarely progress to cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/32\">",
"     32",
"    </a>",
"    ]. Gastric adenomas are much less common than fundic gland polyps in patients with FAP; they are typically isolated and located in the antrum and are associated with a relatively low but real risk of progression to cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/19/2361?source=see_link&amp;anchor=H9#H9\">",
"     \"Gastric polyps\", section on 'Fundic gland polyps'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Duodenal polyps occur in 45 to 90 percent of patients with FAP and are usually adenomatous [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Duodenal adenomas can progress to cancer. Patients with FAP have a 4 to 12 percent lifetime risk of duodenal cancer. At least 50 percent of patients with FAP also have adenomatous change of the periampullary region and 5 to 10 percent develop periampullary cancer. Adenomas can occur rarely in the gallbladder, bile duct, and the small bowel, particularly the distal ileum [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/29,33-35\">",
"     29,33-35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Desmoid tumors, sebaceous or epidermoid cysts, lipomas, osteomas, fibromas, supernumerary teeth, juvenile nasopharyngeal angiofibromas, and adrenal adenomas have also been associated with FAP. Multiple and bilateral patches of congenital hypertrophy of the retinal pigment epithelium (CHRPE) have been associated with FAP [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/36\">",
"     36",
"    </a>",
"    ]. On slit lamp examination, CHRPE can be seen as discrete, darkly pigmented, round, oval, or kidney shaped lesions. The presence of bilateral or multiple (more than four) lesions is specific (94 to 100 percent) but only moderately sensitive (58 to 84 percent) for FAP [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/37-39\">",
"     37-39",
"    </a>",
"    ]. CHRPE appears to be congenital and has been detected in children as young as three months. (See",
"    <a class=\"local\" href=\"#H534324100\">",
"     'Gardner's syndrome'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/11/30906?source=see_link\">",
"     \"Desmoid tumors: Epidemiology, risk factors, molecular pathogenesis, clinical presentation, diagnosis, and local therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with FAP are at risk for several extraintestinal malignancies including follicular or papillary thyroid cancer (2 to 3 percent lifetime risk), childhood hepatoblastoma (1 percent lifetime risk), and central nervous system (CNS) tumors (mostly medulloblastomas) (&lt;1 percent lifetime risk) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/15/8440?source=see_link\">",
"     \"Overview of papillary thyroid cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/0/2058?source=see_link\">",
"     \"Epidemiology, treatment, and prognosis of medulloblastoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H534324085\">",
"    <span class=\"h2\">",
"     FAP variants",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H534324100\">",
"    <span class=\"h3\">",
"     Gardner's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gardner's syndrome was a term used originally to describe families with colonic polyposis with a number of extracolonic manifestations [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/41\">",
"     41",
"    </a>",
"    ]. These extraintestinal manifestations include desmoid tumors, sebaceous or epidermoid cysts, lipomas, osteomas (especially of the mandible), fibromas, supernumerary teeth, gastric fundic gland polyps, juvenile nasopharyngeal angiofibromas, and CHRPE. As Gardner&rsquo;s syndrome is caused by an underlying",
"    <em>",
"     APC",
"    </em>",
"    mutation, the difference between FAP and Gardner&rsquo;s syndrome is semantic and Gardner&rsquo;s syndrome is considered a subset of FAP [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7352?source=see_link\">",
"     \"Gardner syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H625428197\">",
"    <span class=\"h3\">",
"     Turcot's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Turcot's syndrome is a historical term that originally described the association of familial colon cancer with brain tumors (primarily medulloblastomas and gliomas). As the genetics of the familial colon cancers were defined, it became clear that brain tumors were associated with both FAP and Lynch syndrome (hereditary nonpolyposis colorectal cancer). Thus, the term is no longer clinically meaningful. The majority of FAP-associated brain tumors are medulloblastomas, whereas Lynch syndrome is more commonly associated with gliomas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/23/41332?source=see_link\">",
"     \"Histopathology and molecular pathogenesis of medulloblastoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)\", section on 'Extracolonic cancers in Lynch syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9689297\">",
"    <span class=\"h2\">",
"     Laboratory features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with FAP have no abnormal laboratory findings, but some patients may present with iron deficiency anemia due to unrecognized bleeding from adenomas [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1251987977\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of familial adenomatous polyposis (FAP) should be suspected in any patient found to have 10 or more colorectal adenomas regardless of whether the colonoscopy was done for screening or for symptoms such as gastrointestinal bleeding, abdominal pain,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diarrhea on initial",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    follow-up colonoscopy. Patients with attenuated FAP (AFAP), who present at an older age than those with classic FAP, may be asymptomatic, and the diagnosis should be considered if screening and follow-up colonoscopy detect 10 or more adenomas in their lifetime.",
"   </p>",
"   <p>",
"    Genetic testing for a germline mutation in the",
"    <em>",
"     APC",
"    </em>",
"    gene is required for a definitive diagnosis of FAP [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/44-46\">",
"     44-46",
"    </a>",
"    ]. We and others suggest that genetic testing for FAP should be considered in individuals with 10 to 20 adenomas in their lifetime (",
"    <a class=\"graphic graphic_algorithm graphicRef65992 \" href=\"UTD.htm?29/18/29984\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/40,46-49\">",
"     40,46-49",
"    </a>",
"    ]. The larger the number of adenomas found and the stronger the family history of polyposis, the greater the likelihood of FAP.",
"   </p>",
"   <p>",
"    Genetic counseling should be offered prior to genetic testing [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/50\">",
"     50",
"    </a>",
"    ]. If no mutation is found, other conditions such as MUTYH associated polyposis should be considered [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/51\">",
"     51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/1/24602?source=see_link\">",
"     \"Genetic counseling and testing\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/14/16618?source=see_link&amp;anchor=H8#H8\">",
"     \"Familial adenomatous polyposis and MUTYH associated polyposis: Screening and management of patients and families\", section on 'Familial adenomatous polyposis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If a mutation is found, mutation-specific genetic testing should be offered to at-risk relatives of the index case. This includes all first degree relatives of the index case and also first degree relatives of those subsequently found to have an",
"    <em>",
"     APC",
"    </em>",
"    mutation. In addition, second degree relatives can be offered genetic evaluation and testing when a family member declines genetic testing or has died. At-risk children should be offered genetic testing at around age 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/46\">",
"     46",
"    </a>",
"    ]. Genetic testing is not routinely recommended in children prior to age 10 because it would not change clinical management. Exceptions to this are made in rare families with FAP and colorectal cancers diagnosed under age 20; in these families, we recommend that genetic testing begin 10 years younger than the youngest cancer in the family.",
"   </p>",
"   <p>",
"    Prediction models may be used to counsel patients who are undergoing testing as to the probability of an",
"    <em>",
"     APC",
"    </em>",
"    and",
"    <em>",
"     MUTYH",
"    </em>",
"    gene mutation based on personal and family history of adenomas and colorectal cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/52\">",
"     52",
"    </a>",
"    ]. Prenatal genetic testing and specifically preimplantation genetic diagnosis (PGD) should be discussed as options in FAP patients of childbearing age [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/56/23431?source=see_link\">",
"     \"Preimplantation genetic diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1251987850\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple colorectal adenomas, ranging from a few to several hundred, may also be seen in individuals with MUTYH associated polyposis (MAP), but in this case the family history usually does not show an autosomal dominant pattern of polyposis or colorectal cancer since MAP is an autosomal recessive disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/14/16618?source=see_link\">",
"     \"Familial adenomatous polyposis and MUTYH associated polyposis: Screening and management of patients and families\"",
"    </a>",
"    .) Individuals with attenuated familial adenomatous polyposis (AFAP) and a few colorectal adenomas may be difficult to distinguish clinically from Lynch syndrome or sporadic adenomas. Only genetic testing can definitively distinguish between familial adenomatous polyposis (FAP), MAP, and Lynch syndrome, although an autosomal dominant pattern of colorectal cancer makes MAP unlikely. FAP is characterized by germline mutations in the",
"    <em>",
"     APC",
"    </em>",
"    gene, individuals with MAP have biallelic mutations in the",
"    <em>",
"     MUTYH",
"    </em>",
"    genes, and those with Lynch syndrome have germline mutations in DNA mismatch repair genes. (See",
"    <a class=\"local\" href=\"#H547090028\">",
"     'Genetics'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/14/16618?source=see_link&amp;anchor=H18#H18\">",
"     \"Familial adenomatous polyposis and MUTYH associated polyposis: Screening and management of patients and families\", section on 'MUTYH associated polyposis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=see_link&amp;anchor=H6#H6\">",
"     \"Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)\", section on 'Genetics of Lynch syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A significant number of individuals with multiple colorectal adenomas have no mutation in the",
"    <em>",
"     APC",
"    </em>",
"    or",
"    <em>",
"     MUTYH",
"    </em>",
"    genes, suggesting the presence of unidentified genes associated with multiple colorectal adenomas [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/52\">",
"     52",
"    </a>",
"    ]. A cross-sectional study examined the prevalence of",
"    <em>",
"     APC",
"    </em>",
"    and",
"    <em>",
"     MUTYH",
"    </em>",
"    mutations in 8676 individuals with a personal or family history suggestive of a polyposis syndrome who underwent clinical genetic testing [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17016/abstract/52\">",
"     52",
"    </a>",
"    ]. The prevalence of",
"    <em>",
"     APC",
"    </em>",
"    and",
"    <em>",
"     MUTYH",
"    </em>",
"    mutations was 80 and 2 percent, respectively, among individuals with &gt;1000 adenomas (classic polyposis), 56 and 8 percent, respectively, among individuals with 100 to 999 adenomas (classic polyposis), 10 and 7 percent, respectively, among individuals with 20 to 99 adenomas (attenuated polyposis), and 5 and 4 percent, respectively, among individuals with 10 to 19 adenomas. In this study, 34 percent of individuals with classic polyposis (&gt;100 adenomas) and 81 percent of individuals with attenuated polyposis (20 to 99 adenomas) had no mutation in either the",
"    <em>",
"     APC",
"    </em>",
"    or",
"    <em>",
"     MUTYH",
"    </em>",
"    polyposis gene.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?20/47/21234?source=see_link\">",
"       \"Patient information: Familial adenomatous polyposis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11752552\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Familial adenomatous polyposis (FAP) is an autosomal dominant syndrome caused by germline mutations in the adenomatous polyposis coli (",
"      <em>",
"       APC",
"      </em>",
"      ) gene on chromosome 5q21-q22. (See",
"      <a class=\"local\" href=\"#H547090028\">",
"       'Genetics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      FAP occurs in approximately",
"      <span class=\"nowrap\">",
"       1/10,000",
"      </span>",
"      to",
"      <span class=\"nowrap\">",
"       1/30,000",
"      </span>",
"      live births, and accounts for less than 1 percent of the total colorectal cancers in the United States. (See",
"      <a class=\"local\" href=\"#H11752503\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      FAP is characterized by the presence of multiple colorectal adenomas. Classic FAP is characterized as the presence of 100 or more adenomatous colorectal polyps. Polyposis typically develops in the second or third decade of life and colorectal cancer occurs in essentially 100 percent of untreated individuals by age 45 years.",
"      <br/>",
"      <br/>",
"      Attenuated FAP (AFAP) is characterized by more than &gt;10 to 20 adenomas but fewer than 100. Individuals with AFAP have up to an 80 percent risk of developing colorectal cancer at an average age of 56 years. (See",
"      <a class=\"local\" href=\"#H534324675\">",
"       'Colonic manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fundic gland polyps are found in most patients with FAP but rarely progress to cancer. Duodenal adenomas occur in 45 to 90 percent of patients with FAP. Patients with FAP have a 4 to 12 percent lifetime risk of duodenal cancer. At least 50 percent of patients with FAP also have adenomatous change of the periampullary region and 5 to 10 percent develop periampullary cancer. Individuals with FAP are also at risk for follicular or papillary thyroid cancer, childhood hepatoblastoma, and central nervous system (CNS) tumors but these are much less common than colon and duodenal cancer. (See",
"      <a class=\"local\" href=\"#H534324165\">",
"       'Extracolonic manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Genetic testing for a germline mutation in the",
"      <em>",
"       APC",
"      </em>",
"      gene is required to make a diagnosis of familial adenomatous polyposis (FAP). We suggest genetic testing for FAP in individuals with &gt;10 to 20 adenomas in their lifetime and for all at-risk relatives of individuals with a known",
"      <em>",
"       APC",
"      </em>",
"      mutation. (See",
"      <a class=\"local\" href=\"#H1251987977\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/1\">",
"      Wennstrom J, Pierce ER, McKusick VA. Hereditary benign and malignant lesions of the large bowel. Cancer 1974; 34:suppl:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/2\">",
"      Burt RW, DiSario JA, Cannon-Albright L. Genetics of colon cancer: impact of inheritance on colon cancer risk. Annu Rev Med 1995; 46:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/3\">",
"      Bisgaard ML, Fenger K, B&uuml;low S, et al. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat 1994; 3:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/4\">",
"      Laurent-Puig P, B&eacute;roud C, Soussi T. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 1998; 26:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/5\">",
"      Moisio AL, J&auml;rvinen H, Peltom&auml;ki P. Genetic and clinical characterisation of familial adenomatous polyposis: a population based study. Gut 2002; 50:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/6\">",
"      Michils G, Tejpar S, Thoelen R, et al. Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposis (FAP): a Belgian study. Hum Mutat 2005; 25:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/7\">",
"      Aretz S, Stienen D, Uhlhaas S, et al. Large submicroscopic genomic APC deletions are a common cause of typical familial adenomatous polyposis. J Med Genet 2005; 42:185.",
"     </a>",
"    </li>",
"    <li>",
"     Leiden Open Variation Database. InSiGHT (International Society for Gastrointestinal Hereditary Tumours), Leiden University Medical Center. Available at: file://chromium.liacs.nl/LOVD2/colon_cancer/ (Accessed on January 17, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/9\">",
"      Lamlum H, Papadopoulou A, Ilyas M, et al. APC mutations are sufficient for the growth of early colorectal adenomas. Proc Natl Acad Sci U S A 2000; 97:2225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/10\">",
"      Lamlum H, Ilyas M, Rowan A, et al. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat Med 1999; 5:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/11\">",
"      Giardiello FM, Krush AJ, Petersen GM, et al. Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology 1994; 106:1542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/12\">",
"      Heinen CD. Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families. Mutat Res 2010; 693:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/13\">",
"      J&auml;rvinen HJ, Peltom&auml;ki P. The complex genotype-phenotype relationship in familial adenomatous polyposis. Eur J Gastroenterol Hepatol 2004; 16:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/14\">",
"      Giardiello FM, Petersen GM, Piantadosi S, et al. APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis. Gut 1997; 40:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/15\">",
"      Olschwang S, Tiret A, Laurent-Puig P, et al. Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients. Cell 1993; 75:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/16\">",
"      Caspari R, Olschwang S, Friedl W, et al. Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. Hum Mol Genet 1995; 4:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/17\">",
"      Soravia C, Berk T, Madlensky L, et al. Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet 1998; 62:1290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/18\">",
"      Davies DR, Armstrong JG, Thakker N, et al. Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet 1995; 57:1151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/19\">",
"      Saurin JC, Ligneau B, Ponchon T, et al. The influence of mutation site and age on the severity of duodenal polyposis in patients with familial adenomatous polyposis. Gastrointest Endosc 2002; 55:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/20\">",
"      Attard TM, Giglio P, Koppula S, et al. Brain tumors in individuals with familial adenomatous polyposis: a cancer registry experience and pooled case report analysis. Cancer 2007; 109:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/21\">",
"      Petersen GM, Slack J, Nakamura Y. Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology 1991; 100:1658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/22\">",
"      Spirio L, Olschwang S, Groden J, et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell 1993; 75:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/23\">",
"      Brensinger JD, Laken SJ, Luce MC, et al. Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene. Gut 1998; 43:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/24\">",
"      Lynch HT, Smyrk T, McGinn T, et al. Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP. Cancer 1995; 76:2427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/25\">",
"      Burt RW, Leppert MF, Slattery ML, et al. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology 2004; 127:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/26\">",
"      Sieber OM, Segditsas S, Knudsen AL, et al. Disease severity and genetic pathways in attenuated familial adenomatous polyposis vary greatly but depend on the site of the germline mutation. Gut 2006; 55:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/27\">",
"      Hernegger GS, Moore HG, Guillem JG. Attenuated familial adenomatous polyposis: an evolving and poorly understood entity. Dis Colon Rectum 2002; 45:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/28\">",
"      Giardiello FM, Brensinger JD, Luce MC, et al. Phenotypic expression of disease in families that have mutations in the 5' region of the adenomatous polyposis coli gene. Ann Intern Med 1997; 126:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/29\">",
"      Jagelman DG, DeCosse JJ, Bussey HJ. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet 1988; 1:1149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/30\">",
"      Wallace MH, Phillips RK. Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg 1998; 85:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/31\">",
"      Burt RW. Gastric fundic gland polyps. Gastroenterology 2003; 125:1462.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/32\">",
"      Bianchi LK, Burke CA, Bennett AE, et al. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol 2008; 6:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/33\">",
"      Hamilton SR, Bussey HJ, Mendelsohn G, et al. Ileal adenomas after colectomy in nine patients with adenomatous polyposis coli/Gardner's syndrome. Gastroenterology 1979; 77:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/34\">",
"      Parc YR, Olschwang S, Desaint B, et al. Familial adenomatous polyposis: prevalence of adenomas in the ileal pouch after restorative proctocolectomy. Ann Surg 2001; 233:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/35\">",
"      Primrose JN, Quirke P, Johnston D. Carcinoma of the ileostomy in a patient with familial adenomatous polyposis. Br J Surg 1988; 75:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/36\">",
"      Touri&ntilde;o R, Conde-Freire R, Cabezas-Agr&iacute;cola JM, et al. Value of the congenital hypertrophy of the retinal pigment epithelium in the diagnosis of familial adenomatous polyposis. Int Ophthalmol 2004; 25:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/37\">",
"      Wallis YL, Macdonald F, Hult&eacute;n M, et al. Genotype-phenotype correlation between position of constitutional APC gene mutation and CHRPE expression in familial adenomatous polyposis. Hum Genet 1994; 94:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/38\">",
"      Bertario L, Bandello F, Rossetti C, et al. Congenital hypertrophy of retinal pigment epithelium (CHRPE) as a marker for familial adenomatous polyposis (FAP). Eur J Cancer Prev 1993; 2:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/39\">",
"      Tiret A, Taiel-Sartral M, Tiret E, Laroche L. Diagnostic value of fundus examination in familial adenomatous polyposis. Br J Ophthalmol 1997; 81:755.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/40\">",
"      Vasen HF, M&ouml;slein G, Alonso A, et al. Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 2008; 57:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/41\">",
"      GARDNER EJ, RICHARDS RC. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet 1953; 5:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/42\">",
"      Bisgaard ML, B&uuml;low S. Familial adenomatous polyposis (FAP): genotype correlation to FAP phenotype with osteomas and sebaceous cysts. Am J Med Genet A 2006; 140:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/43\">",
"      Croner RS, Brueckl WM, Reingruber B, et al. Age and manifestation related symptoms in familial adenomatous polyposis. BMC Cancer 2005; 5:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/44\">",
"      NCCN colorectal cancer screening practice guidelines. National Comprehensive Cancer Network. Oncology (Williston Park) 1999; 13:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/45\">",
"      Burt R, Neklason DW. Genetic testing for inherited colon cancer. Gastroenterology 2005; 128:1696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/46\">",
"      American Gastroenterological Association. American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing. Gastroenterology 2001; 121:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/47\">",
"      Giardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology 2001; 121:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/48\">",
"      Rex DK, Johnson DA, Anderson JC, et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol 2009; 104:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/49\">",
"      Burt RW, Barthel JS, Dunn KB, et al. NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw 2010; 8:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/50\">",
"      Robson ME, Storm CD, Weitzel J, et al. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 2010; 28:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/51\">",
"      Sieber OM, Lipton L, Crabtree M, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003; 348:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/52\">",
"      Grover S, Kastrinos F, Steyerberg EW, et al. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA 2012; 308:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17016/abstract/53\">",
"      Kastrinos F, Stoffel EM, Balma&ntilde;a J, Syngal S. Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis. Am J Gastroenterol 2007; 102:1284.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2593 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.65.66-4367187BB2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_39_17016=[""].join("\n");
var outline_f16_39_17016=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H11752552\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11752496\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11752503\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H547090028\">",
"      GENETICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11752517\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H534324675\">",
"      Colonic manifestations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H534324030\">",
"      - Classic FAP",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H103627351\">",
"      - Attenuated FAP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H534324165\">",
"      Extracolonic manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H534324085\">",
"      FAP variants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H534324100\">",
"      - Gardner's syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H625428197\">",
"      - Turcot's syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9689297\">",
"      Laboratory features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1251987977\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1251987850\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11752552\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2593\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2593|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?29/18/29984\" title=\"algorithm 1\">",
"      FAP gene testing algorithm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2593|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/26/29101\" title=\"figure 1\">",
"      CRC in genetic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2593|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?8/19/8504\" title=\"picture 1\">",
"      Familial polyposis Endosc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/12/30917\" title=\"picture 2\">",
"      Familial polyposis Gross",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19386?source=related_link\">",
"      Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=related_link\">",
"      Clinical manifestations, diagnosis, and staging of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/11/30906?source=related_link\">",
"      Desmoid tumors: Epidemiology, risk factors, molecular pathogenesis, clinical presentation, diagnosis, and local therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/0/2058?source=related_link\">",
"      Epidemiology, treatment, and prognosis of medulloblastoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/14/16618?source=related_link\">",
"      Familial adenomatous polyposis and MUTYH associated polyposis: Screening and management of patients and families",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7352?source=related_link\">",
"      Gardner syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/19/2361?source=related_link\">",
"      Gastric polyps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/1/24602?source=related_link\">",
"      Genetic counseling and testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/44/43717?source=related_link\">",
"      Glossary of genetic terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/23/41332?source=related_link\">",
"      Histopathology and molecular pathogenesis of medulloblastoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/33/30234?source=related_link\">",
"      Molecular genetics of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/46/43750?source=related_link\">",
"      Non-Mendelian inheritance patterns of monogenic diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/56/35718?source=related_link\">",
"      Overview of Mendelian inheritance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/6/37990?source=related_link\">",
"      Overview of Peutz-Jeghers syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/15/8440?source=related_link\">",
"      Overview of papillary thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29530?source=related_link\">",
"      PTEN hamartoma tumor syndrome, including Cowden syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/47/21234?source=related_link\">",
"      Patient information: Familial adenomatous polyposis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/9/3224?source=related_link\">",
"      Peutz-Jeghers syndrome and juvenile polyposis: Screening and management of patients and families",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/56/23431?source=related_link\">",
"      Preimplantation genetic diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_39_17017="Treatment of early stage (IA to IIA) mycosis fungoides";
var content_f16_39_17017=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of early stage (IA to IIA) mycosis fungoides",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/39/17017/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17017/contributors\">",
"     Richard T Hoppe, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17017/contributors\">",
"     Youn H Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/39/17017/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17017/contributors\">",
"     Timothy M Kuzel, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17017/contributors\">",
"     John A Zic, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/39/17017/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17017/contributors\">",
"     Rebecca F Connor, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17017/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/39/17017/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 12, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mycosis fungoides (MF) is an extranodal, indolent non-Hodgkin lymphoma of T-cell origin that primarily develops in the skin, but can ultimately involve the lymph nodes, blood, and visceral organs. Early stage (IA to IIA) disease consists of papules, patches, or plaques, with limited, if any, lymph node involvement and no visceral involvement (",
"    <a class=\"graphic graphic_table graphicRef75768 graphicRef53711 \" href=\"UTD.htm?6/60/7119\">",
"     table 1A-B",
"    </a>",
"    ). Patients with limited skin involvement plus the more aggressive histopathologic findings of folliculotropism or transformed large cell variants and those with blood involvement are treated as more advanced disease. (See",
"    <a class=\"local\" href=\"#H29\">",
"     'Special scenarios'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The management of early stage mycosis fungoides (MF) will be discussed here. The management of more advanced stage MF and the more aggressive leukemic variant, S&eacute;zary syndrome, is presented separately as are the clinical presentation, diagnosis, staging, and prognosis of MF and S&eacute;zary syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/35/36410?source=see_link\">",
"     \"Treatment of advanced stage (IIB to IV) mycosis fungoides and S&eacute;zary syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4618?source=see_link\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PRETREATMENT EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The standard staging system for MF is based upon an evaluation of the skin (T), lymph nodes (N), visceral involvement (M), and blood (B) (",
"    <a class=\"graphic graphic_table graphicRef75768 graphicRef53711 \" href=\"UTD.htm?6/60/7119\">",
"     table 1A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef75528 \" href=\"UTD.htm?18/6/18541\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/1\">",
"     1",
"    </a>",
"    ]. Details are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4713?source=see_link&amp;anchor=H1118879#H1118879\">",
"     \"Staging and prognosis of mycosis fungoides and S&eacute;zary syndrome\", section on 'Staging'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     STAGE IA DISEASE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stage IA disease includes those patients with patches, plaques, or papules that involve less than 10 percent of the total skin surface with no involvement of lymph nodes or viscera (",
"    <a class=\"graphic graphic_table graphicRef75768 graphicRef53711 \" href=\"UTD.htm?6/60/7119\">",
"     table 1A-B",
"    </a>",
"    ). Patients with stage IA disease who also have greater than 5 percent circulating atypical (S&eacute;zary) cells (ie, those with B1 disease), histologic evidence of the folliculotropic variant, or large cell transformed MF are treated with more aggressive therapy. (See",
"    <a class=\"local\" href=\"#H29\">",
"     'Special scenarios'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Patients with stage IA disease are treated with skin directed therapies. A randomized trial demonstrated that early aggressive therapy with combination chemotherapy plus electron-beam radiation therapy does not appear to improve survival when compared with the use of sequential topical regimens [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Skin directed therapies include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Topical corticosteroids",
"     </li>",
"     <li>",
"      Topical chemotherapy (nitrogen mustard or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/39/33399?source=see_link\">",
"       carmustine",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Topical retinoids",
"     </li>",
"     <li>",
"      Local radiation (x-ray or electron beam)",
"     </li>",
"     <li>",
"      Phototherapy (UVB or PUVA)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite decades of experience in the treatment of MF, well-designed, prospective, controlled clinical studies comparing the efficacy of various therapies are lacking.",
"   </p>",
"   <p>",
"    For most patients with stage IA MF, we recommend the use of skin-directed therapies rather than systemic therapies. The choice among skin-directed therapies is made based upon the physician's experience with these methods, patient characteristics, and side effect profiles. In general, topical corticosteroids are the preferred initial treatment option in our practice. Other clinicians prefer the initial use of topical nitrogen mustard. If a skin-directed therapy fails to obtain a complete response, a rotation to an alternative skin-directed therapy is attempted before progressing to systemic therapies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19277711\">",
"    <span class=\"h2\">",
"     Topical corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Topical corticosteroids are effective in early stage MF with the majority of patients obtaining a complete response (CR). The strength of steroid used depends upon the body area affected (",
"    <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"     table 3",
"    </a>",
"    ). A response is typically seen within three months. While there have been some patients who have responded after this time, patients who have no response by the third month should be offered alternative therapies.",
"   </p>",
"   <p>",
"    A prospective study of class I corticosteroids in 79 patients with stage T1 (51 patients) or T2 patch or plaque MF followed for a median of 9 months reported an overall response rate of 94 percent with 63 percent CRs in patients with T1 disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/3\">",
"     3",
"    </a>",
"    ]. Further follow-up of approximately 200 patients treated with class I corticosteroids at this same institution reported a continued greater than 90 percent response rate in patients with T1 disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19277718\">",
"    <span class=\"h3\">",
"     Topical corticosteroid administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Topical corticosteroids are available in ointments, creams, solutions, foams, and gels. Ointments may be more effective than creams, but some patients prefer the cosmetic appearance of creams. Ointments are preferable for areas or dry skin while foams, solutions, or gels may be more suitable for lesions on the scalp. Gels are useful for treating hairy regions, but are generally too drying for routine use otherwise. Topical corticosteroids are applied once or twice daily to all affected areas. Caution should be used when applying topical corticosteroids near the eye. Plastic film occlusion may enhance the effectiveness [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/4\">",
"     4",
"    </a>",
"    ]. Topical steroids should be discontinued when the lesions are completely cleared. Maintenance regimens are not used with topical steroids due to the concern of skin atrophy. Treatment may be restarted if lesions recur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19277725\">",
"    <span class=\"h3\">",
"     Topical corticosteroid toxicities",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long-term use of topical corticosteroids may result in skin atrophy",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    striae formation. As the potency of the steroid increases, the risk of these complications increases as well. High-potency corticosteroids can result in systemic absorption if applied to large skin surfaces and there have been cases of clinically evident adrenal suppression and Cushing's syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link\">",
"     \"Major side effects of systemic glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Topical nitrogen mustard (HN2)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Topical nitrogen mustard (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/57/40853?source=see_link\">",
"     mechlorethamine",
"    </a>",
"    hydrochloride, HN2) produces clinical response in 70 to 80 percent in patients with limited",
"    <span class=\"nowrap\">",
"     patch/plaque",
"    </span>",
"    (T1) disease, with a median time to skin clearance of six to eight months [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. In a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine 0.02 percent gel formulation, approximately 12 and 36 percent of patients with early stage MF attained a complete and partial response, respectively, as defined by the Composite Assessment of Index Lesion Severity score [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/9\">",
"     9",
"    </a>",
"    ]. When treatment is discontinued, more than one-half of patients will relapse in the skin at some point, but most will respond to a second course of therapy. Approximately 20 to 25 percent of patients treated with topical HN2 will have a durable CR lasting greater than 10 years. Topical HN2 has also been used safely in pediatric patients with MF [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     HN2 administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;HN2 is available in an ointment base or as a powder to be mixed with tap water and applied daily.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nitrogen mustard ointment is prepared by the pharmacist at an initial concentration of 10 to 20 mg of HN2 per 100 grams of AquaphorTM.",
"     </li>",
"     <li>",
"      For the aqueous preparation, patients prepare the solution themselves at a concentration of 10 to 20 mg per 100 mL of tap water and apply it to their skin with a cloth or brush.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These preparations appear to have similar clinical efficacy, although a prospective comparison has not been performed [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/10\">",
"     10",
"    </a>",
"    ]. The choice is often dependent upon convenience, patient preference, or cost issues (ointment preparation uses less HN2 for a similar response).",
"   </p>",
"   <p>",
"    Patients themselves do not have to wear protective gloves when applying the HN2, although they are advised to wash their hands afterwards. The HN2 penetrates the thick epidermis of the palms only slowly. When others help the patient apply the HN2, they should use gloves.",
"   </p>",
"   <p>",
"    Either preparation is initially applied to the entire skin except the genitalia once daily. Areas of disease activity not initially detected may become evident secondary to an inflammatory reaction provoked by the HN2. After a period of several weeks, treatment may then be limited to the affected region. Alternatively, the topical HN2 can be applied initially to the affected anatomical region(s) alone, and then followed clinically for any new areas of involvement. If there is no response by three months, the concentration of the topical HN2 should be increased every few months until the response is satisfactory, up to concentrations of 30 to 40 mg percent, especially if it is to be applied to small areas. Alternatively, the frequency of application may be increased to twice daily.",
"   </p>",
"   <p>",
"    Treatment is continued on a daily basis until complete skin clearance, followed by a variable duration of maintenance therapy. The standard duration of maintenance therapy used at Stanford is one to two months. There is no evidence that more prolonged maintenance therapy is beneficial.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     HN2 toxicities",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary complication of topical HN2 therapy is an acute or delayed hypersensitivity reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/11\">",
"     11",
"    </a>",
"    ]. If a hypersensitivity reaction occurs, a variety of topical or systemic desensitization programs may be used. The aqueous preparation is associated with a much higher incidence of hypersensitivity reactions compared with the ointment preparation (&gt;30 versus &lt;5 percent). In 12 patients with a history of hypersensitivity to topical aqueous HN2, only 3 developed contact dermatitis to the ointment-based preparation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other side effects include hypo- or hyperpigmentation of treated areas. Secondary squamoproliferative lesions have developed primarily in patients treated with multiple sequential topical therapies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. There does not appear to be an increased risk of development of secondary skin cancers in patients who have used topical HN2 as monotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/5\">",
"     5",
"    </a>",
"    ]. In addition, there is minimal systemic absorption of topically applied HN2, thus systemic complications such as bone marrow suppression or infertility have not been observed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Topical carmustine (BCNU)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/39/33399?source=see_link\">",
"     carmustine",
"    </a>",
"    (BCNU) appears to have similar efficacy to topical HN2 with a total response rate of 98 percent (86 percent complete) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. Complete responses generally require 8 to 20 weeks of treatment. Responses appear to be long-lived with approximately 90 percent of patients with T1 disease with disease control at three years.",
"   </p>",
"   <p>",
"    BCNU is generally not advised for patients with greater than 3 percent skin involvement because systemic absorption can lead to hematologic toxicities. In addition, the maximum duration of treatment is limited due to hematologic toxicities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     BCNU administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;BCNU can be mixed in an alcohol solution or incorporated into an ointment with a petrolatum base at a concentration of 10",
"    <span class=\"nowrap\">",
"     mg/100",
"    </span>",
"    g petrolatum. The ointment appears to be better tolerated than the alcohol solution, but may be less effective [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/16\">",
"     16",
"    </a>",
"    ]. BCNU is applied to affected areas once daily. Patients should take care to avoid exposure to the eyes or orifices. Complete blood counts should be monitored every two weeks to evaluate for marrow suppression that can accompany systemic absorption.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     BCNU toxicities",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of patients will develop erythema, often accompanied by a burning sensation, at the areas of application and accentuated in the body folds, groin, and axillae. Erythema usually subsides within a few weeks, but may require localized treatment with cool compresses, cool baths, topical corticosteroids,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    emollients. Patients may also develop skin thinning, hyperpigmentation, and telangiectasias in areas where the drug is applied. Most telangiectasias will resolve. No cases of skin cancer secondary to topical BCNU have been reported.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Topical retinoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/10/31904?source=see_link\">",
"     bexarotene",
"    </a>",
"    (Targretin) is a synthetic retinoid that results in overall response rates of 45 to 65 percent with 20 percent complete responses [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Complete clearance is expected after 12 to 16 weeks and the median response duration from start of therapy is estimated at two years [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/17\">",
"     17",
"    </a>",
"    ]. Since bexarotene is a skin irritant, its use is generally limited to patients with involvement of less than 15 percent of their body surface area.",
"   </p>",
"   <p>",
"    Retinoids have been used primarily in patients with refractory or advanced disease as part of a combination regimen or as adjuvant therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. A phase III trial of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/10/31904?source=see_link\">",
"     bexarotene",
"    </a>",
"    in 50 patients with refractory or persistent early stage disease reported responses in 62 and 50 percent of those with stage IA or stage IB disease, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/18\">",
"     18",
"    </a>",
"    ]. Three patients with stage IIA or IIB disease did not respond to bexarotene gel.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/10/31904?source=see_link\">",
"     Bexarotene",
"    </a>",
"    gel is approved by the United States Food and Drug Administration (FDA) for the topical treatment of cutaneous lesions in patients with stages IA and IB cutaneous T-cell lymphoma who have refractory or persistent disease after other therapies or who have not tolerated other therapies.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/17/19732?source=see_link\">",
"     Tazarotene",
"    </a>",
"    gel has been used for the treatment of mycosis fungoides in a pilot study, but other topical retinoids have not yet demonstrated efficacy in clinical trials and are not approved by the United States FDA [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Bexarotene administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/10/31904?source=see_link\">",
"     Bexarotene",
"    </a>",
"    is available in a 1 percent formulation. Dose intensity is adjusted by changing the frequency of application. Generally, bexarotene is applied to lesions nightly for the first week of treatment, then twice daily. More frequent application, up to four times a day, can be used, if tolerated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Bexarotene toxicities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/10/31904?source=see_link\">",
"     bexarotene",
"    </a>",
"    is generally well tolerated. The most common adverse effects are a mild to moderate irritant dermatitis, pruritus, burning pain at the application site, and skin inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/18\">",
"     18",
"    </a>",
"    ]. Bexarotene is classified as a pregnancy category X drug, and must never be given to pregnant women. All retinoids can also increase sun sensitivity. The use of sun-protective clothing",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sunscreen is recommended, particularly when prolonged sun exposure is anticipated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Radiation therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;MF is extremely sensitive to radiation therapy and ionizing radiation in the form of x-rays is one of the most effective treatments for localized MF [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/23\">",
"     23",
"    </a>",
"    ]. Previously, low energy x-rays (approximately 100 kvp) were used for the treatment of isolated lesions. Unfortunately, short and long-term toxicities limit its use. Electron beam therapy, now widely available, is usually more appropriate, since electrons of appropriate energy can be used to confine the dose of radiation to the superficial layers of the skin to avoid damage to deeper tissues.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Electron beam therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;For the rare patient with a single lesion (unilesional) or localized MF, local electron beam therapy (EBT) can result in efficient disease clearance. Total skin EBT should be reserved for patients with progressive skin disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/24\">",
"     24",
"    </a>",
"    ]. Overall response rates approach 100 percent and complete responses range from 40 to 98 percent depending upon the extent of skin involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/23\">",
"     23",
"    </a>",
"    ]. As many as half of patients with limited disease and a quarter of those with extensive disease will remain free of disease at five years. A long-term follow-up study at Stanford demonstrated that, despite a superior complete response rate with total skin EBT over topical HN2, there did not appear to be a difference in the overall survival outcomes in patients with stage IA disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/6,23\">",
"     6,23",
"    </a>",
"    ]. Side effects include desquamation, xerosis, and erythema of the skin. (See",
"    <a class=\"local\" href=\"#H27\">",
"     'TSEBT toxicities'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Local EBT is delivered to individual lesions with a peripheral margin up to two centimeters, but the exact area treated may be dependent upon the location and proximity to sensitive tissues. The usual total dose is 15 to 25 Gy administered over one to three weeks. The total dose of radiation used in trials has ranged from 8 to 30 Gy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. CRs are seen in greater than 90 percent of cases for those lesions receiving over 3 Gy and lesions typically disappear by two to three weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/25\">",
"     25",
"    </a>",
"    ]. In a retrospective, single center study, a single fraction radiation dose of 4 to 9 Gy produced a complete response in 255 of 270 individual lesions (94 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Following EBT, there are no recurrences within the treatment field, but new lesions can develop outside of the field. Local EBT may be followed by a topical maintenance regimen such as topical HN2 or topical corticosteroids.",
"   </p>",
"   <p>",
"    Treatment related toxicity is dependent upon the dose of radiation used and the location of the tumor. Side effects include erythema and hair loss. Lower dose radiation may have fewer side effects. In one study, two by two Gy radiation was well tolerated with only temporary hair loss in the irradiated fields of some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Phototherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Phototherapy may be administered as ultraviolet B (UVB- broad or narrow band) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/28-30\">",
"     28-30",
"    </a>",
"    ] or PUVA (psoralen + ultraviolet A photochemotherapy) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/31-37\">",
"     31-37",
"    </a>",
"    ]. Since cumulative doses of ultraviolet light are associated with an increased risk of certain skin neoplasms, phototherapy may not be appropriate in patients with a history of extensive squamoproliferative skin neoplasms, basal cell carcinomas, or melanoma. It is common practice to use UVB for most patch disease, reserving PUVA for thicker",
"    <span class=\"nowrap\">",
"     patch/plaque",
"    </span>",
"    lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     UVB",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both narrow- and broad-band ultraviolet B (UVB) treatments have been evaluated in MF. Narrow-band UVB uses a 311 nm wavelength, while broad-band UVB a 290 to 320 nm wavelength. Narrow-band UVB has demonstrated superior efficacy and decreased toxicity when compared with broad-band, but not PUVA [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/36,38\">",
"     36,38",
"    </a>",
"    ]. Narrow-band UVB has demonstrated CR rates of 83 percent in patients with patch-type stage IA disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. Due to its shallow penetration into the dermis, UVB is most appropriate for thin skin lesions. Treatment is administered in a dermatology office three to five times per week with gradual incremental dose delivery. Improvement is generally seen after 20 to 40 treatments. After CR is achieved, the frequency of therapy is tapered very slowly during the maintenance period and then discontinued [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/38\">",
"     38",
"    </a>",
"    ]. The tapering schedule is non-standardized and differs by institution. As an example of a slow taper, after a CR or plateau in response, treatments may be decreased from three times a week to twice weekly for one to two months, then decreased to once weekly for one to two months, followed by discontinuation of therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     PUVA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with limited",
"    <span class=\"nowrap\">",
"     patch/plaque",
"    </span>",
"    (T1) disease treated with PUVA achieve CR rates as high as 90 percent. The usual time to skin clearance is two to six months and the likelihood of clearance is related to the extent of skin involvement. Some patients may obtain a long-term durable response [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    PUVA treatment (320 to 400 nm wavelength) is administered three times a week until skin clearance is achieved, after which the frequency of treatment is tapered very slowly, in a similar fashion to that done with UVB, to as infrequently as once every two weeks. If lesions recur during maintenance therapy, the treatment frequency is increased. Maintenance therapy should be discontinued within one year in order to minimize the risks of cutaneous carcinogenesis. When maintenance therapy is discontinued, the majority of patients will relapse. However, patients who relapse are likely to respond to retreatment.",
"   </p>",
"   <p>",
"    PUVA treatment consists of a timed exposure to UVA light in a phototherapy unit (PUVA box) administered approximately 1.5 to 2 hours after an oral dose of psoralen. In general, the entire body is treated except for the eyes and genitalia, which are shielded routinely. Other selected areas can be shielded to minimize undesired photodamage. Certain \"shadowed\" areas such as the scalp, perineum, axillae, and other skin fold areas will not receive adequate exposure.",
"   </p>",
"   <p>",
"    Acute complications of PUVA treatment include erythema, pruritus, blistering, skin dryness, and nausea [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/40\">",
"     40",
"    </a>",
"    ]. Potential long-term complications include increased risk of cataracts (requiring the use of UVA-opaque goggles during therapy and glasses after therapy). Patients must shield their skin and eyes from the sun for at least 24 hours after ingestion of psoralen. Patients who undergo long-term continuous treatment with PUVA are at risk for developing secondary cutaneous carcinomas or melanomas. Among patients treated for MF, this risk is greatest for patients who have undergone long-term treatment with multiple skin damaging skin directed therapies [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     STAGE IB/IIA DISEASE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stage IB disease includes those patients with patches, plaques, or papules that involve 10 percent or more of the total skin surface with no involvement of lymph nodes or viscera (",
"    <a class=\"graphic graphic_table graphicRef75768 graphicRef53711 \" href=\"UTD.htm?6/60/7119\">",
"     table 1A-B",
"    </a>",
"    ). Stage IIA disease includes those patients with patches, plaques, or papules of any size with reactive palpable lymph nodes (N1) or with isolated and scattered neoplastic cells in the lymph nodes (N2) on histology, but preservation of the nodal architecture, and no involvement of the viscera.",
"   </p>",
"   <p>",
"    Patients with stage",
"    <span class=\"nowrap\">",
"     IB/IIA",
"    </span>",
"    disease who also have greater than 5 percent circulating atypical (S&eacute;zary) cells (ie, those with B1 disease), histologic evidence of the folliculotropic variant, or large cell transformed MF are treated with more aggressive therapy. (See",
"    <a class=\"local\" href=\"#H29\">",
"     'Special scenarios'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Patients with stage",
"    <span class=\"nowrap\">",
"     IB/IIA",
"    </span>",
"    disease are treated with generalized skin directed therapies, used alone or in combination with other skin directed therapies. Options for generalized skin directed therapy include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Topical chemotherapy (nitrogen mustard or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/39/33399?source=see_link\">",
"       carmustine",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Topical corticosteroids",
"     </li>",
"     <li>",
"      Total skin electron beam therapy (TSEBT)",
"     </li>",
"     <li>",
"      Phototherapy (UVB or PUVA)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The degree of skin irritation caused by topical retinoids is too high to allow for total skin therapy. Localized radiation therapy can be added to any of the above modalities for the adjuvant treatment of poorly responding lesions.",
"   </p>",
"   <p>",
"    These treatment options have not been directly compared in prospective, controlled clinical studies. Retrospective analyses have demonstrated varying response rates, but no differences in long-term survival [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/41\">",
"     41",
"    </a>",
"    ]. A prospective randomized trial demonstrated that early aggressive therapy with combination chemotherapy plus electron-beam radiation therapy does not appear to improve survival when compared with the use of sequential topical regimens [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/2\">",
"     2",
"    </a>",
"    ]. In a small randomized trial that was closed early for poor accrual, overall response rates and median duration of response were similar in 37 patients receiving the combination of oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/10/31904?source=see_link\">",
"     bexarotene",
"    </a>",
"    plus PUVA therapy (77 percent and 5.8 months) and in 32 patients receiving PUVA therapy alone (71 percent and 9.6 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For most patients with stage IB or IIA MF, we recommend the use of skin-directed therapies rather than systemic therapies. The choice among skin-directed therapies is primarily made based upon lesion characteristics.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with IB or IIA disease demonstrating thin plaques and an indolent natural history of disease, we suggest the use of topical corticosteroid, topical HN2, or ultraviolet B (UVB) therapy. A choice among these is largely dependent upon the extent and severity of disease. This preference is principally due to the lower side effect profile of these therapies compared with TSEBT.",
"     </li>",
"     <li>",
"      For patients with very symptomatic, generalized, thickened plaques, we suggest TSEBT as initial therapy rather than HN2 or UVB alone. This is principally because the effective depth of treatment of electron beam therapy is more substantial. TSEBT should also be considered for patients with a recent history of rapid progression of disease and for those who have failed treatment with either topical HN2",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      phototherapy. Systemic biologic therapies, histone deacetylase (HDAC) inhibitors, or low-dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      is used if skin-directed therapies fail, if skin symptoms are",
"      <span class=\"nowrap\">",
"       extensive/severe,",
"      </span>",
"      or if patients have a worse prognostic profile such as folliculotropic MF, large cell transformation, or early blood involvement.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients failing to respond to one topical therapy, or who progress after an initial response, may be treated with an alternative topical therapy or combined modality therapy. There is no evidence that development of resistance to one modality affects subsequent response to an alternative topical modality [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/6,41\">",
"     6,41",
"    </a>",
"    ]. Potential combinations include TSEBT plus topical steroids, PUVA plus topical steroids, or by combining phototherapy with localized EBT [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/19,20,43,44\">",
"     19,20,43,44",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/35/36410?source=see_link\">",
"     \"Treatment of advanced stage (IIB to IV) mycosis fungoides and S&eacute;zary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Topical nitrogen mustard",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment with topical nitrogen mustard (HN2) for generalized",
"    <span class=\"nowrap\">",
"     patch/plaque",
"    </span>",
"    (T2) disease is similar to that for patients with limited (T1) disease. A clinical benefit is seen in 50 to 70 percent of patients with T2 disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/7,8,41\">",
"     7,8,41",
"    </a>",
"    ]. When used as a single agent, approximately 12 and 36 percent of patients with early stage MF will attain complete and partial responses, respectively, as defined by the Composite Assessment of Index Lesion Severity score [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Topical nitrogen mustard (HN2)'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Total skin electron beam therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Total skin electron beam therapy (TSEBT) results in CR rates for generalized",
"    <span class=\"nowrap\">",
"     patch/plaque",
"    </span>",
"    (T2) disease of 80 to 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/41,45,46\">",
"     41,45,46",
"    </a>",
"    ]. It is our preferred initial therapy for patients with very thickened plaques, since the effective depth of treatment of electron beam therapy is more substantial than either topical HN2 or",
"    <span class=\"nowrap\">",
"     UVB/PUVA",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/24\">",
"     24",
"    </a>",
"    ]. TSEBT should also be considered for patients with a recent history of rapid progression of disease and for those who have failed treatment with either topical HN2",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    phototherapy. Following completion of total skin EBT, adjuvant treatment with topical HN2 is appropriate and may be continued for a minimum of six months. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Topical nitrogen mustard (HN2)'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A series of 141 patients, 25 of whom had received prior treatment with topical agents for MF, treated with TSEBT (mean total dose of 30 Gy) reported an overall response rate of 95 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/47\">",
"       47",
"      </a>",
"      ]. CRs were obtained in 88 and 85 percent of those with T1 or T2 lesions, respectively. Fifty-four percent of patients demonstrated skin relapse at one year. Retreatment of the first skin relapse with TSEBT led to a significantly greater freedom from second relapse at five years, when compared with those whose first relapse was treated with other modalities (70 versus 39 percent, respectively).",
"     </li>",
"     <li>",
"      A prospective, open-label study evaluated low-dose TSEBT as second line treatment in 10 patients with stage IB to II mycosis fungoides [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/48\">",
"       48",
"      </a>",
"      ]. Four Gy of radiation was administered in four fractions over four days. Clinical responses were seen in eight patients, two of which were complete. Responses were short-lived lasting approximately two to four months. There were no severe side effects. Acute side effects included desquamation, skin erythema, and xerosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     TSEBT administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients are usually treated in the standing position, three to four meters distant from a linear accelerator. This distance allows large surfaces to be treated. Patients either stand on a rotating platform or assume several different positions during treatment in order to treat their entire skin surface area [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/23,49\">",
"     23,49",
"    </a>",
"    ]. The total dose is generally 36 Gy administered over a 10-week period, with a one week respite after 18 to 20 Gy to provide for some relief from the generalized skin erythema that often accompanies TSEBT.",
"   </p>",
"   <p>",
"    With TSEBT, certain portions of the body surface are \"shadowed\" and receive lower electron doses. These areas include the top of the scalp, the perineum, and the soles of the feet. There may also be relatively shielded areas in individual patients because of body habitus such as underneath the breasts of some women and under the panniculus of obese individuals. At Stanford, the perineum, soles of the feet, or other shadowed areas are routinely supplemented with six MeV electrons in 1Gy fractions to a total dose of 20 Gy [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     TSEBT toxicities",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common acute complication of TSEBT is erythema and desquamation. Intermediate-term complications include alopecia, which is incomplete and usually only temporary if the scalp dose is limited to 24 Gy. Most patients experience temporary fingernail and toenail loss two to four months following completion of treatment. Most also report an inability to sweat properly for the first 6 to 12 months following therapy and note chronically dry skin that requires daily use of emollients.",
"   </p>",
"   <p>",
"    In long-term follow-up, occasional patients display scattered telangiectasias, which are rarely evident on casual examination. Although cutaneous malignancies such as squamous cell and basal cell carcinomas are probably increased after the use of TSEBT, the patients in whom these have become problematic are those who have received repeated treatment with multiple therapies, including irradiation, topical HN2, and PUVA [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Phototherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment with narrow band UVB or PUVA for generalized",
"    <span class=\"nowrap\">",
"     patch/plaque",
"    </span>",
"    (T2) disease is similar to that for patients with limited (T1) disease. Complete response (CR) rates for generalized",
"    <span class=\"nowrap\">",
"     patch/plaque",
"    </span>",
"    (T2) disease are 50 to 80 percent for PUVA [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/31-34,42\">",
"     31-34,42",
"    </a>",
"    ]. In general, UVB is used for most cases and PUVA is reserved for patients with thicker lesions. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'UVB'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H21\">",
"     'PUVA'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SPECIAL SCENARIOS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Folliculotropic variant",
"    </span>",
"    &nbsp;&mdash;&nbsp;Folliculotropic MF is a histopathologic and clinical variant of MF with a markedly worse prognosis. These patients often manifest alopecia due to the disease. Patients with stage IA, IB, or IIA folliculotropic MF are treated according to regimens used for stage IIB limited disease. This is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/35/36410?source=see_link\">",
"     \"Treatment of advanced stage (IIB to IV) mycosis fungoides and S&eacute;zary syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4713?source=see_link&amp;anchor=H1118956#H1118956\">",
"     \"Staging and prognosis of mycosis fungoides and S&eacute;zary syndrome\", section on 'Folliculotropic variant'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Large cell transformation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A subgroup of patients with MF will have transformation of their disease to a large T-cell lymphoma. This transformation is often associated with an aggressive clinical course and less favorable outcome. However, some patients may meet histopathologic criteria of large cell transformation, but may have limited tumor nodules with a more indolent clinical behavior. Thus the management of these patients labeled with large cell transformation must be individualized according to the clinical behavior. Patients with stage IA, IB, or IIA MF with large cell transformation are treated according to regimens used for stage IIB, limited tumor disease. This is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/35/36410?source=see_link\">",
"     \"Treatment of advanced stage (IIB to IV) mycosis fungoides and S&eacute;zary syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4713?source=see_link&amp;anchor=H1118949#H1118949\">",
"     \"Staging and prognosis of mycosis fungoides and S&eacute;zary syndrome\", section on 'Transformation to large cell histology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Blood involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with greater than or equal to 5 percent circulating atypical (S&eacute;zary) cells are considered to have involvement of the peripheral blood. Patients with less than",
"    <span class=\"nowrap\">",
"     1000/microL",
"    </span>",
"    S&eacute;zary cells are designated as having B1 involvement while patients with",
"    <span class=\"nowrap\">",
"     1000/microL",
"    </span>",
"    S&eacute;zary cells or more with positive clonal studies have B2 involvement (ie, S&eacute;zary syndrome). Patients with involvement of the peripheral blood require more intensive treatment to clear the circulating tumor cells. Patients with stage IA, IB, or IIA MF with B1 involvement are treated as if they have stage III disease with B1 involvement. This is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/35/36410?source=see_link\">",
"     \"Treatment of advanced stage (IIB to IV) mycosis fungoides and S&eacute;zary syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Pruritus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with MF can have severe pruritus and xerosis (dry skin), either as a result of the disease or therapy. Supportive measures include the aggressive use of emollients, topical corticosteroids, and oral",
"    <span class=\"nowrap\">",
"     antipruritics/antihistamines.",
"    </span>",
"    Bathing should be followed immediately with the generous application of an emollient, selected based upon their personal preference for feel and ease of application.",
"   </p>",
"   <p>",
"    Refractory pruritus is more common in patients with advanced stage disease or S&eacute;zary syndrome. Anecdotal responses of refractory pruritus to the single agents",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/28/33222?source=see_link\">",
"     aprepitant",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/41/32408?source=see_link\">",
"     mirtazapine",
"    </a>",
"    have been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17017/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6058?source=see_link\">",
"     \"Pruritus: Overview of management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    Mycosis fungoides (MF) is an extranodal, indolent non-Hodgkin lymphoma of T-cell origin that primarily develops in the skin, but can ultimately involve the lymph nodes, blood, and visceral organs. Early stage (IA to IIA) disease consists of papules, patches, or plaques, with limited, if any, lymph node involvement and no visceral involvement (",
"    <a class=\"graphic graphic_table graphicRef75768 graphicRef53711 \" href=\"UTD.htm?6/60/7119\">",
"     table 1A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef75528 \" href=\"UTD.htm?18/6/18541\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    For most patients with early stage MF, we recommend the use of skin-directed therapies rather than systemic therapies (",
"    <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"     Grade 1B",
"    </a>",
"    ). The choice among skin-directed therapies is made based upon the physician's experience with these methods, patient characteristics, side effect profiles, and tumor characteristics.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with",
"      <span class=\"nowrap\">",
"       mild/limited",
"      </span>",
"      stage IA MF, we suggest treatment with topical corticosteroid (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Topical nitrogen mustard (HN2) can be used as an alternative or as a subsequent therapy if topical steroid is ineffective. If a skin-directed therapy fails to obtain a complete response, a second skin-directed therapy is attempted before progressing to systemic therapies. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Stage IA disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with stage IB or IIA disease demonstrating thin plaques and an indolent natural history of disease, we suggest the use of topical corticosteroid, topical HN2, or ultraviolet B (UVB) therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). A choice among these is largely dependent on the extent and severity of disease. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Stage IB/IIA disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with highly symptomatic, generalized thickened plaques, we suggest total skin electron beam therapy (TSEBT) or skin-directed therapies in combination with systemic biologic therapies rather than HN2 or UVB alone (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Systemic biologic therapies, histone deacetylase (HDAC) inhibitors, or low-dose",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      are used if skin-directed therapies fail, if skin symptoms are",
"      <span class=\"nowrap\">",
"       extensive/severe,",
"      </span>",
"      or if patients have a worse prognostic profile such as folliculotropic MF, large cell transformation, or early blood involvement. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Stage IB/IIA disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/1\">",
"      Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 2007; 110:1713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/2\">",
"      Kaye FJ, Bunn PA Jr, Steinberg SM, et al. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 1989; 321:1784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/3\">",
"      Zackheim HS, Kashani-Sabet M, Amin S. Topical corticosteroids for mycosis fungoides. Experience in 79 patients. Arch Dermatol 1998; 134:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/4\">",
"      Zackheim HS. Treatment of patch-stage mycosis fungoides with topical corticosteroids. Dermatol Ther 2003; 16:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/5\">",
"      Kim YH, Martinez G, Varghese A, Hoppe RT. Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience. Arch Dermatol 2003; 139:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/6\">",
"      Kim YH, Jensen RA, Watanabe GL, et al. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis. Arch Dermatol 1996; 132:1309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/7\">",
"      Ramsay DL, Halperin PS, Zeleniuch-Jacquotte A. Topical mechlorethamine therapy for early stage mycosis fungoides. J Am Acad Dermatol 1988; 19:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/8\">",
"      Vonderheid EC, Tan ET, Kantor AF, et al. Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma. J Am Acad Dermatol 1989; 20:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/9\">",
"      Lessin SR, Duvic M, Guitart J, et al. Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides. JAMA Dermatol 2013; 149:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/10\">",
"      Hoppe RT, Abel EA, Deneau DG, Price NM. Mycosis fungoides: management with topical nitrogen mustard. J Clin Oncol 1987; 5:1796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/11\">",
"      Ramsay DL, Meller JA, Zackheim HS. Topical treatment of early cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995; 9:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/12\">",
"      Price NM, Hoppe RT, Deneau DG. Ointment-based mechlorethamine treatment for mycosis fungoides. Cancer 1983; 52:2214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/13\">",
"      Abel EA, Sendagorta E, Hoppe RT. Cutaneous malignancies and metastatic squamous cell carcinoma following topical therapies for mycosis fungoides. J Am Acad Dermatol 1986; 14:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/14\">",
"      Smoller BR, Marcus R. Risk of secondary cutaneous malignancies in patients with long-standing mycosis fungoides. J Am Acad Dermatol 1994; 30:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/15\">",
"      Zackheim HS, Epstein EH Jr, Crain WR. Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15-year experience in 143 patients. J Am Acad Dermatol 1990; 22:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/16\">",
"      Zackheim HS. Topical carmustine (BCNU) in the treatment of mycosis fungoides. Dermatol Ther 2003; 16:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/17\">",
"      Breneman D, Duvic M, Kuzel T, et al. Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma. Arch Dermatol 2002; 138:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/18\">",
"      Heald P, Mehlmauer M, Martin AG, et al. Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial. J Am Acad Dermatol 2003; 49:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/19\">",
"      Duvic M, Lemak NA, Redman JR, et al. Combined modality therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1996; 34:1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/20\">",
"      Thomsen K, Hammar H, Molin L, Volden G. Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group. Acta Derm Venereol 1989; 69:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/21\">",
"      Jones G, McLean J, Rosenthal D, et al. Combined treatment with oral etretinate and electron beam therapy in patients with cutaneous T-cell lymphoma (mycosis fungoides and S&eacute;zary syndrome). J Am Acad Dermatol 1992; 26:960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/22\">",
"      Apisarnthanarax N, Talpur R, Ward S, et al. Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study. J Am Acad Dermatol 2004; 50:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/23\">",
"      Jones GW, Hoppe RT, Glatstein E. Electron beam treatment for cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995; 9:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/24\">",
"      Jones GW, Kacinski BM, Wilson LD, et al. Total skin electron radiation in the management of mycosis fungoides: Consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group. J Am Acad Dermatol 2002; 47:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/25\">",
"      Cotter GW, Baglan RJ, Wasserman TH, Mill W. Palliative radiation treatment of cutaneous mycosis fungoides--a dose response. Int J Radiat Oncol Biol Phys 1983; 9:1477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/26\">",
"      Neelis KJ, Schimmel EC, Vermeer MH, et al. Low-dose palliative radiotherapy for cutaneous B- and T-cell lymphomas. Int J Radiat Oncol Biol Phys 2009; 74:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/27\">",
"      Thomas TO, Agrawal P, Guitart J, et al. Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma. Int J Radiat Oncol Biol Phys 2013; 85:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/28\">",
"      Ramsay DL, Lish KM, Yalowitz CB, Soter NA. Ultraviolet-B phototherapy for early-stage cutaneous T-cell lymphoma. Arch Dermatol 1992; 128:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/29\">",
"      Resnik KS, Vonderheid EC. Home UV phototherapy of early mycosis fungoides: long-term follow-up observations in thirty-one patients. J Am Acad Dermatol 1993; 29:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/30\">",
"      Gathers RC, Scherschun L, Malick F, et al. Narrowband UVB phototherapy for early-stage mycosis fungoides. J Am Acad Dermatol 2002; 47:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/31\">",
"      Herrmann JJ, Roenigk HH Jr, Hurria A, et al. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up. J Am Acad Dermatol 1995; 33:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/32\">",
"      H&ouml;nigsmann H, Brenner W, Rauschmeier W, et al. Photochemotherapy for cutaneous T cell lymphoma. A follow-up study. J Am Acad Dermatol 1984; 10:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/33\">",
"      Abel EA, Sendagorta E, Hoppe RT, Hu CH. PUVA treatment of erythrodermic and plaque-type mycosis fungoides. Ten-year follow-up study. Arch Dermatol 1987; 123:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/34\">",
"      Roenigk HH Jr, Kuzel TM, Skoutelis AP, et al. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma. J Invest Dermatol 1990; 95:198S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/35\">",
"      Pabsch H, R&uuml;tten A, Von Stemm A, et al. Treatment of childhood mycosis fungoides with topical PUVA. J Am Acad Dermatol 2002; 47:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/36\">",
"      Diederen PV, van Weelden H, Sanders CJ, et al. Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study. J Am Acad Dermatol 2003; 48:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/37\">",
"      Carter J, Zug KA. Phototherapy for cutaneous T-cell lymphoma: online survey and literature review. J Am Acad Dermatol 2009; 60:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/38\">",
"      Boztepe G, Sahin S, Ayhan M, et al. Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides. J Am Acad Dermatol 2005; 53:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/39\">",
"      Querfeld C, Rosen ST, Kuzel TM, et al. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy. Arch Dermatol 2005; 141:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/40\">",
"      British Photodermatology Group guidelines for PUVA. Br J Dermatol 1994; 130:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/41\">",
"      Kim YH, Chow S, Varghese A, Hoppe RT. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. Arch Dermatol 1999; 135:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/42\">",
"      Whittaker S, Ortiz P, Dummer R, et al. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056). Br J Dermatol 2012; 167:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/43\">",
"      Kuzel TM, Roenigk HH Jr, Samuelson E, et al. Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the S&eacute;zary syndrome. J Clin Oncol 1995; 13:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/44\">",
"      Chiarion-Sileni V, Bononi A, Fornasa CV, et al. Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma. Cancer 2002; 95:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/45\">",
"      Jones GW, Tadros A, Hodson DI, et al. Prognosis with newly diagnosed mycosis fungoides after total skin electron radiation of 30 or 35 GY. Int J Radiat Oncol Biol Phys 1994; 28:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/46\">",
"      Quir&oacute;s PA, Jones GW, Kacinski BM, et al. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides). Int J Radiat Oncol Biol Phys 1997; 38:1027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/47\">",
"      Ysebaert L, Truc G, Dalac S, et al. Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation). Int J Radiat Oncol Biol Phys 2004; 58:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/48\">",
"      Kamstrup MR, Specht L, Skovgaard GL, Gniadecki R. A prospective, open-label study of low-dose total skin electron beam therapy in mycosis fungoides. Int J Radiat Oncol Biol Phys 2008; 71:1204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/49\">",
"      Hoppe RT. Total skin electron beam therapy in the management of mycosis fungoides. Front Radiat Ther Oncol 1991; 25:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/50\">",
"      Demierre MF, Taverna J. Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma. J Am Acad Dermatol 2006; 55:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17017/abstract/51\">",
"      Duval A, Dubertret L. Aprepitant as an antipruritic agent? N Engl J Med 2009; 361:1415.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4757 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-FF084CEA57-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_39_17017=[""].join("\n");
var outline_f16_39_17017=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H34\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PRETREATMENT EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      STAGE IA DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19277711\">",
"      Topical corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19277718\">",
"      - Topical corticosteroid administration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19277725\">",
"      - Topical corticosteroid toxicities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Topical nitrogen mustard (HN2)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - HN2 administration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - HN2 toxicities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Topical carmustine (BCNU)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - BCNU administration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - BCNU toxicities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Topical retinoids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Bexarotene administration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Bexarotene toxicities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Electron beam therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Phototherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - UVB",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - PUVA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      STAGE IB/IIA DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Topical nitrogen mustard",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Total skin electron beam therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - TSEBT administration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - TSEBT toxicities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Phototherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SPECIAL SCENARIOS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Folliculotropic variant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Large cell transformation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Blood involvement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Pruritus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/4757\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4757|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/34/11822\" title=\"table 1A\">",
"      Mycosis fungoides TNMB classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/56/15245\" title=\"table 1B\">",
"      Mycosis fungoides clinical staging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/6/18541\" title=\"table 2\">",
"      Pretreatment evaluation MF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/56/39809\" title=\"table 3\">",
"      Topical corticosteroids",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4618?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of mycosis fungoides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/58/6058?source=related_link\">",
"      Pruritus: Overview of management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/38/4713?source=related_link\">",
"      Staging and prognosis of mycosis fungoides and S&eacute;zary syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/35/36410?source=related_link\">",
"      Treatment of advanced stage (IIB to IV) mycosis fungoides and S&eacute;zary syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_39_17018="Approach to the septic-appearing infant";
var content_f16_39_17018=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the septic-appearing infant",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/39/17018/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17018/contributors\">",
"     Richard J Scarfone, MD, FAAP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17018/contributors\">",
"     Christine Cho, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/39/17018/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17018/contributors\">",
"     George A Woodward, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17018/contributors\">",
"     Jan E Drutz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/39/17018/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/39/17018/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/39/17018/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of critically ill neonates and young infants is challenging because the clinical manifestations of illness (ie, lethargy, poor tone, poor feeding, or irritability) are often atypical or nonspecific. Although many of these septic-appearing patients have overwhelming infections, some may have congenital (eg, congenital adrenal hyperplasia) or acquired (eg, inflicted head injury) conditions that require prompt recognition and specific management.",
"   </p>",
"   <p>",
"    The causes of overwhelming illness among young infants who are septic-appearing are reviewed here. The evaluation and initial management decisions are also discussed. An algorithmic approach to establishing the diagnosis is suggested (",
"    <a class=\"graphic graphic_algorithm graphicRef66424 \" href=\"UTD.htm?13/30/13795\">",
"     algorithm 1",
"    </a>",
"    ). Specific diagnoses are reviewed separately. The evaluation of fever in infants less than three months of age is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=see_link\">",
"     \"Evaluation and management of fever in the neonate and young infant (less than three months of age)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CAUSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although infection is the most likely cause of overwhelming illness among neonates and young infants, a number of other clinical conditions have similar manifestations (",
"    <a class=\"graphic graphic_table graphicRef74535 \" href=\"UTD.htm?41/37/42588\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Infectious causes",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Bacterial infections",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bacterial sepsis &ndash; Neonates can develop sepsis with or without localized infections such as urinary tract infections, pneumonia, or cellulitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28951?source=see_link&amp;anchor=H9#H9\">",
"       \"Definition and etiology of fever in neonates and infants (less than three months of age)\", section on 'Serious bacterial infection'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Possible pathogens include the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In the immediate newborn period, group B streptococcus and Escherichia coli are the two most common pathogens associated with sepsis; Listeria monocytogenes is a less common cause.",
"     </li>",
"     <li>",
"      Beyond the first weeks of life, late-onset disease with any of these pathogens may occur, as well as infections with Streptococcus pneumoniae, Neisseria meningitidis, and, to a much lesser extent, Haemophilus influenzae type b.",
"     </li>",
"     <li>",
"      Infection with community acquired methicillin resistant Staphylococcus aureus (MRSA) must be considered for infants with skin infections or with known exposures.",
"      <br/>",
"      <br/>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30042?source=see_link&amp;anchor=H14#H14\">",
"       \"Epidemiology and clinical spectrum of methicillin-resistant Staphylococcus aureus infections in children\", section on 'CA-MRSA infection'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/6/29802?source=see_link&amp;anchor=H11#H11\">",
"       \"Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children\", section on 'Treatment approach'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      In young infants, the origins of osteomyelitis and septic arthritis are typically hematogenous. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=see_link&amp;anchor=H9#H9\">",
"       \"Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children\", section on 'Pathogenesis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/30/40423?source=see_link\">",
"       \"Bacterial arthritis: Epidemiology, pathogenesis, and microbiology in infants and children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bacterial meningitis &ndash; Bacterial meningitis among neonates and infants is caused by the same organisms that cause sepsis. The incidence of bacterial meningitis in this age group has been declining as the result of universal screening and intrapartum antibiotic prophylaxis for group B Streptococcal disease and the introduction of conjugate vaccines against Haemophilus influenza type b and pneumococcus. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7928?source=see_link\">",
"       \"Clinical features and diagnosis of bacterial meningitis in the neonate\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H2#H2\">",
"       \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Epidemiology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pyelonephritis &ndash; Urinary tract infections are the most common serious bacterial infections in neonates and young infants. Fewer than 10 percent of these children will have coexisting bacteremia or urosepsis. Escherichia coli causes more than 80 percent of these infections. Clinically, it is not possible to distinguish lower from upper urinary tract infection in this age group. A conservative and appropriate approach is to assume pyelonephritis exists among febrile young children with pyuria. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21129?source=see_link&amp;anchor=H3#H3\">",
"       \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\", section on 'Younger children'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pertussis &ndash; Pertussis is an ubiquitous and highly contagious infection with significant morbidity and mortality for young infants. Pertussis should be considered among infants with respiratory failure, apnea",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bradycardia, or an apparent life-threatening event (ALTE). Symptoms may be non-specific, including feeding difficulties, tachypnea, and cough. Gagging, apnea, cyanosis, and bradycardia often develop during paroxysms of cough. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/55/16248?source=see_link&amp;anchor=H10#H10\">",
"       \"Clinical features and diagnosis of Bordetella pertussis infection in infants and children\", section on 'Infants'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Infant botulism &ndash; Infants develop botulism from the ingestion of Clostridium botulinum spores (air-borne or from food), rather than preformed botulinum toxin. The toxin, which impairs impulses at the neuromuscular junction by blocking acetylcholine release, is then produced by organisms that colonize the infant's gastrointestinal tract. Symptoms initially include hypotonia, constipation and poor feeding and progress to respiratory failure. Most infants require intensive care and many need mechanical ventilation. The median age of presentation is four months. The disease is more common among breast-fed infants. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/10/166?source=see_link&amp;anchor=H14#H14\">",
"       \"Neuromuscular junction disorders in newborns and infants\", section on 'Infant botulism'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Viral infections",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Overwhelming viral infection &ndash; Life-threatening viral infections among neonates are most often caused by Herpes simplex virus (HSV) or enterovirus.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      HSV can cause life-threatening disseminated or central nervous system infection in the newborn. As many as one-third of these neonates do not have skin vesicles at presentation, and many are afebrile, making the diagnosis more challenging [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/1\">",
"       1",
"      </a>",
"      ]. Initial symptoms can occur anytime between birth and four weeks. The peak incidence of CNS disease is from 10 to 17 days of life. Those with disseminated infection may have earlier clinical manifestations. The diagnosis should be suspected and consideration should be given to presumptive use of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/38/34400?source=see_link\">",
"       acyclovir",
"      </a>",
"      among infants less than four weeks old who have any of the following risk factors: maternal HSV, vesicular rash, seizures, CSF pleocytosis, or elevated liver enzymes. &nbsp;(See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35321?source=see_link&amp;anchor=H4#H4\">",
"       \"Neonatal herpes simplex virus infection: Clinical features and diagnosis\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Enteroviral serotypes, such as group B coxsackievirus serotypes 2 to 5 and echovirus 11, may produce fulminant myocarditis or hepatitis among neonates. The infection is most often acquired from a symptomatic mother in the perinatal period. Symptoms typically develop between three and seven days of life. However, approximately one-third of cases have a biphasic illness with a period of one to seven days of apparent well-being interspersed between the initial symptoms and the appearance of more serious manifestations. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=see_link&amp;anchor=H16#H16\">",
"       \"Clinical manifestations and diagnosis of enterovirus and parechovirus infections\", section on 'Infections in neonates'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bronchiolitis with apnea &ndash; Young infants, particularly those who are less than one month of age or who were born prematurely, may develop apnea with bronchiolitis [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/2\">",
"       2",
"      </a>",
"      ]. Some may present with severe apnea before they develop typical signs of bronchiolitis, such as respiratory distress or wheezing. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/44/16074?source=see_link&amp;anchor=H18#H18\">",
"       \"Bronchiolitis in infants and children: Clinical features and diagnosis\", section on 'Apnea'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Myocarditis &ndash; Evidence of viral myocarditis has been described in association with apparent life-threatening events (ALTE) and sudden infant death. Myocarditis in children is usually caused by enteroviruses (coxsackie B group) or adenovirus. Infants may present with a fulminant illness characterized by signs of decreased cardiac output, including hypotension, poor pulses, and decreased perfusion. Malignant arrhythmias are common. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34647?source=see_link\">",
"       \"Clinical manifestations and diagnosis of myocarditis in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Congenital conditions",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Malrotation with volvulus &ndash; Malrotation develops as a result of an arrest of normal rotation of the embryonic gut. Abnormal mobility of the small bowel, as the result of a narrow mesenteric base, allows the mesentery to twist. Volvulus occurs when small bowel twists around the superior mesenteric artery, causing vascular compromise to large portions of the midgut (",
"      <a class=\"graphic graphic_figure graphicRef78111 \" href=\"UTD.htm?28/19/28977\">",
"       figure 1",
"      </a>",
"      ). This leads to ischemia and necrosis of the bowel that can quickly become irreversible. Vomiting, which is almost always bilious, occurs in &gt;90 percent of newborns with volvulus and is by far the most common presenting symptom of malrotation in infancy. In one case series, 90 percent of patients were less than eight weeks of age at diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/48/20232?source=see_link\">",
"       \"Intestinal malrotation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Congenital heart disease (CHD) &ndash; Infants with previously undiagnosed CHD who are seriously ill usually fall into one of three categories: cyanotic lesions, obstructive lesions, or (rarely) a coronary artery abnormality. Infants with cyanotic or obstructive heart disease, who are dependent on blood flow through the ductus arteriosus (DA) for pulmonary or systemic circulation, develop severe symptoms as the DA closes over several days to several weeks of life [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/4\">",
"       4",
"      </a>",
"      ]. Depending on the specific cardiac lesion and the delay in seeking care, infants may present with some combination of respiratory distress, cyanosis, shock, or congestive heart failure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=see_link\">",
"       \"Diagnosis and initial management of cyanotic heart disease in the newborn\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=see_link&amp;anchor=H9#H9\">",
"       \"Clinical manifestations and diagnosis of coarctation of the aorta\", section on 'Neonates'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/56/14218?source=see_link&amp;anchor=H13#H13\">",
"       \"Congenital and pediatric coronary artery abnormalities\", section on 'Variations of coronary artery origin from the pulmonary artery'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Common causes of cyanotic heart disease include transposition of the great vessels, tetralogy of Fallot, truncus arteriosus, tricuspid atresia, and total anomalous pulmonary venous return.",
"     </li>",
"     <li>",
"      Obstructive heart lesions include hypoplastic left heart, coarctation of the aorta, and other aortic arch anomalies.",
"     </li>",
"     <li>",
"      For infants with an anomalous origin of one or more coronary arteries from the pulmonary artery, myocardial ischemia may develop as pulmonary vascular resistance normalizes postnatally.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Congenital adrenal hyperplasia (CAH) &ndash; CAH is a group of inherited disorders of impaired cortisol synthesis. More than 95 percent of cases are due to 21-hydroxylase deficiency, which classically manifests in infancy as virilization and adrenal insufficiency. Male infants are usually more difficult to recognize and may present with adrenal crisis. Adrenal crisis typically develops within the first few days to weeks of life. Clinical manifestations include vomiting, diarrhea, hypovolemia, hyponatremia, hyperkalemia, hypoglycemia, and hypotension. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/52/23369?source=see_link&amp;anchor=H6#H6\">",
"       \"Causes and clinical manifestations of primary adrenal insufficiency in children\", section on 'Adrenal crisis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inborn errors of metabolism (IEM) &ndash; Although individual defects are uncommon in the general population, inborn errors of metabolism account for a significant portion of disease among infants.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Several categories of IEM (amino acid disorders, organic acidemias, urea cycle disorders, disorders of carbohydrate metabolism, fatty acid oxidation defects, and mitochondrial disorders) may present with an acute metabolic crisis that is triggered by circumstances such as intake of protein or certain carbohydrates or infection. The deterioration typically occurs after a period of apparent well-being. As an example, newborns with urea cycle disorders or organic acidemias generally present with an acute, severe illness characterized by lethargy, poor feeding, vomiting, and shock, with hyperammonemia and profound acidosis (",
"      <a class=\"graphic graphic_algorithm graphicRef52126 \" href=\"UTD.htm?23/24/23950\">",
"       algorithm 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Infants with galactosemia may present with sepsis, usually from a urinary tract infection with Escherichia coli. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30886?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical features and diagnosis of galactosemia\", section on 'Classic galactosemia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Although IEM may be included in newborn screening tests, infants can present before the results are available. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/0/10250?source=see_link\">",
"       \"Inborn errors of metabolism: Metabolic emergencies\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/2/2088?source=see_link\">",
"       \"Newborn screening\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other causes",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inflicted injury &ndash; Young infants with severe inflicted injury (typically, head injury) often present with altered mental status, seizures,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      respiratory distress. There is usually no clear history of trauma. Since signs of external injury, such as burns or contusions are often minimal or absent, one must maintain a high-level of suspicion. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/19/40249?source=see_link\">",
"       \"Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acquired metabolic conditions",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Hyponatremia &ndash; Hyponatremia usually occurs as the result of water intoxication (intake of excessive amounts of free water), syndrome of inappropriate antidiuretic hormone secretion, or from excessive renal losses (such as with congenital adrenal hyperplasia). Occasionally, infants with cystic fibrosis may present with hyponatremic dehydration [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/5\">",
"       5",
"      </a>",
"      ]. Young infants with hyponatremia may develop lethargy or seizures, and the seizures may be refractory to anticonvulsants until the underlying metabolic derangement is corrected. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/60/27591?source=see_link&amp;anchor=H16#H16\">",
"       \"Fluid and electrolyte therapy in newborns\", section on 'Hyponatremia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypernatremia &ndash; Causes of hypernatremia (150",
"      <span class=\"nowrap\">",
"       meq/L",
"      </span>",
"      or more) include sodium poisoning, excessive loss of free water (as can occur with diabetes insipidus), or loss of water in excess of sodium losses. Severe hypernatremic dehydration has been reported in association with breast feeding difficulties [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/6,7\">",
"       6,7",
"      </a>",
"      ]. Lethargy, irritability, seizures,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      coma may occur with hypernatremia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/60/27591?source=see_link&amp;anchor=H19#H19\">",
"       \"Fluid and electrolyte therapy in newborns\", section on 'Hypernatremia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypoglycemia &ndash; Several factors place infants at increased risk for hypoglycemia (plasma glucose value of &le;40",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [2.22 mM]). These include low muscle mass, diminished glycogen storage capacity, immaturity of gluconeogenesis and ketogenesis, increased glucose demand, and decreased oral intake during times of stress. Hypoglycemia can be caused by various metabolic, endocrinologic, toxic, and infectious etiologies. Timely recognition and treatment is crucial since prolonged",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      severe hypoglycemia can precipitate seizures",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      permanent brain damage [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/8\">",
"       8",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/16/17673?source=see_link\">",
"       \"Neonatal hypoglycemia\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Seizures &ndash; Seizures occur more commonly in infancy than at other times during childhood, yet they remain difficult to recognize because generalized tonic-clonic activity typically does not to occur. Hypoxic-ischemic injury is the most common cause of neonatal seizures [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/9\">",
"       9",
"      </a>",
"      ]. Other causes include infections, metabolic disturbances, trauma, structural brain disease, or drug withdrawal (",
"      <a class=\"graphic graphic_table graphicRef73867 \" href=\"UTD.htm?7/34/7724\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/23/41335?source=see_link\">",
"       \"Etiology and prognosis of neonatal seizures\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Arrhythmias, of which supraventricular tachycardia is the most common, may go unrecognized. Initial signs are non-specific and the infant typically tolerates the rapid heart rate. Eventually, congestive heart failure develops. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/54/31593?source=see_link&amp;anchor=H12#H12\">",
"       \"Supraventricular tachycardia in children: AV reentrant tachycardia (including WPW) and AV nodal reentrant tachycardia\", section on 'Heart failure'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Toxic exposures &ndash; Infants may become ill from exposure to environmental toxins, therapeutic or intentional overdose of medications, or (rarely) from substances in breastmilk. Conditions that result from environmental exposures include the following:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Methemoglobinemia &ndash; Methemoglobinemia has been described in young infants in association with severe diarrheal illness and following exposure to oxidants (such as water or foods high in nitrites and some topical anesthetics) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]. Infants are susceptible to acute methemoglobinemia because of the relative immaturity of the hemoglobin reductase enzyme system that maintains hemoglobin iron in a reduced state. Patients with methemoglobinemia typically are cyanotic or ashen and do not improve with supplemental oxygen. Oxygen saturation, as measured with pulse oximetry, is normal or near-normal. In addition, blood samples are dark-red, chocolate, or brownish to blue in color and do not change with the addition of oxygen (",
"      <a class=\"graphic graphic_figure graphicRef58540 \" href=\"UTD.htm?16/60/17344\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/33/8729?source=see_link\">",
"       \"Clinical features, diagnosis, and treatment of methemoglobinemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Carbon monoxide poisoning &ndash; Infants may develop carbon monoxide poisoning as the result of occult exposure from sources such as improperly vented home heating systems or automobile exhaust fumes [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]. The diagnosis may be difficult to make without a history of exposure or symptomatic contacts. Presenting symptoms include lethargy and irritability. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10345?source=see_link\">",
"       \"Carbon monoxide poisoning\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Incarcerated hernia &ndash; An inguinal hernia develops when intraabdominal contents enter the inguinal canal through a patent processus vaginalis. An incarceration results when the hernia cannot be reduced back into the intraabdominal cavity. Incarceration can rapidly progress to strangulation, in which hernia contents become ischemic. Inguinal hernia is six times more common in boys and has a greater incidence among premature infants. Incarceration develops most commonly during the first year of life. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21561?source=see_link&amp;anchor=H18#H18\">",
"       \"Overview of inguinal hernia in children\", section on 'Incarcerated mass'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pyloric stenosis &ndash; Hypertrophy of both the circular and longitudinal muscular layers of the pylorus results in obstruction. This is a common condition estimated to occur in about 1 of 300 live births. Eighty percent of patients with pyloric stenosis are male [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/14\">",
"       14",
"      </a>",
"      ]. A heightened clinical awareness and the liberal use of ultrasound to establish the diagnosis has led to less delay in diagnosis and better outcomes. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/29/3545?source=see_link\">",
"       \"Infantile hypertrophic pyloric stenosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Necrotizing enterocolitis (NEC) &ndash; NEC is characterized by bowel wall necrosis that may lead to perforation (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef78676 \" href=\"UTD.htm?15/9/15508\">",
"       image 1",
"      </a>",
"      ). It is most common in premature neonates, especially those of very low birth weight. It may occur in full-term infants, usually within the first 10 days of life. Term infants who develop NEC typically have an underlying condition, such as congenital heart disease or protracted diarrhea. Systemic signs are nonspecific and include apnea, respiratory failure, lethargy, poor feeding, temperature instability, or hypotension resulting from septic shock in the most severe cases. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41591?source=see_link\">",
"       \"Clinical features and diagnosis of necrotizing enterocolitis in newborns\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acute bilirubin encephalopathy (ABE) &ndash; Unconjugated bilirubin is a neurotoxin, which, at very high levels, can cause encephalopathy with permanent neurologic sequelae (kernicterus). Term infants may develop bilirubin neurotoxicity when total serum bilirubin concentrations exceed 25",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (513",
"      <span class=\"nowrap\">",
"       &micro;mol/L).",
"      </span>",
"      Infants who are at increased risk for ABE include those who are &lt;37 weeks gestation, breastfed, have hemolytic disease,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      are discharged home before 48 hours. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/63/25593?source=see_link&amp;anchor=H9#H9\">",
"       \"Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants\", section on 'Neurologic manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Apparent life-threatening event (ALTE) &ndash; ALTE is not a specific diagnosis; rather, it describes a \"chief complaint\" that brings an infant to medical attention. It may be defined as an episode that is frightening to the observer and is characterized by some combination of apnea, color change, change in muscle tone, choking, or gagging. Ill-appearing infants with a history of ALTE have a myriad of potential diagnoses (",
"      <a class=\"graphic graphic_table graphicRef51356 \" href=\"UTD.htm?17/20/17741\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/34/31272?source=see_link\">",
"       \"Apparent life-threatening event in infants\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Unusual causes",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Kawasaki disease (KD) &ndash; Kawasaki disease is rare among young infants. However, in this age group, the presentation is frequently incomplete or atypical. As a result, patients are at increased risk for coronary artery (CA) aneurysms, primarily because of delay in treatment. The diagnosis should be considered in any child under age six months with seven or more consecutive days of unexplained fever. &nbsp;(See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12248?source=see_link\">",
"       \"Kawasaki disease: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Appendicitis &ndash; Neonatal appendicitis has been reported infrequently. The appendix is typically perforated at the time of diagnosis among infants. Symptoms are nonspecific and include lethargy, irritability, and vomiting. Infants often have signs of sepsis, such as hypotension. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/3/32826?source=see_link&amp;anchor=H5#H5\">",
"       \"Acute appendicitis in children: Clinical manifestations and diagnosis\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     EVALUATION AND DECISION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms reported by caretakers of septic-appearing infants are typically nonspecific:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among young infants, constitutional symptoms such as increased sleepiness, irritability, or poor feeding are nonspecific complaints that occur with a variety of serious conditions.",
"     </li>",
"     <li>",
"      Absence of fever does not exclude infection. Young infants with normal or low core temperatures may have serious infections. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7928?source=see_link&amp;anchor=H5#H5\">",
"       \"Clinical features and diagnosis of bacterial meningitis in the neonate\", section on 'Temperature instability'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cough can be associated with pneumonia, bronchiolitis, or congenital heart disease (CHD).",
"     </li>",
"     <li>",
"      Infants with inflicted head injury often have nonspecific symptoms (such as seizures, breathing difficulty, apnea, or lifelessness). There is typically no clear history or an inconsistent history of trauma. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/19/40249?source=see_link&amp;anchor=H3#H3\">",
"       \"Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children\", section on 'History'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast, the following complaints are often associated with specific conditions (",
"    <a class=\"graphic graphic_table graphicRef76560 \" href=\"UTD.htm?32/13/32987\">",
"     table 4",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bilious emesis is a serious sign of bowel obstruction. In one retrospective series, 97 percent of infants with malrotation and volvulus had a history of bilious emesis [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/48/20232?source=see_link\">",
"       \"Intestinal malrotation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Neonates who have been well, but develop lethargy, poor feeding, vomiting, and shock may have an inborn error of metabolism (IEM). The urine of some infants with IEM may have an unusual odor (",
"      <a class=\"graphic graphic_table graphicRef74441 \" href=\"UTD.htm?20/58/21420\">",
"       table 5",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Congenital conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Herpes simplex virus infection must be considered for a neonate whose mother has genital vesicular lesions.",
"     </li>",
"     <li>",
"      Abnormal rhythmic movements (such as twitching, blinking or chewing) may represent seizure activity.",
"     </li>",
"     <li>",
"      Infants who develop projectile vomiting may have pyloric stenosis.",
"     </li>",
"     <li>",
"      An infant who is not moving an extremity may have osteomyelitis, septic arthritis, or a fracture.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Important features of the perinatal history include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Maternal infections, fever, and Group B streptococcal testing and results",
"     </li>",
"     <li>",
"      Mode of delivery",
"     </li>",
"     <li>",
"      Prematurity",
"     </li>",
"     <li>",
"      Birth asphyxia",
"     </li>",
"     <li>",
"      Need for neonatal intensive care",
"     </li>",
"     <li>",
"      Length of stay in the newborn nursery",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Finally, information regarding fever, vomiting, type and frequency of feeding, stooling patterns, and ill contacts may provide useful clues to the etiology of the infant's symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants who have respiratory or circulatory compromise must be quickly identified and their conditions stabilized.",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22327?source=see_link&amp;anchor=H2#H2\">",
"     \"Initial assessment and stabilization of children with respiratory or circulatory compromise\", section on 'Evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    By definition, infants with conditions that mimic sepsis are ill-appearing. The general appearance typically includes nonspecific features such as irritability, lethargy, poor tone, and decreased activity. A careful physical examination may identify a combination or pattern of clinical features that suggest the etiology of an infant's symptoms (",
"    <a class=\"graphic graphic_table graphicRef63744 \" href=\"UTD.htm?1/24/1420\">",
"     table 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Features of vital signs to consider include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pulses and blood pressure measurements should be obtained in both arms and both legs. Diminished pulses and blood pressure in the lower extremities suggest left ventricular outflow obstruction, as occurs with hypoplastic left heart syndrome, critical aortic stenosis, or coarctation of the aorta. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=see_link&amp;anchor=H1088178828#H1088178828\">",
"       \"Clinical manifestations and diagnosis of coarctation of the aorta\", section on 'Blood pressure and pulses'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Lack of fever does not exclude an infectious illness.",
"     </li>",
"     <li>",
"      An infant with a heart rate over 220 beats per minute (bpm) probably has a tachyarrhythmia, most commonly supraventricular tachycardia. Sinus tachycardia rarely exceeds 220 bpm. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/54/31593?source=see_link&amp;anchor=H10#H10\">",
"       \"Supraventricular tachycardia in children: AV reentrant tachycardia (including WPW) and AV nodal reentrant tachycardia\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Respiratory symptoms (such as tachypnea, grunting, or retractions) may be nonspecific. However, rales",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    wheezing suggest a pulmonary disorder or heart failure.",
"   </p>",
"   <p>",
"    Features of the cardiac examination may suggest a congenital defect. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=see_link&amp;anchor=H6#H6\">",
"     \"Diagnosis and initial management of cyanotic heart disease in the newborn\", section on 'Physical examination'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=see_link&amp;anchor=H6#H6\">",
"     \"Clinical manifestations and diagnosis of coarctation of the aorta\", section on 'Clinical manifestations'",
"    </a>",
"    .) Findings to note include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The presence of a heart murmur suggests cardiac disease, although the absence of a murmur does not exclude it.",
"     </li>",
"     <li>",
"      A gallop rhythm, the presence of rales, and hepatomegaly likely indicate heart failure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Abdominal distention may indicate bowel obstruction, but it is a nonspecific finding. A normal abdominal examination does not exclude serious conditions. In one retrospective series describing children with malrotation, 60 percent of those with volvulus had a normal abdominal examination [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Skin findings may include signs of infection, such as vesicles, cellulitis, or abscess formation. Jaundice suggests acute bilirubin encephalopathy. Acrocyanosis may be the result of poor perfusion. Infants with central cyanosis that does not respond to supplemental oxygen, however, may have cyanotic heart disease or methemoglobinemia.",
"   </p>",
"   <p>",
"    Physical findings that are suggestive of a specific etiology include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infants with congenital obstructive left heart disease and respiratory distress are more likely to have cardiomegaly and diminished extremity pulses than are infants with sepsis [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/15\">",
"       15",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Congenital conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An infant with apnea, bradycardia, a focal neurologic examination, and retinal hemorrhages has an inflicted head injury until proven otherwise (",
"      <a class=\"graphic graphic_picture graphicRef69754 \" href=\"UTD.htm?38/62/39919\">",
"       picture 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/19/40249?source=see_link&amp;anchor=H2#H2\">",
"       \"Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Volvulus is the probable cause of bilious emesis and abdominal distention for an infant with malrotation. [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/48/20232?source=see_link\">",
"       \"Intestinal malrotation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In comparison to myoclonus, the amplitude of movements of a seizure is typically not altered by gentle restraint. Tachycardia and hypertension occur more commonly during a seizure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/11/6328?source=see_link&amp;anchor=H16#H16\">",
"       \"Clinical features and electrodiagnosis of neonatal seizures\", section on 'Autonomic signs'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Ancillary studies",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Laboratory studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants under two months of age who are septic-appearing are seriously ill. The following laboratory studies should generally be performed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cultures of blood and urine should be obtained. Infants who are stable enough to undergo lumbar puncture (LP) should usually have cerebrospinal fluid (CSF) sent for culture as well. LP may be deferred for those who are afebrile and for whom an alternative diagnosis (such as congenital heart disease or volvulus) is quickly established. Specific cultures (such as of stool or a localized infection) should be obtained as indicated from the history and physical examination.",
"     </li>",
"     <li>",
"      Urine should be collected by urethral catheterization and sent for urinalysis (UA) and culture. An enhanced UA (microscopic analysis performed on an uncentrifuged specimen that includes a Gram stain and cell count using a hemocytometer) improves the accuracy of UA for detecting urinary tract infections. Enhanced UA should be requested, when available. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21129?source=see_link&amp;anchor=H12#H12\">",
"       \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\", section on 'Rapidly available tests'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      CSF should be sent for cell count, protein, glucose, gram stain, and culture whenever a LP is performed (",
"      <a class=\"graphic graphic_table graphicRef54464 \" href=\"UTD.htm?35/19/36158\">",
"       table 7",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef76324 \" href=\"UTD.htm?13/55/14204\">",
"       table 8",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H19#H19\">",
"       \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Interpretation of CSF'",
"      </a>",
"      .) Additional testing (such as for enterovirus or HSV) should be sent as indicated from the history and physical examination.",
"     </li>",
"     <li>",
"      Herpes simplex virus (HSV) cultures of skin vesicles, oropharynx, conjunctiva, urine, blood, stool or rectum, and CSF, as well as polymerase chain reaction (PCR) testing of CSF for HSV and liver function tests, should be performed for infants &le;28 days of age with the following risk factors:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Mucocutaneous vesicles",
"     </li>",
"     <li>",
"      Seizure",
"     </li>",
"     <li>",
"      CSF pleocytosis with negative gram stain",
"     </li>",
"     <li>",
"      Mother known to have HSV",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The following chemistry tests should be sent for critically ill infants:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Electrolytes, glucose, BUN and creatinine. Infants with hypernatremia, hyponatremia, or hypoglycemia frequently have nonspecific neurologic symptoms, including seizures.",
"     </li>",
"     <li>",
"      Calcium, magnesium, and phosphate levels should be determined for an infant who may have had a seizure.",
"     </li>",
"     <li>",
"      Total and direct bilirubin levels should be sent for infants who appear jaundiced.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Blood levels for ammonia, lactate, pyruvate, as well as blood and urine ketones, should be sent when an inborn error of metabolism is suspected (",
"      <a class=\"graphic graphic_table graphicRef76373 \" href=\"UTD.htm?37/63/38908\">",
"       table 9",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef67745 \" href=\"UTD.htm?1/63/2045\">",
"       table 10",
"      </a>",
"      ) .",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imaging studies should be obtained for specific indications, including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A chest radiograph should be obtained for infants with signs or symptoms of pulmonary or cardiac disease [",
"      <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/16,17\">",
"       16,17",
"      </a>",
"      ]. Infants with cardiomegaly or abnormal cardiac silhouettes may have congenital heart disease.",
"     </li>",
"     <li>",
"      Plain films of the abdomen are indicated for infants with abdominal distention or vomiting. Abnormalities that may be seen with necrotizing enterocolitis (NEC) include pneumatosis intestinalis (gas within the intestinal wall), portal venous gas, or pneumoperitoneum (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef78676 \" href=\"UTD.htm?15/9/15508\">",
"       image 1",
"      </a>",
"      ). With malrotation and pyloric stenosis, there may be duodenal or gastric distention with a paucity of air distally.",
"     </li>",
"     <li>",
"      Infants with bilious emesis should receive contrasted upper gastrointestinal (UGI) studies with small bowel follow through. A duodenal bulb that overlies the spine",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a medially directed cecum suggests malrotation (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef77126 \" href=\"UTD.htm?18/59/19391\">",
"       image 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef72551 \" href=\"UTD.htm?35/63/36848\">",
"       image 3",
"      </a>",
"      ). A corkscrew appearance in the small bowel can be seen with volvulus (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef75419 \" href=\"UTD.htm?29/1/29713\">",
"       image 4",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      An abdominal ultrasound is the preferred study to detect pyloric stenosis (",
"      <a class=\"graphic graphic_picture graphicRef78683 \" href=\"UTD.htm?18/4/18498\">",
"       picture 2",
"      </a>",
"      ). A \"string sign\" may be seen on UGI with pyloric stenosis (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef69939 \" href=\"UTD.htm?42/6/43104\">",
"       image 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Infants with seizures or focal neurologic examinations should receive head computed tomography (CT). A skeletal survey (plain films of all bones) to screen for old or new fractures should be performed when inflicted head injury is suspected. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/19/40249?source=see_link&amp;anchor=H10#H10\">",
"       \"Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children\", section on 'Imaging'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Other studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;An electrocardiogram (EKG) should be performed routinely for any infant believed to have CHD. EKG findings may suggest a specific anatomic lesion (",
"    <a class=\"graphic graphic_table graphicRef79941 \" href=\"UTD.htm?26/1/26653\">",
"     table 11",
"    </a>",
"    ). An injury pattern may identify infants who have myocardial ischemia as the result of aberrant coronary arteries. An emergent echocardiogram may be needed to assess some critically ill newborns.",
"   </p>",
"   <p>",
"    The hyperoxia test can help to distinguish cardiac from pulmonary disease. Oxygen saturation is measured using pulse oximetry before and while the infant is breathing 100 percent oxygen. Oxygen saturation should improve by at least 10 percent for pulmonary causes of cyanosis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/18\">",
"     18",
"    </a>",
"    ]. An abnormal or equivocal response suggests cardiac disease and must be verified by measurement of an arterial blood gas, taken from the right radial artery, while the infant is breathing 100 percent oxygen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=see_link&amp;anchor=H21#H21\">",
"     \"Diagnosis and initial management of cyanotic heart disease in the newborn\", section on 'Hyperoxia test'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Initial management decisions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants who are breathing spontaneously and effectively but have evidence of respiratory distress or cardiovascular compromise require immediate resuscitation with supplemental oxygen and intravenous fluids. Other more critically ill infants may need to be supported with bag mask or mechanical ventilation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22327?source=see_link\">",
"     \"Initial assessment and stabilization of children with respiratory or circulatory compromise\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=see_link\">",
"     \"Emergent endotracheal intubation in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26762?source=see_link\">",
"     \"Initial management of shock in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some critically ill infants may require specific life-saving interventions before definitive diagnoses have been established. In this situation, the emergency clinician must determine the likelihood that an infant may have the diagnosis, while considering the potential harm of the treatment. Treatments that should be considered include the following:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of overwhelming infection are notoriously nonspecific in young infants. Once cultures of blood and urine (and CSF, if possible) have been obtained, most ill-appearing young infants should receive antibiotics (",
"    <a class=\"graphic graphic_table graphicRef55679 \" href=\"UTD.htm?1/16/1292\">",
"     table 12",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=see_link&amp;anchor=H12#H12\">",
"     \"Evaluation and management of fever in the neonate and young infant (less than three months of age)\", section on 'Evaluation and management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Acyclovir",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early treatment with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/38/34400?source=see_link\">",
"     acyclovir",
"    </a>",
"    is associated with improved outcomes among infants with HSV infections [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/1,19\">",
"     1,19",
"    </a>",
"    ]. However, the definitive diagnosis may depend on culture results or other tests that are not immediately available, such as polymerase chain reaction (PCR) testing.",
"   </p>",
"   <p>",
"    Since the incidence of HSV among infants is low,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/38/34400?source=see_link\">",
"     acyclovir",
"    </a>",
"    should be administered selectively. Infants &le;28 days of age who are ill-appearing and have any of the following features should receive acyclovir:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mucocutaneous vesicles",
"     </li>",
"     <li>",
"      Neurologic symptoms such as seizures",
"     </li>",
"     <li>",
"      CSF pleocytosis with a negative CSF Gram stain",
"     </li>",
"     <li>",
"      Red blood cells in CSF from an atraumatic lumbar puncture",
"     </li>",
"     <li>",
"      Maternal history of HSV",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Cultures for HSV, as well as a specimen of CSF for HSV PCR, should be obtained before",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/38/34400?source=see_link\">",
"     acyclovir",
"    </a>",
"    is given. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=see_link&amp;anchor=H12#H12\">",
"     \"Evaluation and management of fever in the neonate and young infant (less than three months of age)\", section on 'Evaluation and management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Prostaglandin E1 (alprostadil)",
"    </span>",
"    &nbsp;&mdash;&nbsp;For infants with cyanotic or obstructive heart disease who are dependent on blood flow through the ductus arteriosus (DA) for pulmonary or systemic circulation, severe symptoms can develop when the DA closes over the first several days to weeks of life. Structural closure of the DA is usually completed by 2 to 3 weeks of age, making the diagnosis of a ductal-dependent cardiac defect unlikely among infants older than 28 days. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/52/35656?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical manifestations and diagnosis of patent ductus arteriosus\", section on 'Fetal and transitional ductal circulation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For hypoxic, hemodynamically unstable infants with ductal-dependent congenital heart disease, treatment with prostaglandin E1 (PGE1,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/57/23445?source=see_link\">",
"     alprostadil",
"    </a>",
"    ) to reopen the ductus arteriosus (DA) can be life-saving [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Circulation through the DA temporarily restores pulmonary or systemic blood flow while the patient undergoes further evaluation in preparation for definitive treatment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=see_link&amp;anchor=H27#H27\">",
"     \"Diagnosis and initial management of cyanotic heart disease in the newborn\", section on 'Prostaglandin E1'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Infants &le;28 days of age who do not respond to initial resuscitative efforts and are likely to have a ductal-dependent defect, but for whom diagnosis may be delayed (such as those who must be transferred to another facility for echocardiography), should receive PGE1, ideally after consultation with a neonatologist or pediatric cardiologist [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/22\">",
"     22",
"    </a>",
"    ]. Side effects of PGE1 infusion include hypotension, tachycardia, and apnea. Equipment to provide advanced airway management should be readily available and infants should have reliable IV access.",
"   </p>",
"   <p>",
"    PGE1 should be started as an intravenous infusion at a dose of 0.05",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per minute. In order to limit side effects, the dose may be titrated down to the lowest dose at which the patient's condition remains improved. Apnea is less likely with doses &lt;0.01",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per minute [",
"    <a class=\"abstract\" href=\"UTD.htm?16/39/17018/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Indications of a ductal-dependent cardiac lesion include one of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Failed hyperoxia test, suggesting cyanotic heart disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=see_link&amp;anchor=H21#H21\">",
"       \"Diagnosis and initial management of cyanotic heart disease in the newborn\", section on 'Hyperoxia test'",
"      </a>",
"      .)&nbsp;",
"      <strong>",
"       or",
"      </strong>",
"     </li>",
"     <li>",
"      A pulse or blood pressure gradient between the upper and lower extremities, suggesting an obstructive cardiac defect. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=see_link&amp;anchor=H1088178828#H1088178828\">",
"       \"Clinical manifestations and diagnosis of coarctation of the aorta\", section on 'Blood pressure and pulses'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Hydrocortisone",
"    </span>",
"    &nbsp;&mdash;&nbsp;An infant (usually male) with previously undiagnosed congenital adrenal hyperplasia may develop adrenal crisis and present as septic-appearing. Treatment with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/28/35264?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    may be life-saving.",
"   </p>",
"   <p>",
"    Specific manifestations of adrenal insufficiency include hyponatremia, hyperkalemia, hypoglycemia, and hypotension. Patients with these findings must promptly receive stress doses of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/28/35264?source=see_link\">",
"     hydrocortisone",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/0/31754?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and children\", section on 'Management in neonates'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     ALGORITHMIC APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systematic approach to the emergent evaluation of a young infant who appears septic (including a focused history, careful physical examination, and selected ancillary studies) can generally identify those with a condition other than sepsis that requires emergent evaluation and treatment (",
"    <a class=\"graphic graphic_table graphicRef74535 \" href=\"UTD.htm?41/37/42588\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef76560 \" href=\"UTD.htm?32/13/32987\">",
"     table 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef63744 \" href=\"UTD.htm?1/24/1420\">",
"     table 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_algorithm graphicRef66424 \" href=\"UTD.htm?13/30/13795\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Specific history or physical findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Features of the history or physical examination may suggest the diagnosis and guide evaluation and treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Cutaneous findings",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Focal areas of erythema, warmth, or tenderness suggests skin infection which may be localized (as with mastitis or omphalitis). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Bacterial infections'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infants who are jaundiced may have acute bilirubin encephalopathy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/63/25593?source=see_link&amp;anchor=H9#H9\">",
"       \"Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants\", section on 'Neurologic manifestations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Central cyanosis that does not improve when the patient is breathing 100 percent oxygen occurs with cyanotic congenital heart disease and methemoglobinemia. Blood from patients with methemoglobinemia is dark-red, chocolate, or brownish to blue in color and does not change with the addition of oxygen (",
"      <a class=\"graphic graphic_figure graphicRef58540 \" href=\"UTD.htm?16/60/17344\">",
"       figure 2",
"      </a>",
"      ). In addition, patients with methemoglobinemia may appear cyanotic or dusky but have normal or near-normal oxygen saturations as measured by pulse oximetry. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=see_link\">",
"       \"Diagnosis and initial management of cyanotic heart disease in the newborn\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/33/8729?source=see_link\">",
"       \"Clinical features, diagnosis, and treatment of methemoglobinemia\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Respiratory distress",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical findings such as tachypnea, grunting, retractions, and apnea are nonspecific signs of respiratory distress that can occur in a number of conditions, including inflicted head injury, infant botulism, bronchiolitis, or pertussis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/19/40249?source=see_link\">",
"     \"Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/10/166?source=see_link&amp;anchor=H14#H14\">",
"     \"Neuromuscular junction disorders in newborns and infants\", section on 'Infant botulism'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/55/16248?source=see_link&amp;anchor=H10#H10\">",
"     \"Clinical features and diagnosis of Bordetella pertussis infection in infants and children\", section on 'Infants'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H5\">",
"     'Viral infections'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Infants with wheezes",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    rales may have pneumonia, bronchiolitis, or heart failure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/44/16074?source=see_link&amp;anchor=H18#H18\">",
"     \"Bronchiolitis in infants and children: Clinical features and diagnosis\", section on 'Apnea'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Abnormal cardiac examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;An abnormal cardiac examination that may include decreased pulses or blood pressure in the lower extremities, the presence of a murmur or gallop, a heart rate over 220 bpm, or an injury current on EKG, suggests a cardiac condition such as congenital heart disease, myocarditis, pericarditis, supraventricular tachycardia, or aberrant coronary arteries. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=see_link&amp;anchor=H6#H6\">",
"     \"Diagnosis and initial management of cyanotic heart disease in the newborn\", section on 'Physical examination'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=see_link&amp;anchor=H6#H6\">",
"     \"Clinical manifestations and diagnosis of coarctation of the aorta\", section on 'Clinical manifestations'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34647?source=see_link\">",
"     \"Clinical manifestations and diagnosis of myocarditis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/54/31593?source=see_link&amp;anchor=H12#H12\">",
"     \"Supraventricular tachycardia in children: AV reentrant tachycardia (including WPW) and AV nodal reentrant tachycardia\", section on 'Heart failure'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/56/14218?source=see_link&amp;anchor=H13#H13\">",
"     \"Congenital and pediatric coronary artery abnormalities\", section on 'Variations of coronary artery origin from the pulmonary artery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Musculoskeletal findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants who are not moving an extremity or have swollen extremities or joints may have osteomyelitis, septic arthritis, or a fracture. Inflicted injury must be considered for patients with fractures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20087?source=see_link&amp;anchor=H7#H7\">",
"     \"Clinical features of hematogenous osteomyelitis in children\", section on 'Newborns'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/30/13802?source=see_link\">",
"     \"Orthopedic aspects of child abuse\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Bilious vomiting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with bilious vomiting must be emergently evaluated for causes of bowel obstruction, particularly malrotation with volvulus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/48/20232?source=see_link\">",
"     \"Intestinal malrotation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21561?source=see_link&amp;anchor=H18#H18\">",
"     \"Overview of inguinal hernia in children\", section on 'Incarcerated mass'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     No specific clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Young infants who appear to have sepsis are seriously ill and require ancillary studies to identify the cause of their symptoms. These studies may be particularly useful for patients without specific clinical features. However, infants who are seriously ill may have very few distinguishing clinical characteristics and relatively normal ancillary studies. Examples include some patients with sepsis, overwhelming viral illnesses, inflicted head injury, and infant botulism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Abnormal cerebrospinal fluid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with CSF pleocytosis usually have meningitis or encephalitis. HSV infection must be considered when there is CSF pleocytosis with no organisms on gram stain or there are red blood cells from an atraumatic lumbar puncture (",
"    <a class=\"graphic graphic_table graphicRef76324 \" href=\"UTD.htm?13/55/14204\">",
"     table 8",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7928?source=see_link\">",
"     \"Clinical features and diagnosis of bacterial meningitis in the neonate\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H19#H19\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Interpretation of CSF'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35321?source=see_link&amp;anchor=H4#H4\">",
"     \"Neonatal herpes simplex virus infection: Clinical features and diagnosis\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Abnormal chest radiograph",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung infiltrates on a chest radiograph may represent infections (such as pneumonia or bronchiolitis) or heart failure. Infants with cardiomegaly or abnormal cardiac silhouettes may have congenital heart disease or myocarditis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Pyuria",
"    </span>",
"    &nbsp;&mdash;&nbsp;An abnormal urinalysis, particularly with pyuria, suggests urosepsis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21129?source=see_link&amp;anchor=H14#H14\">",
"     \"Clinical features and diagnosis of urinary tract infections in infants and children older than one month\", section on 'Microscopic exam'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Abnormal blood chemistries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities in blood chemistries may help to identify a specific condition. In addition, many of these abnormalities must be urgently treated.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acidosis is a nonspecific consequence of many disorders that may mimic sepsis, including other conditions that cause shock, such as CAH (",
"      <a class=\"graphic graphic_table graphicRef51117 \" href=\"UTD.htm?16/52/17229\">",
"       table 13",
"      </a>",
"      ). Acidosis may also occur with inborn errors of metabolism, methemoglobinemia, carbon monoxide poisoning, dehydration, necrotizing enterocolitis, and appendicitis.",
"     </li>",
"     <li>",
"      Infants with pyloric stenosis may develop hypochloremic alkalosis from loss of gastric hydrochloric acid as the result of persistent vomiting. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/29/3545?source=see_link&amp;anchor=H5#H5\">",
"       \"Infantile hypertrophic pyloric stenosis\", section on 'Classic presentation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hyponatremia may develop as the result of water intoxication (intake of excessive amounts of free water), syndrome of inappropriate antidiuretic hormone secretion, or from excessive sodium losses (such as renal losses with CAH or losses from the skin with cystic fibrosis). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/60/27591?source=see_link&amp;anchor=H16#H16\">",
"       \"Fluid and electrolyte therapy in newborns\", section on 'Hyponatremia'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H7\">",
"       'Other causes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypernatremia typically occurs as the result of sodium (salt) poisoning, excessive loss of free water (as can occur with diabetes insipidus), or loss of water in excess of sodium losses. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/60/27591?source=see_link&amp;anchor=H19#H19\">",
"       \"Fluid and electrolyte therapy in newborns\", section on 'Hypernatremia'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H7\">",
"       'Other causes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infants who are seriously ill are frequently hypoglycemic. Severe hypoglycemia is also associated with shock, congenital adrenal hyperplasia, and inborn errors of metabolism. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/16/17673?source=see_link\">",
"       \"Neonatal hypoglycemia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hyperammonemia is a characteristic finding in urea cycle defects, organic acidemias, fatty acid oxidation defects, and liver dysfunction (",
"      <a class=\"graphic graphic_algorithm graphicRef52126 \" href=\"UTD.htm?23/24/23950\">",
"       algorithm 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Young infants who are profoundly ill are often initially presumed to have sepsis. Although that is often the case, some patients may have other conditions that have similar, nonspecific clinical features (",
"    <a class=\"graphic graphic_table graphicRef74535 \" href=\"UTD.htm?41/37/42588\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Causes'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Historical features, physical findings, and ancillary studies may identify a specific diagnosis (",
"      <a class=\"graphic graphic_table graphicRef76560 \" href=\"UTD.htm?32/13/32987\">",
"       table 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef63744 \" href=\"UTD.htm?1/24/1420\">",
"       table 6",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Evaluation and decision'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial management of septic-appearing infants consists of resuscitation with supplemental oxygen and intravenous fluids. Specific interventions include the following (see",
"      <a class=\"local\" href=\"#H16\">",
"       'Initial management decisions'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Once cultures of blood and urine (and CSF, if possible) have been obtained, most ill-appearing young infants should receive antibiotics (",
"      <a class=\"graphic graphic_table graphicRef55679 \" href=\"UTD.htm?1/16/1292\">",
"       table 12",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=see_link&amp;anchor=H13#H13\">",
"       \"Evaluation and management of fever in the neonate and young infant (less than three months of age)\", section on 'Neonates (0 to 28 days)'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=see_link&amp;anchor=H310880#H310880\">",
"       \"Evaluation and management of fever in the neonate and young infant (less than three months of age)\", section on 'Ill-appearing infants (29 to 90 days)'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Infants &le;28 days old who have mucocutaneous vesicles, seizures, CSF pleocytosis with a negative Gram stain, or maternal herpes simplex virus (HSV) infection should receive",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?33/38/34400?source=see_link\">",
"       acyclovir",
"      </a>",
"      . HSV culture and PCR for HSV testing should ideally be obtained prior to treatment. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=see_link&amp;anchor=H15#H15\">",
"       \"Evaluation and management of fever in the neonate and young infant (less than three months of age)\", section on 'Acyclovir'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypoxic, hypotensive, and acidotic infants &le;28 days old, who do not respond to resuscitative efforts and are likely to have ductal-dependent congenital heart disease (as suggested by either a failed hyperoxia test or a pulse or blood pressure gradient between the upper and lower extremities), should receive prostaglandin E1 (",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/57/23445?source=see_link\">",
"       alprostadil",
"      </a>",
"      ). A neonatologist or pediatric cardiologist should be consulted. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=see_link&amp;anchor=H27#H27\">",
"       \"Diagnosis and initial management of cyanotic heart disease in the newborn\", section on 'Prostaglandin E1'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Critically ill infants with signs of adrenal crisis (hyponatremia, hyperkalemia, hypoglycemia, and hypotension) should receive",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/28/35264?source=see_link\">",
"       hydrocortisone",
"      </a>",
"      ideally after blood has been drawn for baseline ACTH and cortisol measurements. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31078?source=see_link&amp;anchor=H9#H9\">",
"       \"Treatment of adrenal insufficiency in children\", section on 'Adrenal crisis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An algorithmic approach to the emergent evaluation of the septic-appearing infant can be useful (",
"      <a class=\"graphic graphic_algorithm graphicRef66424 \" href=\"UTD.htm?13/30/13795\">",
"       algorithm 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Algorithmic approach'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/1\">",
"      Kimberlin DW, Lin CY, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001; 108:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/2\">",
"      Willwerth BM, Harper MB, Greenes DS. Identifying hospitalized infants who have bronchiolitis and are at high risk for apnea. Ann Emerg Med 2006; 48:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/3\">",
"      Bonadio WA, Clarkson T, Naus J. The clinical features of children with malrotation of the intestine. Pediatr Emerg Care 1991; 7:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/4\">",
"      Lee C, Mason LJ. Pediatric cardiac emergencies. Anesthesiol Clin North America 2001; 19:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/5\">",
"      Ballestero Y, Hernandez MI, Rojo P, et al. Hyponatremic dehydration as a presentation of cystic fibrosis. Pediatr Emerg Care 2006; 22:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/6\">",
"      Oddie S, Richmond S, Coulthard M. Hypernatraemic dehydration and breast feeding: a population study. Arch Dis Child 2001; 85:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/7\">",
"      Shroff R, Hignett R, Pierce C, et al. Life-threatening hypernatraemic dehydration in breastfed babies. Arch Dis Child 2006; 91:1025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/8\">",
"      Sperling MA, Menon RK. Differential diagnosis and management of neonatal hypoglycemia. Pediatr Clin North Am 2004; 51:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/9\">",
"      Gold, CR, Pierog, J. A rational approach to pediatric seizures. Pediatric Emergency Medicine Reports 2000; 5:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/10\">",
"      Pollack ES, Pollack CV Jr. Incidence of subclinical methemoglobinemia in infants with diarrhea. Ann Emerg Med 1994; 24:652.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/11\">",
"      Murone AJ, Stucki P, Roback MG, Gehri M. Severe methemoglobinemia due to food intoxication in infants. Pediatr Emerg Care 2005; 21:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/12\">",
"      Piatt JP, Kaplan AM, Bond GR, Berg RA. Occult carbon monoxide poisoning in an infant. Pediatr Emerg Care 1990; 6:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/13\">",
"      O'Sullivan BP. Carbon monoxide poisoning in an infant exposed to a kerosene heater. J Pediatr 1983; 103:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/14\">",
"      Hulka F, Campbell TJ, Campbell JR, Harrison MW. Evolution in the recognition of infantile hypertrophic pyloric stenosis. Pediatrics 1997; 100:E9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/15\">",
"      Pickert CB, Moss MM, Fiser DH. Differentiation of systemic infection and congenital obstructive left heart disease in the very young infant. Pediatr Emerg Care 1998; 14:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/16\">",
"      Bramson RT, Meyer TL, Silbiger ML, et al. The futility of the chest radiograph in the febrile infant without respiratory symptoms. Pediatrics 1993; 92:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/17\">",
"      Crain EF, Bulas D, Bijur PE, Goldman HS. Is a chest radiograph necessary in the evaluation of every febrile infant less than 8 weeks of age? Pediatrics 1991; 88:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/18\">",
"      Brousseau T, Sharieff GQ. Newborn emergencies: the first 30 days of life. Pediatr Clin North Am 2006; 53:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/19\">",
"      Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001; 108:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/20\">",
"      Freed MD, Heymann MA, Lewis AB, et al. Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease. Circulation 1981; 64:899.",
"     </a>",
"    </li>",
"    <li>",
"     Zahka, KG, Siwik, ES. Principles of medical and surgical management. In: Neonatal-perinatal Medicine, 9th, Martin, RJ, Fanaroff, AA, Walsh, MC (Eds), Mosby-Elsevier, Philadelphia 2011. Vol 2, p.1290.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/22\">",
"      Hallidie-Smith KA. Prostaglandin E1 in suspected ductus dependent cardiac malformation. Arch Dis Child 1984; 59:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/39/17018/abstract/23\">",
"      Kramer HH, Sommer M, Rammos S, Krogmann O. Evaluation of low dose prostaglandin E1 treatment for ductus dependent congenital heart disease. Eur J Pediatr 1995; 154:700.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6467 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-47BF19C4B0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_39_17018=[""].join("\n");
var outline_f16_39_17018=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H33\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CAUSES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Infectious causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Bacterial infections",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Viral infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Congenital conditions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Unusual causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      EVALUATION AND DECISION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Ancillary studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Laboratory studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Other studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Initial management decisions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Acyclovir",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Prostaglandin E1 (alprostadil)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Hydrocortisone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      ALGORITHMIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Specific history or physical findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Cutaneous findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Respiratory distress",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Abnormal cardiac examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Musculoskeletal findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Bilious vomiting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      No specific clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Abnormal cerebrospinal fluid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Abnormal chest radiograph",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Pyuria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Abnormal blood chemistries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6467\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6467|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?13/30/13795\" title=\"algorithm 1\">",
"      Algorithm septic appearing infant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?23/24/23950\" title=\"algorithm 2\">",
"      Evaluation of hyperammonemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6467|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?15/9/15508\" title=\"diagnostic image 1\">",
"      Plain radiographs - necrotizing enterocolitis in preterm infants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?18/59/19391\" title=\"diagnostic image 2\">",
"      UGI duodenal bulb",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?35/63/36848\" title=\"diagnostic image 3\">",
"      Medial directed cecum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?29/1/29713\" title=\"diagnostic image 4\">",
"      Volvulus corkscrew",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?42/6/43104\" title=\"diagnostic image 5\">",
"      Upper GI pyloric stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6467|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/19/28977\" title=\"figure 1\">",
"      Midgut volvulus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/60/17344\" title=\"figure 2\">",
"      Acquired methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6467|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/62/39919\" title=\"picture 1\">",
"      Dome shaped hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?18/4/18498\" title=\"picture 2\">",
"      Ultrasound pyloric stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6467|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/37/42588\" title=\"table 1\">",
"      Causes septic appearing infant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/34/7724\" title=\"table 2\">",
"      Etiologies of neonatal seizures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/20/17741\" title=\"table 3\">",
"      Differential diagnosis of apparent life-threatening event",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/13/32987\" title=\"table 4\">",
"      History septic appearing infant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/58/21420\" title=\"table 5\">",
"      Urinary clues to inborn errors of metabolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/24/1420\" title=\"table 6\">",
"      Examination of the septic appearing infant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/19/36158\" title=\"table 7\">",
"      Normal cerebrospinal fluid indices neonate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/55/14204\" title=\"table 8\">",
"      CSF analysis in CNS infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/63/38908\" title=\"table 9\">",
"      Laboratory findings inborn errors of metabolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/63/2045\" title=\"table 10\">",
"      Laboratory evaluation for inborn errors of metabolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/1/26653\" title=\"table 11\">",
"      Findings cyanotic heart disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/16/1292\" title=\"table 12\">",
"      Empiric treatment febrile infant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/52/17229\" title=\"table 13\">",
"      Pediatric causes metabolic acidosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/3/32826?source=related_link\">",
"      Acute appendicitis in children: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/34/31272?source=related_link\">",
"      Apparent life-threatening event in infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/30/40423?source=related_link\">",
"      Bacterial arthritis: Epidemiology, pathogenesis, and microbiology in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/44/16074?source=related_link\">",
"      Bronchiolitis in infants and children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/6/10345?source=related_link\">",
"      Carbon monoxide poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/52/23369?source=related_link\">",
"      Causes and clinical manifestations of primary adrenal insufficiency in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/19/40249?source=related_link\">",
"      Child abuse: Evaluation and diagnosis of abusive head trauma in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/55/16248?source=related_link\">",
"      Clinical features and diagnosis of Bordetella pertussis infection in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7928?source=related_link\">",
"      Clinical features and diagnosis of bacterial meningitis in the neonate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/10/30886?source=related_link\">",
"      Clinical features and diagnosis of galactosemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/39/41591?source=related_link\">",
"      Clinical features and diagnosis of necrotizing enterocolitis in newborns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21129?source=related_link\">",
"      Clinical features and diagnosis of urinary tract infections in infants and children older than one month",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/11/6328?source=related_link\">",
"      Clinical features and electrodiagnosis of neonatal seizures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/39/20087?source=related_link\">",
"      Clinical features of hematogenous osteomyelitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/33/8729?source=related_link\">",
"      Clinical features, diagnosis, and treatment of methemoglobinemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=related_link\">",
"      Clinical manifestations and diagnosis of coarctation of the aorta",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=related_link\">",
"      Clinical manifestations and diagnosis of enterovirus and parechovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34647?source=related_link\">",
"      Clinical manifestations and diagnosis of myocarditis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/52/35656?source=related_link\">",
"      Clinical manifestations and diagnosis of patent ductus arteriosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/63/25593?source=related_link\">",
"      Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/56/14218?source=related_link\">",
"      Congenital and pediatric coronary artery abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/17/28951?source=related_link\">",
"      Definition and etiology of fever in neonates and infants (less than three months of age)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=related_link\">",
"      Diagnosis and initial management of cyanotic heart disease in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=related_link\">",
"      Emergent endotracheal intubation in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/21/30042?source=related_link\">",
"      Epidemiology and clinical spectrum of methicillin-resistant Staphylococcus aureus infections in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/0/17416?source=related_link\">",
"      Epidemiology, pathogenesis, and microbiology of hematogenous osteomyelitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/23/41335?source=related_link\">",
"      Etiology and prognosis of neonatal seizures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/26/28074?source=related_link\">",
"      Evaluation and management of fever in the neonate and young infant (less than three months of age)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/60/27591?source=related_link\">",
"      Fluid and electrolyte therapy in newborns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/0/10250?source=related_link\">",
"      Inborn errors of metabolism: Metabolic emergencies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/29/3545?source=related_link\">",
"      Infantile hypertrophic pyloric stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22327?source=related_link\">",
"      Initial assessment and stabilization of children with respiratory or circulatory compromise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26762?source=related_link\">",
"      Initial management of shock in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/48/20232?source=related_link\">",
"      Intestinal malrotation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12248?source=related_link\">",
"      Kawasaki disease: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/31/35321?source=related_link\">",
"      Neonatal herpes simplex virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/16/17673?source=related_link\">",
"      Neonatal hypoglycemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/10/166?source=related_link\">",
"      Neuromuscular junction disorders in newborns and infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/2/2088?source=related_link\">",
"      Newborn screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/30/13802?source=related_link\">",
"      Orthopedic aspects of child abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/3/21561?source=related_link\">",
"      Overview of inguinal hernia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/54/31593?source=related_link\">",
"      Supraventricular tachycardia in children: AV reentrant tachycardia (including WPW) and AV nodal reentrant tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31078?source=related_link\">",
"      Treatment of adrenal insufficiency in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/0/31754?source=related_link\">",
"      Treatment of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/6/29802?source=related_link\">",
"      Treatment of invasive methicillin-resistant Staphylococcus aureus infection in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_39_17019="Muscle strength test";
var content_f16_39_17019=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F66888&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F66888&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Muscle strength grading scale*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Grade",
"      </td>",
"      <td class=\"subtitle1\">",
"       Demonstrated strength",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       5",
"      </td>",
"      <td>",
"       Muscle contracts normally against full resistance.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       4",
"      </td>",
"      <td>",
"       Muscle strength is reduced but muscle contraction can still move joint against resistance.&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       3",
"      </td>",
"      <td>",
"       Muscle strength is further reduced such that the joint can be moved only against gravity with the examiner's resistance completely removed.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       2",
"      </td>",
"      <td>",
"       Muscle can move only if the resistance of gravity is removed (eg, in the horizontal plane).",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       1",
"      </td>",
"      <td>",
"       Only a trace of movement is seen or felt or fasciculations are present.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       0",
"      </td>",
"      <td>",
"       No movement.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * This scale relies on full patient effort and cooperation. Thus, patients who are unable to follow instructions due to young age, cognitive deficits, or decreased level of consciousness cannot be tested in this manner.",
"     <br>",
"      &bull; This system is relatively less sensitive for the evaluation of mild weakness. To compensate for this, the addition of 4+ and 4- categories are sometimes added to the scale.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_39_17019=[""].join("\n");
var outline_f16_39_17019=null;
var title_f16_39_17020="Continuous thoracic murmurs";
var content_f16_39_17020=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F50660&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F50660&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of continuous thoracic murmurs (in order of frequency)*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Diagnosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Key findings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cervical venous hum",
"       </td>",
"       <td>",
"        Disappears on compression of the jugular vein",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatic venous hum",
"       </td>",
"       <td>",
"        Often disappears with epigastric pressure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mammary souffle",
"       </td>",
"       <td>",
"        Disappears upon pressing hard with stethoscope",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Patent ductus arteriosus",
"       </td>",
"       <td>",
"        Loudest at 2nd left intercostal space",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Coronary arteriovenous fistula",
"       </td>",
"       <td>",
"        Loudest at lower sternal borders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ruptured aneurysm of sinus of Valsalva",
"       </td>",
"       <td>",
"        Loudest at upper right sternal border, sudden onset",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bronchial collaterals",
"       </td>",
"       <td>",
"        Associated signs of congenital heart disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        High-grade coarctation",
"       </td>",
"       <td>",
"        Brachial-pedal arterial pressure gradient",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anomalous left coronary artery arising from pulmonary artery",
"       </td>",
"       <td>",
"        Electrocardiographic changes of myocardial infarction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Truncus arteriosus",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulmonary artery branch stenosis",
"       </td>",
"       <td>",
"        Heard outside the area of cardiac dullness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pulmonary AV fistula",
"       </td>",
"       <td>",
"        Same as above",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Atrial septal defect with mitral stenosis or atresia",
"       </td>",
"       <td>",
"        Altered by the Valsalva maneuver",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aortic-atrial fistulas",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Sapira JD. The Art and Science of Bedside Diagnosis. Urban &amp; Schwartzenberg, Baltimore 1990. Copyright &copy; 1990 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_39_17020=[""].join("\n");
var outline_f16_39_17020=null;
var title_f16_39_17021="Initial labs encephalitis";
var content_f16_39_17021=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F63632&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F63632&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Suggested initial laboratory evaluation for children and adolescents with encephalitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        For nonimmunocompromised patients",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Blood",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Complete blood count with differential count and platelets",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Blood culture",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Serum electrolytes, glucose, ammonia, blood urea nitrogen, creatinine; blood pH",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Serum aminotransferases (alanine aminotransferase, aspartate aminotransferase)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Coagulation studies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Serology for EBV, HIV",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anti-NMDAR and anti-VGKC antibodies if clinically indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Acute serum sample (to hold for subsequent serologic testing if necessary)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        CSF",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Opening pressure (when feasible)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cell count, differential, protein, glucose, Gram stain, acid fast stain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bacterial culture;",
"        <em>",
"         M. tuberculosis",
"        </em>",
"        culture (if clinically indicated)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        PCR: HSV, enterovirus (PCR for other",
"        <em>",
"         Herpesviridae",
"        </em>",
"        , WNV, influenza, and other pathogens, as indicated by history and epidemiology)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        CSF sample (to hold for subsequent testing)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Respiratory samples",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Respiratory panel (PCR) (influenza, adenovirus, human metapneumovirus, and respiratory syncytial virus)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Viral culture of respiratory secretions and nasopharynx",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Throat swab for HSV, enterovirus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Stool (or rectal swab)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Viral culture of stool",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Enterovirus PCR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Urine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Urinalysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Urine toxicology screen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Skin lesions (if present)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Biopsy for DFA and PCR for",
"        <em>",
"         R. rickettsia",
"        </em>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Culture and/or DFA of skin lesions for HSV, VZV, and enteroviruses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        For immunocompromised patients",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Above tests, plus:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Blood: Serum cryptococcal antigen,",
"        <em>",
"         Toxoplasma gondii",
"        </em>",
"        IgG",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        CSF: Cryptococcal antigen, Histoplasma antigen; PCR for CMV, CJ, HHV6, WNV",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Urine: Histoplasma antigen",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     EBV: Epstein-Barr virus; HIV: human immunodeficiency virus; NMDAR: N-methyl-D-aspartate receptor; VGKC: voltage-gated potassium channel; CSF: cerebrospinal fluid; PCR: polymerase chain reaction; HSV: herpes simplex virus; WNV: West Nile virus; DFA: direct fluorescent antibody; VZV: varicella zoster virus; CMV: cytomegalovirus; CJ: Creutzfeldt-Jakob disease; HHV6: human herpesvirus 6.",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Willoughby RE, Long SS. Encephalitis, meningoencephalitis, acute disseminated encephalomyelitis, and acute necrotizing encephalopathy. In: Principles and Practice of Pediatric Infectious Diseases, 2nd ed, Long SS, Pickering LK, Prober CG (Eds), Churchill Livingstone, New York 2008. p.310.",
"       </li>",
"       <li>",
"        Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47:303.",
"       </li>",
"       <li>",
"        Cherry JD, Shields WD, Bronstein DE. Encephalitis and meningoencephalitis. In: Feigin and Cherry's Textbook of Pediatric Infectious Diseases, 6th ed, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia, 2009. p.504.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_39_17021=[""].join("\n");
var outline_f16_39_17021=null;
var title_f16_39_17022="Noninvasive tech pred accuracy";
var content_f16_39_17022=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79730&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79730&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dobutamine echocardiography is the most useful technique for predicting improvement of LV function after CABG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 425px; height: 274px; background-image: url(data:image/gif;base64,R0lGODlhqQESAcQAAP////8AAAAzmYCAgH8AAAAAAEBAQMDAwAAZTNDQ0PDw8DAwMBAQEHBwcFBQUKCgoODg4GBgYCAgILCwsJCQkAAMJgAmcj8AAL8AAAAGEwAshQATOQAfXwAAAAAAAAAAACH5BAAAAAAALAAAAACpARIBAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AQgkHhAmBh4iJOQ0FjQUGipGSkykFDAOYD5SbnIoSA52hooANBoQHhqOqq3IGjo+ssbJqD5iZs7i5uru8vSQKDpYNvsTFTa4GCwWgxs3OQgUTIqXP1dY6lwDADjOoJBMDFBAj4OLX57KMjtIwCQOw0wULDAzjjPP16PqqFAYO7DBcwVNgCQCFAg0IMjCIcJ/DagfgRYQ0cSIAiyIO2LJ14KFHPQYSlDJAclgMjBYr/8LCeHHjAAPMPs7S6HJAR0QFDghsBOkkvATyAEwo4ADoAqFEU2CSiYvmS5g2iSU4uOCAAgASogXTlHXCVqUxmeJaOgnmNG4BX3VMoIyBSbbCVJAVOzYsIggDJEBd0JPJXLqy/iKK+GqZE8GAVyEOpODAggiFnizO4XTjzcRqJgcawA2CAYBLNN9wShLTZcxoRP9hoAlAhL6h7f5QjVoM7T45Rbw8LNvH7dpffu9ZsGDCBLe8iQgHzmV5nqGN8jVxPoM6cyzW7+A1l3xI9utVvtcZFHl67x7iwUtJL0cdz+5C2NOpzDGUfDiWbLX2e57HfTmkQXUaJf+58cl6/e1QIP8dC87R4BqlnJIKf8olGMmDcWCYxk7wUOidhYpo+IaIZ9SinwkP3GRcfCDiQGIbL7IRIxnklUeCWQBQE8SLM2bWIiI9isEhbIS9ghYQPP54SJCpKamHie9QQEICBjCglz8TzuYkDUye0aUZXwoZAYoD7rhldWf6ESYZa3JB3nGwiZCAAyQZYBKSacbQpm158rGnFhzKlpUjcaLX5wt/gpFocIfOAeV+JCRVRJKqLOqFpVTklKIKDtz5YYWVNpoHplMs85iEJkTAQJ2e+iYqC6RuEesR9NVka2m25lpfK4V1OMKQLII6yqxGDHABAcgmq+yyyF5wLLPQKnvBq1ooQIH/Xiead5KuuuLKra1l2kHspAQEYO656KZrLrLqtpsuAdRukcA4KShQypyguarns9FC62y//U7rZ7y2leuuu+wejDDBZQSTUwRHqgDOAPQKFU7FJzg3gMEKv8txx+jCO3AfG4PsscnvMkxGAf1oVGiq8jCQ2z30YFyCxh+bnDDK66p8qc+X5gzyzjyLLMdVLERjij9JF6DAOwMoxFCrJODM87pCDw10c1s3l7XCRKNsdIaf2FyCqlYWACkKERQgAXGNrdQhfTgi+vXBYevctRbjKnc3wn8v7KjMRK09AjBxsUCVJYPI3RfdW5Z8dd5aj+xn4OpS3vHYcjzgMANSlgAO/wB4ZXkCUJAcFFJQQ0V8c+SYn3x1AJzj0bd3sYece8h7U5FAVoUeCADTKkBgyQRtj9nVVyhYPfnu59Z+x+3xQU+79bT3DoUCnjsyZgm5AbDbCg9kxUAEV8GFHFh6xo5Bsv8SgEHR2l9B/Y7Waw52/U08QPj5phOBBNCngMcECwaS69j7mDU/sfEvPA8MT/6wJz0YPcJwVVPLAe02uw72zHJ7SKDYKBhBJcyrBQ/wR770hUDsebCCdbgfkibYQRjGgSQowqCW2ufBGpYQQSSj4exsCAccloBOxYJdD4f4wyjIcDZCnFwTj1Go8qHKTDxcIv1AqAcR6oyEDupVoYCFxf8WanGLIZwiFLw4NDDK4R2FqeJGdKgD552xcmkM4hDdCIjG+HGDLmDjHdtFxDeqUTJRROMfHtAIx1DNP0oc5OYOqa3L7dGHgXibBFwGyBYIUpK84+KoEunAQOTEFDrCUxZBKbg8WvJ5mATEABcwgPWp0oysbGUXKTkdUuptDnUKJtWgYwmzQXKVuUxZGmr1rac0E1xp+CTe+IgfMZ7uYp/CZTKVmRp+AUxa3vwm/HjpIl/iERDlMOYxtbnN6JHzBtIEXCy9ZM5J1sFa2SKBexgQwHVysJ2hTE099xfNgeLtnUJw2HvA54ADHMd1hkImQAsZtEsysaAWlWIdEHJK2VT/RTcvU1AkAfpBgWZUkWAyqC7lkJN6jE+fUCkNHeE5UpJStAvxJCQ1y5DTzO0UDqxxgARWZQIOLZSF/yRp9jAKy4uatKkapcMDHpAAegSwRldEaiBdOM+UnrSUTy3aT6thR5sitAY9lV1U6fnVX0qVcL5SQlknelYuqZSQda3OXTOXVx/IjFXw2apSS8pWqKKUp3vl5hxsKZma0pWpYu0qYtt6zvZ8bwUHgEwnYcVVpxY2sp71qmHBCsxXhBQAQHlEP3Mw13be1GuUtWdYRyhZOIykJJgdwExFMDF6pVMujnVtXyXaxtqOIa26M24fINCAy9ZLGcTpCM2kk7HgbvO1/7JKbEA/S9vQyqEf/zgB9wRy2hG0LXTaKMhBHqkb6yYTu3zTrjsh2921tucVoEmAqhxRFBb8VR4QSMncXFI3wQ4WvllAbvTGWrDYEpQOhgEGbN5xvqGEywSNTJ6AH0dg9+YSwdiRL2FFC1r7xiEa05iwJSJg4RbI7CKqZZ2kqkvc6w6XnV9UbhgUjDUdsyEYyWDZL1LovdWSoG0DQDJWtKI29uFYuPTNsXfZJOKl0gFxjCUBXoDHAsQ1BLVtYW97a/zeGye1voelsoMPqogJoHeHT7ZxlIs75eNWGcQ7hgCUdEsCnbBjAqbY7Ap4vEQ8W4HQ+mPzbKVsYjec0rRHXv/ICM4naLl0ttF2XvNKJztat8bBKljNkhFFMGo4n/mxi6YzphsMsgUSIH4N9LQcsHqaKiFNAUQt46mhnOrNMXjH7oNWrCt7w8JIh5GfyIuQdW1gpRpagprG65zlTAcDRAATEnAApUXQNkJlc9fU5i6j05zpA5sZGzfhTCpRi4kVatWTlyY3q0ssb2AP1sqLrcoE+DK+dyChteEmMZpJK3BUh3EdDviev48A8DJPG2y/VlS8CQ4gTJjuHcG0U6WVMnFZc5reFFezue95r/COAI6QZja87/1sKiA64sHpOLHh4LDMRuwdp7CRqZtt1odP08cxZ/m5c8AyU7xUfAX4t4f/WdnyKbwc6BUdOYQBrZOIaUTpZP7w0Dkbbb76nOlbvwHasrLbb/Pc4AVXdb0lLvR7BiPLC3gA0ia1dFA2fT13Drul206HBKy2LREwsj/Pzmtxqz3k5Xa23mtQ6hLoV2YSoMDcd75yqRve11DHqcxlO4d9r2C8jYiAOl1Ud0ne3Yl5/7rdF08DMqKAuQy4MOmzDnbV+zTzsLV8e4TZgskPvvKKt71a1x503e+hdHjBxOhZW/pBnn6Nqe+1w9Ukgbg1omsN17rwk1vneffcDxqPyFM23rzNP/jyEMd9dvneB41TKUflnX2cp4/+n3ff3saHAz5vYV5+igAC23ZL4EZ//2mHeffHdvn3Bq4HY48gELLHfLS3etu3YOoXX+zHUlWhcwDgP9FRdiMQYBPyW042gNonffa3avgXfHRAS5j1gCZQQPAwXaOXfbVngvJ0gMWngnPQAMnGZyegES44AuoACVKzXiNIeAH3cQPncSKng7zibYczVAfRCO5WAuLnODDGYRtRYMD3ffV3gyiIgE4YB6FGAlPoNrUEUSWgABLQABuWhSMAORFoeqyXMdH3hRKoJkfBgkf3g3FkFEihhmM2fyWIh7eHg1E3ho6mEymnG5+ALY33goRAFYawPE3WPM13R8+HSF2nWAVIgAooErx3ctbUAhihPmImPpl4Rpt4GP93+ImFyAe14oFotYpa1Iq91InbBYs1iAiNQX52eIFKOG6I531o9weZFVcRRYi9yIs6VYEJZn6K5gdb5gipKH8k2IzDeHhMmHhe2B6tQQFhcYbKUIUiNYfOV4cmkFauBmvEl4jf+AaNcSoHgESkuEkAED4qx3UJaIzu4mrKMmyc54x0OAdF4j3fMCjKEIQ0hY6aqI43I42b1oTx6AZbBhWSZwKZRTjX2JDMmIeGmI4TeIsQ2Q7LJwLcwxfAuI4SKW02CJIEKZJvBYUoeQD0EmAn6ZHZCJPbmIQUeYxA1YAaNwIHkQpA8Wbvxo+K6I1AyZSFJwdZ9itHMQIquY+D1pL/XveSBamVMkk+tpKTU9BcKJAMJFCVAoiEoPiTT9mTaXkCJhIBPQiWUrCA5yUCB+FcSXmVwqiWPumUfZkCOjEGtzWU/wdXjSB42IiWsciWi8mXbQmY8TcGc9IIH7WSEbmXfvmYKViRKhCYYgAXBxB5gdWFTamR0IR3mOmPf4kCnhkG+HAA6yZXtlhoLRIgpuF0WOmJjKmNmBWZV6A0nFRJO7mViFJXhNZDuOgXubmLLNCaYAA6nzFAo6mUnAlch7ac88WVDwkDzhkcGlQCkXiWpLmWsGKc2Dliu8mTvUkG4OVufWiVe9ePR4ia8imG1cmavikGjABY8MlxqTmfqPef//ZZmvg5BhQAV2PUiJRHnQSKidcpoDl4nz+Yn1VgCfzpIcPZlYFknhAKjw2qkRRKBcKDAvYSEiYnngxKnoPGofUZoR9qhSE6BaGZTyNQcxBjmVVznvi2oQ/aoh6qopA5BspAkyNQdMGJonrpo6/To0upmpo5oWNAFFlVpFRHPCrAPcpHDtgEoEnapFzKiUqae14KpfqJl2dDD2QHK46QDzL4pf4ZpifHomPqokBaoEKioCj5dh15EeMQDFGjXl9GYx9JnDwKbUrKTAxZLDoKX93pBYNJNSeEWnLpGmrzhhnRYQ7JipEjpxIah7aAK4lKLiwHFc+UZD1YqruCBTjynv8oAIiW2hJbOJvIualM2qnryKkTVQEIsKu82qu+igAbkAG/Oqy/WgFqVKL4MiVVciW5Rj4MsADpI2OCqIqZSpJ6gqt16qCG6mwIIADe+q3gGq4CYAEVIK7mKq4IoEY2anXGZo5EKQx8Zol0RIPquaK1+qJLuq021a3naq7k2q8Am65OYKRHZxUNQIukBmmoaJ2D6nykWqregqpRgT8dmq8ut6j8CrDg+q8aa64C2wTAaaX5CJsIq5OKyXS6SqzEWgEpq7LDaqzVU7FVg63XlbEdO67lerPh+rFMMHaXKAJEgS38h6Txya06+627erRIi32LSqv6OlE227Ecq7QCwLP/S4BlreIeRJqXRbuvVJu0X8u0Mhun9+paUauxU6u0VqsEvud49OgN/Vl+LHe2Ggu2aiu2cDqIFzu3Spu2R7u2SZAMcrdGsvpCdBuwhxuweDunt1q2Ndu3ORu2TuAemlUCHHhUC9qlXqu2iduvgOsfTXutjvtenSuufquzn4sECgBoyigBwBOAmdu1UPu1peuxi2urFoubfHu0p3uzqWsEIjEoZhoNSSeWcRuMB1a7O6u8O3u7+Dqzo/thzOutvduxv1sErtCG/ZQTtGSPRPumRsu5VFu1zputgrq3yQu540u+TkAB7voYcLSntVithTa93mq3f1u+q6mt6Bu+Olu9/3V7SO7AHShAAUjJteC7uX9rv/erv096vrqbvrwbuXfrBIwUHYhpduP5uOIruRSbt9T6tGarvuN7vUTAAA21b9NKd/SLnAyMv6jrwB/2sM8Usagaqnq1u/9Lwfk7sOkWo8uYoZr4wgzMvh/sbC3rsr3Kskr8sjLMdPYLwIrrBAvwCQ0QlVjXsENMuyX8xHZHxF0csxK8w+trwkNQVZTZtlksxKyovBbAq0yMABbQw0eswKhbxGZsA8dpuCTswU4At9OpubMrtcM6xzEsxv57x2Fcx4NMxovMBOEZGy3Mx+vrx1Ckw4psyb6BsX1cwdMBxN8rt2NcyYfMyCPcwZ48Q/+YLLU8XMpMsJ+4JZwn+8WknMqXPMq+i8debHpR3Mq+q0YLKJuTXENFXMa77HxgrMnowckTbMxLUrjEXMt0rMq4bL26jMh2zMrO3AQleqIYOsu8LM2ufMuJnMuPTM7ZjLa+bL3AjF+BLLunLM4BjM2NnMm2vMmrrM7bzAQRZpaSrMVtLM/sTM/xbM/TjM713K8csKvByqsacNBKYHKc8c4JnNACja7HvMWoDNHLnM/mutC/+tDjrARwSRKuS5hJQK/hfNGem9EBvdEj3dHVzNJL6wRGpYxJNMxDVMznjM8zjbg9LdPlTNM1HQdYOrgMy8a3yNPKDLoeDdRNrSDMTNT/zesE++eDPKAMrjCVbirKQ03VeYxWU23QMe3UP03TYQ0Eg4K5OdA6ABAM7qrSyEzVGE3QHLzAQW3WX03Uaf0DUqqBLmIYUNNnBEbDzWQA4SROiu0vSdzEjr2yhi2xh53Yi13ZzdLYTRzHj72rFRDZks0tiG3Zoi0tmL3Zpt3ZEovDLWC8syHYhuGpW+jZnz3btF3bth3bt53bur3bECvbvP3bwD3bXIgDF8zWOGCEjHDA0DssJSnMzN0DFhrLO2A8m5QVy/dETtTcKa3da6wDI/oD5eM2u4XdhBsq5s0DPEijzi0K5N1Y570Dwbzd720f3M1wDFOGTUAIJRBgp4Ba/xoIAeKI1FMyIX6nDaeANPyt3ymQ4Gvx3wHetgUuJ4bQGISA4DlnhaGqABMCAZMqAlPlAxGu4UOg4KJjcUWQAFcByiYQ4hl8EqpdPFkCAS3+b6Q6PNcWAQuQCg9QHAdwLUXFAFeBaxSRbPj4ErYgFzVubUmW4x7O4z4OnkCuDUQ1o3nREUYuHq25GJPRIFUyDo2KvZBBdS2QdDEQaDliCGR+A11+ESpeLBPW5mdp5r+jABBQfYeTEa2h5Bv4Gmw+ZrfxF3JefXU+d0hzAHl+bXtOET2xFPKR5aDwAF7hACkOEwFGJ+hDre6gAArwGocCE2MSmE8DE2rcAxTgXFeRQv+iRzq1YABSIn6aQDEUMxLsMCesXueI/gDjQOaA1l8y4Ol9HupR43Kl6HSQYZPDcxkRYMCPND6mIAEAUBUUoW8GMA5JRgjXXezjYOauoewZ0xPN/uyB6RgONe3ig+024OjDMwwUwA0RABkaPg6lrooAqAkf1QB9sjQBBgmInmRE8BmWK+mheRGbxIYcnhNoTunSQPB1juKStwAU0BGBlnReQed2XuY6ke+uAQr87nTDvh4CcuxxShZ1UlQuYxNDjglmceUPqPIg314iH4lGBxPhnmwp//E1gO5mnnRkYS0OoJID0ABxh1rJxuetRwiQAQmSBgBJHwTaLgINRWqD4O3/HZHmaQ6bVdLjnmLmEf/W11blvW70gZn0S79Gbw5BN4LsE+A5kULybNgYio6SOt8igI72al+kbF994d4TBBHCo9EXS5HzIezwbi8+VmII4g7YLxBoBpBC+Wj3Q5Ds4HkTpuCZWw+0vMXkRhcWWj/1w/PwFf71w8P4VE8FMq5lM27fZ9/kArQfZG7opHYZeS8nzv7nmn8TO776ju/6Ld/nnvk7fG8DbS8CHxVoXiE+JuE0GwgJFsdPuGaUjNcRoQkJ4VWPRBCa9IIKFDAMbNjnII/8jW/82pCBzo5aw8MOWz/R2tDhry/w0i8N1D/fyZAMl046rxHLzA77FLEqyWAI/7QPAoAIGEsZKSIUGW0jDoZoHOMhH0y7JMAwjILCIREwMS2AJJOhBzElHhIDywd8MBIJpLLondVIskSr+T2jg8eWA6KILBYTwA3sW7wKIoXJsagN9BmZkNToATQgQaQJ0cyMlfUwTlJWWl5iZmpucnZ+OXqGio6SlpqeoqaqrrIOgbbCxsrO0tba3uLm6u7y9vr+AgcLDxMPJ6SQytQ2SBazMjtHS+9CZx4OXaNmB71Ob3Zzh3mPk4ceTLAkTFCJPCzGOPQ8TDg4KMRQiDS0zB0UDDwwYsDBnALrIliaV++egXyI+NH5FzCBg4YkKNRbVE7IgTBKBqx7AUFChCstlP84mpCPooE5qAZAgPnGgJJ1LQHMVPIgAYUJXQakiIFi0k4KgKikYFlzYI+ODx5Q0LhTYLyNpGJASMAgoIOANDACUEeigQIKfxRIWDQHLQQIBQ6oW6AAQsACXANSMkDW7AG2RnCmdQt35LF8essitDrih4hDBgE4oMDHKJ0UXQtNyPLEDbhRBWg+qdFgQAIJcwP+QQTEgIQBByT0KK1a4CTWrkfTzlLWiL2R9xg0eBDBIQMI9OaaVhyKMYBDjGk8WDC1EB1ljg7sY2BIBMEgzrswum69BnYD2puLoPBihHjlMJQ4FlEHVEzbF2EDoEAzBnhSh0r/wAIEDFAG4ABVgEL/AUIRBMTADwNs80kYDv6ghwQN9AVZSQNIcABzsgmn4Q8dutcJc99Rh11rKY53RA+OHNINinmR1yIP1M1oRx3undiYfDI4MtIcz0kglw8RdHSARqYccsAfHTkRCA1PwkUdYGil8FaStYWhZUc4YcSAAg0leU8XNDhQA5kdIVOiJj1aUcgxtLVXyAAv8GFIUIn1kGN4NYJxJ06pFZDCayK8CKh76gHglo+IGNbPAiKUVIhZCryGTDOlHKJAFoi2hVOhn4ZlJQAsJGZRqX/O4FBTIvwxgAN7xNTFA6zBMCtOS7qJCZzPnYNEotWBwcdAqQVCFhw0oRcnjcQWYqwfgOBx/8dALJaIll6OnZDCGqf2sVoNcCgQXQkuMTnCFiXAhMREXJiaQAEaKeDHArqmAUq9ccxq73qJlFBrEFuNAPACvPaasMKsRLiwww9DHHERDUtcscUXY5yxxhtz3LHHH4Mcssgjk1yyySejnLLKK7PcsssvwxyzzDPTXLPNN+Ocs867JClOAj3P1fOX7mEq9JjrffLCPmEZgJebRVfpBRlOkzL1zrMUkHUBnxqg9VsQek3xOP6E7Y8yX3xGgh4xiVMi2VnjR4Q//RHR9SVsXy1L1vkVMGvXRvUFwQEUFPBkth1lzeZn+g11QEWqpm033g/oBISH9NgTA9XBmE0HA2LitP9PBE0V0AALc+DN9mv/KMnCYXSAtJDmjboGAOWYS3Krqnl7snfnXW9oQ9oK791Y4RIUgNCBMdjVHJB6zK32DHpAyMACWy/AwLzEdH5qAflkH0hx/rR2/c//RASQ9k3fcGDyPmCPvfaCo991kQVIgEjpDnzPe+//XM8rXhPe2XpVPOeJSgZl8QP6Ige9+sWIem9BIITaBozuQYg0pTPC96I3AdahL3p2awcL0lZBCmoJgrDSAwNaA6EC+s8an2na9CzYvYQdcHhpyx4FCAcEB6ZPetI7oQknOIzuRcAu0ZvbEkFoORXqD0NFNIQMKijCCDbHhQCJIScOOL0NaeSGBrz/hg5lgD/sNPB5QeSfAxqgPfhREY7cK5yHCieCFjquAOdDkvnk5aCurcYgZDDIA6aIQsQFcnqQYR3luLgJL6pNa2EQo5tyqIy0FfIzaZRe9ErTt+vJ0ZBH1BoDhhKW60kgIP7QHsH0RxL0ZeZ7WtFkFSc4xSsq8g2spJsje+nLXwIzmMIcJjGLacxjIjOZnkjADx6QlDKpoGdL8glp6CA0hHlML8pEZhJN4ECtBQRsWQMCH7z2Nq3xkmPD2yYx/TEpMKkNLluDH5KU5D0UlOVnTuogNh/muNfZriJkWRxS0jMQdLGTd24pXANc0jVDSHA/i9Bem9hjRIt9sI19g58DvjhEtgUgDyEN2N9jEuq/CSAvawgBHv+UZ87mNOyhGOPfiFiYP5woIG05lYH1RIUvk+4MGXTZW9dMABT4gQd5YVAAMmR6MUA+CIEjKKNU1wlUnb3GKIR7Xtte+IMaFBI4DSBRPDFGuDShY5FGSRNV+eeT/l11ZxBwACuH4lQYeE0JFEhpG2qYMQ5lbVa6xJ9bLqlA/gEnropdLGMb69jHQjaykp0sZStr2ctiNrOa3SxnO+vZz4I2tKIdLWlLFgIAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pooled data demonstrate that improvement in regional left ventricular (LV) function is best predicted by dobutamine echocardiography which had a positive and negative predictive accuracy of 83 and 81 percent, respectively and positron emission tomography (PET) with enhanced fluorodexyglucose (FDG) uptake relative to myocardial blood flow (MBF) which had a positive and negative predictive accuracies of 82 and 83 percent, respectively. In contrast, the postive and negative predictive accuracies with thallium single photon emission computed tomography (SPECT) are 69 and 90 percent, respectively.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Bonow RO. Circulation 1996; 94:2674.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_39_17022=[""].join("\n");
var outline_f16_39_17022=null;
var title_f16_39_17023="Growth puberty chart in boys";
var content_f16_39_17023=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F74388&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F74388&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Growth and pubertal development in boys",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 334px; height: 350px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Longitudinal standards for height and pubertal development in boys. The units for penis stage and pubic hair growth range from 2+ to 5+ and for testes volume from 4 mL to 12 mL. Each tick on the lines of pubertal development represents a percentile ranging from 97th to the 3rd percentile.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.&nbsp;Arch Dis Child 1976; 51:170.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_39_17023=[""].join("\n");
var outline_f16_39_17023=null;
